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Tricuspid regurgitation (TR), back flow of blood from the right ventricle to the 
right atrium, has been reported in approximately 85% of the population, with 16% having 
mild or severe TR. Patients with untreated moderate to severe TR are likely to experience 
decreased exercise capacity and have increased morbidity and mortality, thus affecting 
the patient’s quality of life. Current methods of repair offer limited rates of success, and 
many patients require further operations to correct returning levels of TR.  Incomplete 
repair may be due to incomplete understanding of the functional anatomy and mechanics 
of the TV and the underlying causes of TR.  
It was hypothesized that alterations in the geometry of tricuspid valve annular 
and subvalvular apparatus induced by ventricular dilatation determine the severity 
of TR. In vivo measurements of papillary muscle (PM) position in patients with single or 
biventricular dilatation revealed PM displacement away from the center of the annulus as 
compared to control patients. Additionally, pulmonary arterial pressure, annulus area, 
ventricular size and apical displacement of the anterior PM were highly correlated with 
the severity of TR. An in vitro right-heart simulator was developed to investigate isolated 
mechanics of TR. Through these in vitro studies it was demonstrated that the tricuspid 
valve begins to leak at only 40% dilation, much lower than the mitral valve. Additionally, 
it was shown that isolated PM displacement resulted in significant TR. The highest levels 
of TR were achieved with a combination of annular dilatation and PM displacement. 
Alterations in leaflet coaptation, as quantified by measuring the amount of leaflet 





PM displacement, both isolated and combined. The changes in leaflet coaptation resulted 
in redistribution of the forces on the chords originating from the anterior PM and 
inserting into the anterior and posterior leaflets.  
The findings herein provide the clinical and scientific community with a 
mechanistic understanding of the tricuspid valve to further improve intervention and 





Tricuspid regurgitation (TR), back flow of blood from the right ventricle to the 
right atrium through the tricuspid valve (TV), a once ignored disease, has been rapidly 
gaining interest of clinicians in the cardiovascular field1, 2. If left untreated, TR can 
worsen over time and have detrimental effects on morbidity and mortality1, 3.  As with 
any new treatment, the specific surgical repair techniques and replacement valve design 
specifications  for TR therapies remains controversial and is often only done in 
conjunction with other valve repairs3, 4 2.  
 Functional tricuspid valve regurgitation (TR) is increasingly recognized as a 
source of morbidity in patients with severe left sided valvular heart disease, particularly 
those with chronic mitral valve regurgitation5, 6. Early investigators believed functional 
TR would resolve after surgical correction of left sided valve disease7 and did not 
advocate concomitant tricuspid surgery. As it was recognized that severe TR often 
persisted despite corrective, left-sided valve surgery8, and that reoperation for severe 
functional TR was perilous, interest grew in simultaneously repair of the tricuspid valve 
along with the mitral valve.  Tricuspid valve dilatation was soon thereafter recognized as 
the primary mechanism of functional TR and remodeling annuloplasty with a prosthetic 
ring, became the treatment of choice for most surgeons9-11.  More recent studies have 
further clarified the role of annular dilatation centered around the right ventricular free 
wall portion of the tricuspid annulus as the primary lesion 12, 13 and thus target of 
remodeling strategies, and American and European Guidelines recommend concomitant 
1 
 
annular remodeling for severe annular dilatation or for moderated to severe TR in 
patients undergoing left-sided valve surgery 14, 15.   
 Currently, treatment options are limited for correction of TR. Past research has 
focused primarily on the mitral and aortic valves, and as a result, the mechanisms which 
are responsible for TR have yet to be elucidated and remain understudied. Though TV 
repairs have been attempted, 30% of current repairs fail, requiring patients to return to the 
operating room16. This recurrent TR is likely due to an incomplete understanding of the 
tricuspid valve apparatus and alterations associated with different diseases. While it is 
widely accepted that annular dilatation9, 17 and pulmonary hypertension18, 19 contribute to 
TR, it is uncertain as to which other factors which may be involved and the relative 
contribution of these factors to disease progression. Previous studies have identified 
changes in ventricular geometry as well as papillary muscle (PM) displacement as 
contributing factors to TR. As a result of PM displacement, the valve leaflets may 
become tethered, thus restricting the motion and preventing proper coaptation. Leaflet 
tethering itself may be used as a predictor of TR20-22. Additionally, changes in the 
ventricle geometry may directly affect the PMs as they are directly connected to the 
ventricular wall.  It is believed that RV dilatation may result in displacement of the 
anterior PM (APM)23, 24, while another study reported displacement of the septal PM 
(SPM) towards the center of the RV with LV dilatation 25. However, these prior studies 
were unable to directly correlate these finding to the magnitude of TR. 
 Though numerous studies have been conducted to understand the normal and 
disease mitral valve (MV), studies on the mechanics of the TV are lacking. Perhaps an 
oversimplification of the relationship between the valves is responsible for the direct use 
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of MV repair techniques to TV disease. While various aspects of the two valves are 
certain to overlap, the difference in valve structure warrants studies specifically 
investigating the TV. Efforts to provide a better understanding of the valve have been 
ongoing 12, 17, 21, 23, 26, but have mostly been conducted in vivo, which often restrict the 
ability to complete a detailed mechanistic investigation of the valve under both normal 
and disease conditions.  
  Interestingly functional mitral regurgitation has been much more carefully 
studied on the lab bench and by imaging techniques and is recognized to involve 
primarily posterior papillary muscle displacement, leading to leaflet tethering and a 
compromised zone of leaflet coaptation 27. It is generally accepted that with annular 
dilatation, TR will occur 21, 22, 28 but the mechanism by which this occurs has yet to be 
demonstrated.  As in functional mitral regurgitation, another possible mechanism for TR 
is papillary muscle (PM) displacement, which may result from right ventricular 
dilatation. The role of PM displacement is much less well defined in functional TR, and 
this may have important clinical implications. It is possible one of the mechanisms of 
recurrent TR after tricuspid valve repair with an annuloplasty ring, which occurs in up to 
30 percent of patients16, is failure to address the leaflet tethering, due to PM 
displacement. Understanding the mechanisms of TR will lead to improved diagnosis and 
treatment. 
 With displacement of the PMs the chords become tethered and the leaflets lose 
the ability to move freely and properly coapt. While leaflet tethering has been observed 
clinically it is not clear as to what actually causes the tethering whether it is due to 
annular dilatation or PM displacement or a combination of the two. Along with leaflet 
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mobility, chordal forces may also be affected by these disease conditions, as they are an 
integral part of the system. If a chord’s force is significantly increased it may become 
elongated or in extreme cases rupture, both of which would be detrimental to proper 
valve function. By investigating chordal forces we can begin to identify which chords 
may be responsible for certain types of tethering.  We believe that disease conditions may 
lead to restricted leaflet mobility thereby altering the chordal forces. It is important to 
understand these interactions to provide surgeons with sufficient information to make 
appropriate repairs, which aim to restore the valve to its normal state. Through this study 
we intend to provide a more complete picture of how disease alters TV annular and sub 
valvular geometry, thus affecting leaflet mobility and changing the force distribution on 
the tendinous chords. 
 In general the extreme lack of data and general understanding of the tricuspid 
valve warrants a thorough investigation. While clinical data has been analyzed they are 
often retrospective in nature. Carefully designed studies which aim to understand certain 
aspects of TV disease are therefore necessary. These sentiments have been shared both in 
literature and again and again at clinical conferences. The clinicians are inquiring for data 
to assist in their understanding and to aid in their development of tricuspid valve specific 
treatments.  
 The overall goal of this thesis was to understand the mechanisms which cause TR 
and specifically the impact of ventricular dilatation on the severity of TR.  It is 
hypothesized that ventricular dilatation can affect TR in three ways, by dilating the 
annulus, displacing the PMs and a combination of both. Specific aims 1 through 3 will 
help to understand how changes in ventricular dilatation lead to changes in PM position 
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and annulus size, which affect chordal forces, thus altering leaflet mobility and causing 
improper leaflet coaptation and finally resulting in TR.  
 This will be achieved by first identifying geometrical changes induced by 
dilatation of the ventricles in vivo. In specific aim 1 the degree of PM displacement for 
each PM with respect to RV dilatation, LV dilatation and combined RV/LV dilatation 
will be determined.  In addition to determining PM position the correlation between the 
degrees of ventricular dilatation to the severity of TR will be determined. The next step is 
to understand the underlying mechanisms involved in the development of TR due to 
annular and sub-valvular geometric alterations. In specific aim 2, isolated annular 
dilatation with normal PM position and isolated PM displacement with normal annular 
size in vitro will be investigated. The effects of these perturbations on chordal stresses, 
leaflet mobility, leaflet coaptation and severity of TR will be explored. In specific aim 3 
combined annular dilatation and PM displacement in vitro will be investigated. As in 
specific aim 2, the effect of dilating the annulus and PM displacement on chordal 
stresses, leaflet mobility, leaflet coaptation and finally severity of TR will be 
investigated. The information on the effects of isolated and combined annular dilatation 
and PM displacement from specific aims 2 and 3 will be compared to help propose an 
integrated mechanism explaining the impact of ventricular dilatation on the severity of 
TR.  
 Although some information as to the impact of ventricular dilatation on the 
severity of TR can be provided by in vivo studies, in vitro studies allow detailed 
investigation into the underlying mechanisms. In vitro experimentation allows for precise 
5 
 
control over annular size and PM position, allowing for isolated cases and specific 






2.1 Tricuspid Valve (TV) Anatomy 
 The tricuspid valve is one of the two atrioventricular valves which separate the 
atrium from the ventricle. The tricuspid valve is located on the right side of the heart 
between the right atrium and right ventricle. The valve operates under much lower 
pressures than the left side of the heart with a peak systolic pressure of only 40 mmHg as 
compared to 120 mmHg. The valve consists of valvular, leaflets and an annulus, as well 
as subvalvular components, tendinous chords and papillary muscles (PM) (Fig 2.1). 
 
Figure 2.1: Right Heart Anatomy, showing location of tricuspid valve, annulus, 
leaflets, chordae tendineae and papillary muscles. (Modified from Carpentier’s 
Reconstructive Valve Surgery) 
 The purpose of the TV is to prevent backflow of blood from the right ventricle to 
the right atrium during systole and also allow optimal ventricular filling during diastole.  
A normal functioning valve opens during diastole and allows the blood to flow from the 
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right atrium and fill the right ventricle. During systole the ventricle contracts and the 
pressure raises closing the valve and preventing backflow. Proper closure is obtained 
through coaptation of the leaflets, which is achieved through the combination of all the 
components of the valve working together. The PMs and chords work together to prevent 
the leaflets from prolapsing into the atrium during systole and thus proper coaptation 
geometry and position are achieved. 
2.1.1 Annulus 
 The annulus is a fibrous ring located on the perimeter of the valve and connects 
the leaflets to the myocardial wall. The annulus has a complex 3D geometry as seen in 
figure 2.2 29-36. While some studies have reported the annulus to be oval 29, 37, others 
report that  it is triangular 32.  Studies have shown this to be a dynamic structure which 
contracts during systole and expands during diastole 33, 34, 38. Annulus areas range from 
7.6 to 11.2 cm2 during systole and 11.3 to 18.35 cm2 during diastole 34, 37, 38.The tricuspid 
valve annulus area significantly increases from early to late systole in healthy subjects by 
5.4 ± 1.6 % 34 and experiences differences ranging from 28% to 48% from its minimum 
to maximum area throughput the cardiac cycle 33, 36, 38.  The area of the TV annulus is at 
its maximum during diastole increasing the efficiency of filling by providing a larger 
orifice 36 and minimum during systole aiding coaptation of the leaflets.  In addition to 
changes in area throughout the cardiac cycle, the annulus changes its shape as well. The 
annulus of the TV has a 3 dimensional saddle 33-35, as seen in Figure 2.2,  with the 





Figure 2.2: Results from an in vivo sonomicrometry study on sheep show the 
clockwise rotation motion of the papillary muscles over the cardiac cycle 36. 
 
2.1.2 Leaflets  
The three leaflets are named according to their position in the heart: anterior, 
posterior and septal leaflet. The septal leaflet is located along the septal wall and is 
attached to the wall with short chordae 32. The anterior and posterior leaflets are located 
along the free wall with the anterior leaflet reported to be the largest 37, 39, 40. While it is 
typically accepted that the TV has three main leaflets, numerous studies have reported 
there to be a variable number of leaflets ranging from 2 up to 7 leaflets 32, 41. The septal 









The chords are made predominately of collagen 6  which attach the leaflets to the 
PMs. Each PM has several chords which attach to the two corresponding leaflets, for 
example the anterior PM has chords that insert into the anterior and posterior leaflets.  
Chords are classified based upon their insertion location into the leaflet with four 
categories: marginal/primary, inserting into the free edge of the leaflet, 
rough/supplemental, inserting between the marginal and intermediate chords, 
intermediate/secondary, inserting into the belly of the leaflet and basal chords, inserting 
near the annulus32. Silver et al report the deep/strut chordae to be the longest (1.7 ± 0.4 
cm). All chords have similar thickness ranging from 0.8 ± 0.3 cm to 1.1 ±  0.4 cm 32.  
2.1.4 Papillary Muscles (PM):  
 The PMs connect the leaflets to the ventricle wall through the chords and directly 
relate the TV to ventricle function. The PMs on the right side of the hearts are not as well 
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defined as those seen on the left side of the heart as with the mitral valve 42. There are 
three main PM groups which are named according to their location in the ventricle: 
anterior, posterior and septal.  The septal papillary muscle is located on the anterior side 
of the septum between the septal and anterior leaflets, while the posterior PM is located 
on the posterior side between the septal and posterior leaflets. The anterior PM is located 
on the free wall between the anterior and posterior leaflets.  The anterior PM the most 
well defined with one main PM head 42, 43.  The posterior PM often has multiple heads, 
while the septal PM is often fused to the wall with no protruding PM head 42. In human 
patients a moderator band has been reported which connects the septal wall to the free 
wall, but its function is unknown. The PMs are classified into three groups based upon 
structure: finger-like, with the muscle protruding, tethered, with the muscle imbedded in 
the wall, and vestigial with the chords attaching directly to the well 42 (Fig. 2.4).   
 
Figure 2.4: Classification of the three groups of papillary muscles: F-Finger-like, T-
Tethered, and V-Vestigial.  As classified using excised porcine hearts by Joudinaud 
in 2006 42. 
Juaon et. al. studied the dynamics of the three PMs of the right side of heart 36 
during the cardiac cycle and found that the PMs move in a clockwise manner during 
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systole. The anterior PM experiences the greatest movement during the cardiac cycle, due 
to the contraction of the myocardium since the PM is located on the free wall.  The 
motion of the PMs has been observed to twist, shift, and bend in relation to the annulus 
plane, while the distance from the PMs to the annulus plane remains relatively constant 
36. 
2.2 Disease of the Tricuspid Valve and Treatment 
 When the valve fails to coapt properly regurgitation of blood may occur. TR is the 
back flow of blood from the right atrium to the right ventricle. TR was initially thought of 
as benign, but has recently been shown to have a significant impact on morbidity and 
mortality 1. Uncorrected significant TR can adversely affect durability of left heart repairs 
and is associated with poor survival in severe cases 24 3. Symptoms are often nonspecific, 
but may include fatigue and reduced exercise capacity 1, 2. Additionally they may also 
experience symptoms associated with right heart failure such as ascites, congestive 
hepatopathy, peripheral edema, decreased appetite, and abdominal fullness2. 
 If left untreated TR may become worse over time and eventually lead to death11. 
A retrospective study performed by Nath et al. in 5223 patients found there to be a worse 





Figure 2.5: Kaplan-Meier survival curves for patients with and without tricuspid 
regurgitation. Patients with moderate and severe TR had significant worse survival 
rates (Nath et al. 2004). 
 
 In addition, patients with higher levels of TR also have worse outcomes after 
tricuspid valve repair. It is believed that if treatment for TR is to be preformed it should 
be conducted sooner rather than later45, 46.  A recent study by Topilsky et al. analyzed 189 
patients after tricuspid valve replacement and found late mortality to be associated with 




Figure 2.6: Observed postoperative survival for patients operated on for severe 
tricuspid regurgitation with minimal symptoms (New York Heart Association 
[NYHA] class II, red line), intermediate symptoms (NYHA class III, green line) or 
severe symptoms (NYHA class IV, blue line) before surgery. Compared with 
patients with preoperative NYHA class II or III, those with NYHA class IV heart 
failure incur considerable excess postoperative mortality. The dashed line 
represents the expected survival. Even those with minimal symptoms (NYHA class 
II) incurred excess long-term mortality compared with the expected mortality 
(Topilsky et al. 2011). 
 
2.2.1 Diagnosis: 
 The amount of tricuspid regurgitation is classified similar to the mitral valve with 
the use of color Doppler visualization of the jet in the four chamber view.  Quantitative 
measurements of the regurgitant volume are obtained with the proximal isovelocity 
surface area (PISA) method. There are four different grade classifications: trace (1+), 
mild (2+), moderate (3+) and severe. Images of the various TV regurgitation volumes 
have been measured using color Doppler 47 and are shown in figure 2.7. In addition, 
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echocardiographic studies typically report a central jet, as seen in the apical 4 chamber 
view 47. 
 
Figure 2.7: Color Doppler images of various degrees of tricuspid regurgitation.  A 
clear increase in the jet can be seen from trace (1+) to severe (4+) (Bajzer et al. 
2008).  
 
2.2.2 Prevalence:  
 TR is typically found in 82% of men and 86% of women (US population), of 
which 15% of men and 19% of women have mild to severe TR , as was determined in a 
population-based cohort study of patients attending routine examination at the 
Framingham Study48. The prevalence of TR of more than or equal mild increases with 
age, independent of sex48. 
2.2.3 Cause:  
 TR is more commonly functional rather than organic49, 50 in that the regurgitation 
is secondary to another mechanism and not due to disease of the leaflets. These other 
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mechanisms can include, but are not limited to changes in preload, after load and RV 
function 9, 16. The amount of TR varies with the mechanisms.  Although there are various 
indicators for TR, various arguments exist as to which is the key contributor. Dreyfus 
believes that the annulus and RV must be dilated in order to leak 9, while Matsuyama and 
Abe agree with RV dilatation, but also believe it to be associated with pulmonary 
hypertension 50, 51. It is also believed that TR occurs in conjunction with left side heart 
disease and ventricular dysfunction 33. Visualization of TR for various patient etiologies 
is shown in the below figure (2.8). 
 
Figure 2.8: Echocardiographic appearance of tricuspid regurgitation (TR) from 
various pathologies. (A) Left ventricular (LV) dysfunction with mitral regurgitation 
and left atrial (LA) enlargement, with secondary right heart enlargement (mild TR). 
(B) An RV pacemaker lead present(arrow) (mild TR). (D) Cardiac contusion from 
motor vehicle accident with anterior papillary muscle rupture. The papillary muscle 
can be seen prolapsing into the RA with systole (arrow), resulting in torrential TR 





2.2.3.1 Pacing Leads: 
 One of the most common causes of TR is the presence of a pacemaker or 
defibrillator lead, as the lead passes through the TV and attaches to the ventricle. The 
leads may restrict the motion of the leaflets by pressing the leaflet again the wall. The 
leads themselves may also puncture the leaflets or become entangled in chords. Many 
studies have shown pacing leads to be responsible for TR and if not removed at the time 
of tricuspid valve repair result in residual TR11 (Fig 2.9). An echocardiograph study by 
Kim et al. of pre and post implantable pacemaker or defibrillator patients found the grade 
of TR to be worsened by a grade of 1 or more with lead placement through the TV52.  
 
Figure 2.9: Influence of preoperative permanent pacemaker on evolution of 
postoperative 3_ and 4_ tricuspid regurgitation. Open circles _ pacemaker; solid 
circles_ no pacemaker. PPM, Permanent pacemaker; TR, tricuspid regurgitation 
(McCarthy et al. 2004). 
 
2.2.3.2 Ventricle Dilatation: 
 One of the proposed mechanisms of TR is caused by dilation of the right 
ventricle.  Since the valve apparatus is part of the ventricle with its PMs attached directly 
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to the ventricular wall and its annulus located in the wall between the atrium and 
ventricle, changes in the ventricle are directly transferred to the valve apparatus.  The 
dilatation of the right ventricle has detrimental effects on the mechanics of the tricuspid 
valve.  One of these includes less-than-normal systolic reduction in annulus 38 which is 
caused by the decrease in right ventricular function. This RV enlargement also causes 
tricuspid annulus deformations and displacement of PMs 17, 18, 28, 33, 38, 53, 54, which also 
play a role in TR.  It has also been reported that with RV systolic “failure” diastolic 
pressure rises, increasing pulmonary pressure and moving the septum towards the left 
side 3. In addition, dilatation of the left ventricle may affect proper closure of the valve. It 
is possible for the septal and posterior PMs to be affected by LV dilation since the two 
ventricles are connected, but has yet to be identified.  Studies have shown that PM 
position effects TR, but the specifics of which PMs are displaced with specific etiologies, 
the direction of displacement, and how much they are displaced is speculative and 
controversial. 
2.2.3.3 Annular Dilatation: 
Recently most of the focus has been directed at investigating how the annulus 
dilates in the diseased condition.   Many believe annular dilation to be the key contributor 
to TR. Human clinical studies have reported that the tricuspid annulus is significantly 
larger in patients with TR as compared to normal subjects 38 and found the diameter in 
fact to be two times the size, measuring 35 mm and 70 mm respectively.  Studies may 
have focused on annular dilatation because it is believed to be a better indicator of TV 
pathology then TR 9 since patients with no TR initially and a dilated annulus developed 
TR.  This same study also reports that annular dilatation may not always result in TR, and 
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may be dependent on other factors 9. It is believed that without dilatation there is a low 
probability that the valve will leak 9. It is important to note that it is believed that only the 
anterior and posterior segments of the annulus can dilate, since on they are the only 
segments on the free wall 9.  This is best illustrated in figure 2.10.  
 
Figure 2.10:  This figure demonstrates the free wall dilatation which results in an 
increase in annulus area along the anterior and posterior regions.  
It is important to investigate this further and in more detail as this is essential to 
understanding the mechanics of TR and how to repair it. Once the annulus becomes 
dilated it cannot return to original size and may continue to dilate 9. 
 It is not just the increase in annulus size which is believed to cause TR, but the 
loss of the dynamic function of the annulus. The loss of systolic annular contraction in 
TR patients may be an important pathogenesis 38, 51.  In normal patients the annulus 
decreases in area during systole to further prevent regurgitation, but this change from 
diastole to systole is lost in patients with TR, and their annulus reflects a size more 
favorable to diastolic filling.  Numerous studies have investigated the loss of dynamic 
annulus area during the cardiac cycle38 33. 
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 Although it is know that TR occurs with annular dilatation it is not know at which 
amount of dilatation TR begins.  A clinical study reported by Ubago, reported this size to 
be between max diameter of rheumatic without TR and minimum with moderate to 
severe TR.  This threshold is reported to be 27 mm/m2 17.  It is important to know this 
threshold as to determine a preferential annulus size for patients, so if a repair is to be 
performed there is a specific goal.  Also it is important to understand why the threshold is 
what it is.  It may be due to the geometry and excess leaflet tissue which can only overlap 
and coapt up to a certain point, or it may have to do with the change in 3D geometry of 
the annulus, or most likely a combination of the two. 
2.2.3.4 PM Displacement and Leaflet Tethering: 
 Another effect of right ventricular dilation is papillary muscle displacement which 
leads to leaflet tethering 20 and possibly leaflet prolapse depending on the type of 
dilatation.  Restoration of the annulus to its original size does not always eliminate TR 
completely after repair and may allow for TR to return26, 33, thus reducing the annulus 
may not be enough to correct TR 26, 55. Thus additional mechanisms have been 
investigated, specifically the effects of PM displacement. TV tethering has been shown to 
be an independent predictor of TR after TV annuloplasty 26, 55 and may indicate PM 
displacement as another factor in TR. A study by Min et al. repaired TR with the use of 
an annuloplasty and found preoperative tenting volume to be a predictor of residual TR. 
Additionally, the reported that will most geometric parameters were decreased with ring 
implantation leaflet tethering angle increased56. This shows that PM displacement may be 
responsible for TR and if the PM displacement is not corrected tethering will persist even 
in the presence of annuloplasty repair. 
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 It may be a combination of these factors: annular dilatation and PM displacement 
in conjunction with nonspecific designed devices which do not adequately correct TR. It 
is our incomplete understanding of the normal and diseased anatomy of the valvular and 
subvalvular components of the tricuspid valve which do not allow us to completely repair 
the valve and remove all current and possibility for recurrent TR.   
2.2.4 Treatment and Repair:  
 Current treatment includes repairs, such as an annuloplasty, which reduces the 
annulus to its original size, and complete valve replacement.  Annular repairs include 
various rings, as well as a De Vega annuloplasty which uses a suture to cinch the size of 
the annulus. Annulus cinching has also been conducted by creating a bicuspidization in 
which the posterior annular section and leaflet are brought together by sutures. These 
techniques are shown below in figure 2.11. 
 
 
Figure 2.11: The main surgical approaches for correcting functional TR in the 
presence of a dilated annulus are shown. (A) Dilated tricuspid annulus (B) Rigid or 
flexible annular bands are used to restore a more normal annular size and shape 
(ovoid), thereby reducing or eliminating TR. The open ring shown spares the 
atrioventricular node (AVN), thus reducing the incidence of heart block. (C) 
DeVega–style suture annuloplasty in which a purse-string suture technique is used 
to partially plicate the annulus and reduce annular circumference and diameter. (D) 
Suture bicuspidization is performed by placement of a mattress suture from the 
anteroposterior to the posteroseptal commissures along the posterior annulus. CS 
indicates coronary sinus (Rogers and Bolling 2009). 
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 Most current repair procedures focus solely on the annular apparatus, while 
numerous studies have suggested that repairing the annulus may not be enough 26, 33, 55. 
As tethering of the leaflets are becoming a more widely accepted mechanism of TR and 
are a predictor of residual TR, methods have been developed to address this. Anterior 
leaflet augmentation, a recent surgical technique to reduce leaflet tethering has been 
introduced by Dreyfus et al. In addition to the placement of an annuloplasty ring, this 
technique uses a pericardial patch to extend the surface of the anterior leaflet and provide 
for addition leaflet for coaptation (Fig. 2.12)57.  
 
Figure 2.12: Schematic diagrams demonstrating tricuspid leaflet augmentation: (a) 
anterior leaflet detached from the tricuspid annulus; (b) autologous pericardial 
patch sewn onto the tricuspid annulus and the detached anterior leaflet. AL, 
anterior leaflet; PL, posterior leaflet; SL, septal leaflet (Dreyfus et al. 2008). 
 
 Although, recent trends are towards repairing the valve there are only a small 
number of devices and repairs are designed specifically for the TV, and operations to 
treat returning levels of TR are often required 33. Until recently repair of TR was 
conservative as surgeons believed it would be relived with repair of the left side disease7. 
More recent studies have shown excellent results with repair of TR at the time of MV 
repair 8, 9, 49. Many questions remain surrounding the repair of the tricuspid valve such as 
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the optimal timing of replacement, the choice of repair, and the prediction of TR after 
MV repair 3.   
 To provide solutions to annular and subvalvular problems associated with TR, we 
must first understand the mechanisms that lead to TR. If we can determine the 
independent and combined role of annular and subvalvular alterations, then specific 
devices and repairs can be developed to restore the valve back to its native geometry. 
This study will provide some of the missing scientific knowledge into how the tricuspid 
valve achieves proper coaptation and how it is affected by various diseases which result 






HYPOTHESIS AND SPECIFIC AIMS 
 
 Tricuspid regurgitation (TR), back flow of blood from the right ventricle to the 
right atrium, has been reported in approximately 85% of the population, with 16% having 
clinically severe (mild or severe) TR48. Out of this population, 8,000 per year are treated 
8, 58, either with complete valve replacement or with repair such as an annuloplasty, which 
reduces the size of the valve annulus to its physiological size. If left untreated, patients 
with moderate to severe TR have increased morbidity and mortality16, 39, 50 and may 
experience decreased exercise capacity, thus affecting the patients’ quality of life. It has 
also been shown that TR may affect the durability of mitral valve repairs3, 24. Though TR 
was previously thought to be benign, recent studies showing the role of correcting TR 
with an improved patient outcome have increased interest in TR1, 2. Although current 
practice repairs the valve and corrects the TR, there are a limited number of devices and 
procedures which are specific to the tricuspid valve (TV), and those that do exist are 
often adapted from the mitral valve. These current methods of repair offer limited 
success, with many patients requiring further operations due to reoccurrence of TR 47. 
The presence of unsuccessful repairs may be due to incomplete understanding of the 
functional anatomy and mechanics of the TV and the underlying cause of TR. Although 
current scientific information is lacking, current studies have begun to provide insight 
into the cause of TR. While studies have associated TR with annular dilatation, they have 
found that repairing the annulus alone may not eliminate TR completely, and in many 
cases TR returns26, 33. Additional studies have pointed to annular dilatation combined 
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with papillary muscle (PM) displacement and have shown that TV tethering, or 
restriction of leaflet mobility caused by PM displacement, is an independent predictor of 
TR after tricuspid valve annuloplasty 26, 55. These studies provide insight into a possible 
mechanism, but do not completely explain the role of the leaflets, chordae tendineae, and 
papillary muscles in providing proper coaptation, or how the valve and subvalvular 
apparatus are altered in disease. The amount of PM displacement in patients with TR has 
yet to be quantified nor related to the severity of TR. In addition, the independent and 
combined effects of annular dilatation and PM displacement on the severity of TR have 
not been investigated. This study seeks to understand how the valvular and subvalvular 
apparatus work together to provide proper coaptation and how alterations in the normal 
function of these components lead to regurgitation.  
 The overall hypothesis of this proposal is alterations in the geometry of 
tricuspid valve annular and subvalvular apparatus induced by ventricular 
dilatation alter the function of the valve and impact the severity of TR. The objective 
of this study is to clearly delineate the geometric alterations of the tricuspid valve that 
cause TR and correlate such alterations with different disease conditions which occur 
with tricuspid regurgitation. In addition to quantifying the relationship between annulus, 
papillary muscles, and the ventricles in healthy and diseased humans, the impact of each 
geometric change on tricuspid valve function will be understood in an in-vitro right heart 
simulator. The in-vitro methodology allows for precise control over the tricuspid valve 
geometry and allows for measurement of specific hemodynamic and mechanicistic 
parameters that could potentially aid in elucidating the underlying causes of TR in 
different disease etiologies. Insight to the underlying causes of TR will help both 
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physicians and biomedical engineers to make more educated decisions for repair 
strategies and device development. 
Specific Aim 1: Measure the change of PM position and annular size due to ventricle 
dilatation in vivo and quantify the impact of ventricular size/shape on tricuspid 
valve function. These aim measures, in vivo, the effects of ventricular dilatation on PM 
position and annular size, and uses 3D echocardiography to quantify PM position 
inhuman patients. Both RV and LV size will be correlated with the severity of TR and 
alteration in valve geometry. 
Specific Aim 2: Elucidate the effect of isolated annular dilatation and PM 
displacement on tricuspid valve function and mechanics. The impact of isolated 
annular dilatation and PM displacement on coaptation geometry and chordal forces of the 
tricuspid valve within a physiological in vitro environment will be investigated using 
porcine tricuspid valves. This aim should provide an in depth understanding of the 
independent mechanisms and their effect on TR. 
Specific Aim 3: Determine the effect of combined annular dilatation and PM 
displacement on tricuspid valve function and mechanics. Changes in coaptation 
geometry and chordal forces of the tricuspid valve with combined annular dilatation and 
PM displacement within a physiological in vitro mechanical environment using porcine 
valves will be measured. By simulating combined annular dilatation and PM 
displacement we gain an understanding of these effects on the severity of TR. In addition, 
an understanding of the combined effects in comparison to isolated cases on alterations in 






4.1 In Vivo 
3D echocardiography was used to make anatomical cardiac measurements in vivo. 
The following section describes in detail the machine and post processing software used 
to complete this. 
4.1.1 GE Echo Machine 
All images were acquired using a GE Vivid 7® (GE Healthcare, Wauwatosa, WI) 
ultrasound system with a 4V-D probe. Routine transthoracic exams were conducted on 
patients with the addition of 3D images of the right ventricle (RV).  Views which were 
acquired for measurements included: 3D full volume, 4-chamber (black and white and 
color Doppler) and inferior vena cava (IVC).  3D full volume echo images were acquired 
with the probe positioned apically to focus on the RV. A 4-chamber view was used to 
determine end diastolic area (EDA) for both the RV and left ventricle (LV). The grade of 
TR was assessed using color Doppler, graded from trace to severe based upon the size of 
the jet area in relation to the area of the right atrium. Pulmonary arterial (PA) pressure 
was determined using a standard clinical method, that is using the modified Bernoulli’s 






4.1.2 GE EchoPAC 
GE EchoPAC® (GE Healthcare, Wauwatosa, WI) was used to interrogate the 3D 
RV volume with 2D slices along the apical 4-chamber and parasternal short axis views 
(Fig. 1) to measure: Annular area, distance from the tricuspid valve annulus plane and 
each of the three RV PM tips, and the position of the PM tips with respect to the center of 
the annulus. The slice option in GE EchoPAC was used to manipulate the 2D planes 




Figure 4.1: Screenshot of GE EchoPac in which three slices of the original 3D echo 






4.2 In Vitro 
In this section the various components needed to investigate the effect of annular 
and subvalvular alteration on TR in vitro are presented. Including in this section is the 
model which was developed and used and measurement techniques. 
4.2.1 Tricuspid Valve Selection 
Due to the difficulty of obtaining numerous human TVs, porcine valves were used 
as they have been reported to have similar anatomy to humans43. A further detailed 
geometrical comparison between these two valve types can be found in Appendix A. 
Porcine hearts were acquired from a local abattoir (Holifield Farms, Covington, GA) and 
transported to the lab in a cooler. A selection criteria form was completed for each valve. 
A combination of qualitative and quantitative metrics was used for valve selection. 
Appropriate PMs and relative size of leaflets was identified using quantitative means. 
Annulus segments and leaflets lengths were measured and accepted if they fell within a 
specific range. See appendix B for specific values and selection form. Valves with an 
annular area of 6 cm2 were selected by measuring the annulus of the pressurized heart33, 
38. In addition the annular perimeter and segment length of the septal and combined 
anterior/posterior section was measured and compared to reported values for humans33, 38. 
The intact leaflet height and width were then measured with the use of a flexible ruler to 
confirm appropriate size, as previously reported for human valves22, 32, 40. The selection 
criteria for these measurements were determined from the average of the reported values 
in literature. Further selection criteria was based upon chordal insertions and three 
distinct PM groups (anterior, posterior and septal), to allow for placement in the 
simulator. Selected valves were excised with the annulus, leaflets, chords and PMs intact.  
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4.2.2 In Vitro Flow Loop 
Experiments were conducted in an in vitro right heart simulator. The right heart 
simulator was designed based upon the Georgia Tech left heart simulator, which has been 
widely used to conduct studies on native mitral valves59, 60.  Adjustments were made to 
accommodate for the lower pressures on the right side of the heart and the difference in 
valve anatomy: an additional PM holder and a TV specific annulus plate. In order to 
reduce the resistance to flow, a large compliance for the pulmonary chamber (42 x 28 x 
28 cm) and larger diameter pipe and tubing of 3.8 cm were used. This allowed for an 
appropriate cardiac output with a much lower driving force as compared to the left heart 
simulator. The main components of the simulator consisted of a clear acrylic ventricle 
and atrial chamber, an outer pump chamber with a flexible bulb pump connected to 
solenoid valves and a compressor, a pulmonary reservoir, compliances, an adjustable 
annulus plate, adjustable PM holding rods, and a rigid pulmonic outflow with a 
mechanical valve. The atrial reservoir (30 x 28 x 8 cm) was contained within the 
pulmonary reservoir such as when the pulmonary reservoir filled it poured over the edge 





Figure 4.2: Right heart simulator, top view. Ventricular and atrial chamber, atrial 




The triggered solenoid valves (pulse duplicator) controlled inflow of compressed 
air to expand and deflate the bulb pump, altering ventricle pressure and controlling the 
pulsatility of the system. Time durations of 220 milliseconds for systole and 640 
milliseconds for diastole, a total of 860 milliseconds, was used to simulate a single 
cardiac cycle. Physiological conditions were maintained throughout experimentation: 5 
L/min average cardiac output, 70 beats/min heart rate, and 40 mmHg peak transvalvular 
pressure as seen in figure 4.3. 
 
Figure 4.3: Representative transvalvular in vitro pressure and flow curves, averaged 
over 15 cardiac cycles. 
 Atrial and pulmonary pressures were maintained through the reservoir height. 
Cardiac output was controlled through resistances upstream of the TV and downstream of 
the pulmonary valve (Omniscience, tilting disc mechanical valve). 0.9% saline solution 
was used as a blood analog in the system. A flow probe (600 Series, Carolina Medical 
Electronics, North Bend, SC) and pressure transducer (DP9-30, Validyne Engineering 
Corp., Northridge, CA) allowed for real-time pressure and cardiac output monitoring 




 The atrial and ventricle chambers were constructed of 0.5 inch thick clear acrylic. 
Engineering drawings for both chambers can be found in appendix C. The annulus plate 
was pressed between the two chambers and sealed with foam tape. The top plate of the 
ventricular chamber could be removed when necessary for easy access to the valve and 
PM rods. The three PM rods, which could be adjusted in all 3 dimensions, were attached 
to the ventricle chamber. Pressure ports were located on both the atrial and ventricular 
chambers at the same height. A mechanical pulmonary valve maintained pressure in the 
ventricular chamber during diastole and provided an outlet for the flow during systole. 
 
Figure 4.4: Side view of the chamber used to house native tricuspid valve. Annulus 
plate is mounted between the atrial and ventricular chambers. 
4.2.4 Papillary Muscle Rods 
Papillary muscle adjustments were achieved with three-dimensional adjustable 




Figure 4.5: 3D adjustable papillary muscle rod, used for apical/basal, 
anterior/posterior and lateral/septal movement. 
To displace the PMs apically, each rod was pulled in the apical direction away 
from the valve annulus.  Anterior/posterior and lateral movement was achieved by 
rotating the angle of the rod as well as moving the extender rod up and down the threaded 
rod. Trigonometric ratios were used to calculate the angle and number of turns of the 
threaded rod as needed to achieve a specific displacement (Fig. 4.6). See appendix D for 
sheet used in experimentation to calculate adjustments needed to create PM 
displacements for specific disease conditions. These rods allowed for precise and 





Figure 4.6: Repositioning of PMs as achieved with 3D rods.  Front view depicts both 
isolated posterior/anterior and lateral as well as combined displacement. Side view 
depicts isolated anterior and apical displacement. 
 
4.2.5 Annulus Plate 
The plate consisted of an adjustable annulus that was sutured to a flexible 
membrane. The membrane was then sandwiched between two acrylic plates in which a 
section the size of the dilated annulus was removed. The sandwiched membrane and 
plates were attached to a larger acrylic plate. Image of assembled plate can be seen in 
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figure 4.7. Valves were sutured to the adjustable annulus plate with attachment points on 
the three commissures: septal/anterior, anterior/posterior, and posterior/septal. A running 
mattress suture (3-0, silk) was used attach the valve annulus to the plate.  
4.2.5.1 Dilatation 
Physiological dilatation was achieved through an adjustable anterior and posterior 
section, similar to reported physiological dilation that is associated with displacement of 
the free wall section12, 13 (Fig. 4.7). The size of the annular area was adjusted from normal 
(6 cm2) to 100% dilatation (12 cm2) with septal/lateral (2.27 ± 0.05 to 3.53 ± 0.04 cm) 
and anterior/posterior (3.13 ± 0.04 to 4.10 ± 0.07 cm) diameters, replicating previously 
reported human measurements (area33, 38, septal/lateral diameter33, 62, anterior/posterior 
diameter12, 33) at normal and all levels of dilatation.  The annulus was constructed out of a 
flexible spring (anterior/posterior section) which was attached to a hollow acrylic tube 
(septal section) on both ends and surrounded by silicone-lined Dacron cloth.  A wire was 
inserted into the spring and pulled to adjust the size of the annulus. Physiological shape 
change from a triangle, in a normal state, to an oval, in a diseased state,32, 37 was 





Figure 4.7: Dilating annulus plate used to simulate physiological dilatation. 
Dilatation was created with the use of a rigid rod for the septal section and a spring 
for the anterior and posterior sections. 
 
4.2.5.2 Annular Saddle Shape 
The saddle-shape was implemented based on the clinical data reported by Fukuda 
et. al and Ton-Nu et. al, with the posteroseptal and anterolateral segments (highlighted in 
blue, Fig. 4.8) of the annulus being pulled back into the ventricular chamber 6 mm each, 
resulting in saddle height of 3mm towards the atrium and 3mm into the ventricle12, 33. 
This resulted in an approximate annulus width to commissural height ration of 10%. 
Suture (1-0, silk) was attached at low points on the annulus and pulled through the back 


























Figure 4.8: Implementation of a saddle shape on the annulus plate A) flat 
configuration, B) saddle configuration with saddle height of 6mm. C) Schematic of 
high (red) and low (blue) saddle points,  with posteroseptal and anterolateral 
segments of the annulus low and the anteroseptal and posterolateral segments high. 
 
4.2.6 Chordal Force Transducers 
 Miniature c-shaped force transducers were used to measure individual chordal 
force during experimentation. Strain gauges were bonded to the c-ring surface to measure 
deformation in the c-ring. C-ring transducer production was adapted from the previously 
published protocol63. 
First, the c-shaped brass frame was degreased, conditioned, neutralized, and 
coated with three coats of M-bond 43-B adhesive. Each adhesive layer was cured for an 
hour at 125° C (255° F). A strain gauge was mounted on the inner and outer curved 
surfaces of the c-ring frame. Resistance of the gauge was checked after each step in the 
manufacturing process to ensure a resistance of 350 ± 5 Ω. Thin triple conductor wires 
were then soldered to the strain gauge at terminals on both sides to create a Wheatstone 
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half bridge connection. The c-ring was then coated with M-bond 43-B adhesive and three 
Nitrile rubber coatings to create a moisture barrier and mechanical protection. The thin 
wire was soldered to thick triple conductor wire and then to a connector, which was 
plugged into the amplifier box. Each c-ring was calibrated after manufacturing and after 
each experiment. A final c-ring assembly can be seen in figure 4.9. 
 
Figure 4.9: Completed c-ring used to measure chordal forces. Scale shown in cm. 
 An amplifier box was used to convert the resistance to voltage and adjust the gain 
for the signal. The amplifier was attached to the DAQ system to allow for force 
measurements. 
4.2.7 Leaflets Markers 
 Tissue marking dye (Thermo Scientific, Pittsburgh, PA) was used to put markers 
on the leaflets to allow for measurement of RLL. A 2 mm × 2 mm grid was attached to a 
rubber sheet and placed behind the leaflet to allow for accurate leaflet marking. Image of 






4.2.8.1 Video  
 Video of the marked leaflets was recorded from the atrial side, perpendicular to the 
leaflets, throughout the cardiac cycle for all conditions. The camera (Sony, DCR-TRV30, 
Japan) was mounted on a tripod with video captured for at least three cardiac cycles to 
ensure all leaflets were visible and in focus.   
4.2.8.2 Echocardiography 
 3D echo images were acquired using a Phillips Intera (Philips iE33 system, Philips 
Healthcare, Andover, MA), with the probe (X7-1, Pediatric Probe) positioned on the front 
of the atrial chamber in the central region of the valve, perpendicular to the annulus. Full 
volume images were acquired for all conditions. Acquisition of echo measurements was 
triggered with the flow loop trigger system. Phillips QLAB software was used for all 








5.1 In Vivo 
 As minimal data currently exists as to the location of the PMs in the right 
ventricle and how they are altered in disease, it was necessary to develop an in vivo study 
to obtain this information. The methods utilized to measure PM position and identify 
correlates to the grade of the TR are detailed in the following sections. 
5.1.1 Patient Recruitment/Classification 
 64 subjects were prospectively recruited at Emory University Hospital, Atlanta, 
Georgia, and underwent a standard transthoracic echo analysis with an additional 3D 
echocardiographic image focusing on the RV. End-diastolic area (EDA) was measured 
and reviewed by a physician to classify ventricular geometry: Control (RVEDA ≤ 20 
cm2, LVEDA ≤ 33 cm2, n = 21); Isolated RV Dilatation (RVEDA ≥ 20 cm2, LVEDA ≤ 
33cm2, n = 17); Isolated LV Dilatation (RVEDA ≤ 20cm2, LVEDA ≥ 33cm2, n = 13); and 
both RV and LV Dilatation (RVEDA ≥ 20 cm2, LVEDA ≥ 33 cm2, n = 13)64. The control 
group included patients with no known heart disease (n = 12) and healthy volunteers (n = 
9). The study was approved by the Emory University Institutional Review Board for 
human subjects, with all patient identifiers removed and patient privacy protected 
according to HIPAA regulations (Appendix E). Informed consent was obtained from all 
patients prior to enrollment in the study (Appendix F). Patients were excluded from the 
study if they had a congenital heart defect, pacemaker lead or AICD, tricuspid valve (TV) 
repair or prosthesis, or poor image quality. Exclusion criteria ensured TR was caused by 
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geometry alone and not influenced by congenital abnormality or presence of a device, as 
these are known to cause TR. 
5.1.2 Image Acquisition and Analysis 
EDA for both the RV and LV was determined by analyzing the 4-chamber view 
using the area tool and tracing the ventricular border in the echo image using EchoPAQ 
software. TR was assessed with color Doppler and graded from trace to severe, based 
upon the size of the jet area in relation to the area of the right atrium65. PA pressure was 
calculated from the TR velocity jet and right atrial pressure using standard clinical 
application of the modified Bernoulli’s equation, shown in eq. (1). 
  (1) 
where  is pulmonary pressure,  is TR jet velocity and  is estimated right atrial 
pressure. Right atrial pressure was estimated from the diameter of the inferior vena cava 
(IVC)66: 5 mmHg (IVC small and collapsed), 10 mmHg (IVC < 2 cm in size and 
collapses 50% with inspiration), and 15 mmHg (IVC > 2 cm in size and collapses 50% 
with inspiration), 20 mmHg (IVC > 2 cm in size and > 50% collapse or non-collapsing). 
GE EchoPAC was used to interrogate the 3D image of the RV with 2D slices 
along the apical 4-chamber and parasternal short axis views. The use of EchoPAC for 
measurement of the annulus area and PM positions is detailed below. The video of the 
complete geometry was viewed and stopped at end systole, when the ventricle was fully 
contracted, and used to make measurements.  
5.1.2.1 Annulus Area Measurements 
 The annulus plane was identified within the 4-chamber image by noting the 
location of leaflet attachment and increased image intensity. The border was determined 
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by distinction of low (blood) and high intensity (annulus) signals. The annulus area was 
measured in the annulus plane using the area tracing tool in GE EchoPAC (Fig. 5.1). This 
measurement was repeated three times by the same observer and then averaged.  
 
Figure 5.1: 4-chamber view schematic and echo image in which the annulus is 
identified. Measurement of the annulus area, within the annulus plane, is outlined in 
white.  
 
5.1.2.2 Papillary Muscle Position Measurements 
The apical, septal/lateral and anterior/posterior distances were measured on a 
single PM and then repeated for the additional two PMs. If three distinct PMs could not 
be identified, the PMs that were visible were measured and recorded. The slice option 
within GE EchoPAC provided the user with 3 slices that could be moved in three-
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dimensional space. The 3 slices were used to visualize the PM (4-chamber view), identify 
the reference (short axis view), and intersection of the PM tip (short axis view) for 
measurement from the reference. 
5.1.2.2.1 Distance of PMs from Annulus Plane (Apical) 
Once the annulus plane was identified using a short axis slice, the long axis (4-
chamber) view was then moved anteriorly and posteriorly throughout the RV until the 
PM/chordae could be seen. The PM was most easily identified by the location of chordae 
tendineae insertion, with the video playing throughout the cardiac cycle. The video was 
then stopped at peak systole and a third plane was moved parallel to the annulus to the 
PM tip within the 4-chamber view (Fig. 5.2A).  The caliper tool was then used to 
measure the perpendicular distance between these two planes (annulus and PM tip) and 
recorded as the apical distance for the specific PM (Fig 5.2 A). This was repeated for all 
3 PMs. 
5.1.2.2.2 Distance of PMs from Center of Annulus (Septal/Lateral, Anterior/Posterior) 
The short axis plane at the tip of the PM remained in position, while the annulus 
viewing plane was rotated to bisect the annulus, parallel to the septum. The distance from 
the PM tip to the reference was measured in the short axis plane (Fig 5.2 B). This 
distance was used to determine septal or lateral displacement from control, with positive 
displacement being towards the septum (septal) and negative being away from the septum 
(lateral). 
The reference plane for calculating the septal/lateral distance was then rotated to 
bisect both the RV and LV, perpendicular to the septum. If necessary the PM plane was 
moved to the annulus plane to ensure that the reference plane bisected both the RV and 
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LV. The perpendicular distance was then measured from the PM tip to the reference 
plane, in the short axis plane (Fig. 5.2 C). This distance was used to determine anterior or 
posterior displacement from control, with positive displacement from the center of the 




Figure 5.2: Schematic and echo image of distance measured from PM tip to A) 
annulus, B) annulus center, and C) bisection of the RV/LV. Reference plane and PM 
tip plane are shown in grey, with the measurement distance shown in white. 
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5.1.3 Statistical Analysis 
 All data was assessed for normality with an Anderson Darling and equal variance 
with a Levene’s test prior to running an ANOVA. Statistical differences in annulus area, 
PM displacement and tethering, as compared to normal subjects, were determined using a 
One-Way ANOVA, with a Dunnett’s post hoc test. If data were not normally distributed 
a Kruskal-Wallis test was used to test significance in the non normal group as compared 
to control and the ANOVA re ran with the non normal group removed. Significance was 
determined at p<0.05. Distances were normalized by body surface area (BSA), as this is a 
standard technique to scale cardiac anatomy and  account for variations in patient size. 
All measurements are expressed as mean ± standard deviation. 
 Correlates to the grade of TR were determined with a Spearman’s test.  All 
variables which were significantly correlated with the grade of TR were initially included 
in the multivariate regression model. Variables with the highest p value were 
incrementally removed until only variables with a p value ≤ 0.10 remained.  
 
5.2 In Vitro 
  In vitro studies allow for simulation of specific diseases and investigation of 
incremental changes, with the measurement of detailed metrics. For this reason the 
following in vitro methods were utilized to determine the effect of alterations in the 
annular and subvalvular tricuspid valve apparatus on TR and valve mechanics. These 
include methods used to ensure an accurate disease model and measurement techniques 




5.2.1 Valve Instrumentation 
Selected valves, as described in detail in the materials section and appendix A, 
were excised with the annulus, leaflets, chordae and PMs intact. Valves were then sutured 
to the adjustable annulus plate with a continuous mattress suture and attachment points at 
the three commissures corresponding to annulus segments. While ensuring no restriction 
of chordae, the papillary muscles were wrapped with Dacron cloth to prevent tearing the 
PMs.  A button was then attached to the cloth, parallel to the tip on the base of the PM, to 
allow for attachment of the PMs to the adjustable PM rods in the simulator. 
5.2.2 Loop Preparation and Tuning  
Once the valves were placed in the simulator, the PMs were placed in a normal 
position. Normal position was defined with the septal PM (SPM) perpendicularly aligned 
to the septal and anterior commissure, anterior PM (APM) to the anterior and posterior 
commissure, and the posterior PM (PPM) to the septal and posterior commissure. The 
APM was positioned furthest from the annulus plane and the SPM closest, as reported for 
normal subjects using MRI25. This was achieved with three-dimensional adjustable rods 
using a system of gears, as used in previous studies as described in chapter 459, 61. Finally, 
the PMs were adjusted apically to ensure the chordae were neither taut nor slack. Slight 
anterior/posterior and septal/lateral adjustments were made once the simulator was 
running to account for valve to valve variability and to ensure proper leaflet coaptation. 
This is the same method used for previous in vitro MV experiments61, 67, 68. Once proper 
coaptation was ensured, the resistance and compliance of the right heart simulator were 
adjusted for each valve as well as each experimental condition to ensure that pressure and 
flow were maintained at 5 L/min and 40 mmHg peak systolic transvalvular pressure.  
48 
 
5.2.3 Hemodynamics  
Flow and pressure data acquired using the custom Labview program was 
averaged over 15 cardiac cycles. Tricuspid regurgitation (TR) volume was calculated by 
subtracting the closing volume, as determined from negative volume in the control 
condition, and normalized by the stroke volume, as shown in the representative image 
(Fig. 5.3). 
 
Figure 5.3: Depiction of closing volume and stroke volume as measured from the 
integration of the average flow curve. 
 
5.2.4 Residual Leaflet Length 
5.2.4.1 Preparation 
Markers were placed in a 2 mm × 2 mm grid on the entire surface of each leaflet 
with tissue marking dye (Thermo Scientific, Pittsburgh, PA).  The leaflet was first patted 
dry with a cloth and then attached to a rubber marker grid with pins. The leaflet and 
rubber surface was again patted dry prior to placing markers. The dull end of a needle 
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was dipped into marker dye and then dotted on the leaflet surface following the grid 
which was visible through the transparent leaflets. Both cross and box references were 
dispersed throughout the marker grid to aid in analysis of peak systolic images (Fig. 5.4). 
Once the entire leaflet surface was marked it was left to dry and allow the ink to soak into 
the tissue for approximately 5 minutes. The leaflet surface was then dabbed with a dry 
cloth to remove any access dye which was not absorbed into the tissue. An image was 
taken prior to placement in the simulator to serve as a baseline and to determine the 
original length of the leaflets along lines of interest. This was completed for each leaflet 
individually. 
 
Figure 5.4: Image of leaflet with grid (shown as dot) and reference markers (shown 
as x and □), which is used as a baseline measurement for RLL. 
 
5.2.4.2 Data Acquisition 
Video images (Sony, DCR-TRV30, Japan) of the marked leaflets were recorded 
from the atrial side, perpendicular to the leaflets, throughout the cardiac cycle for all 
conditions. Approximately four cardiac cycles were acquired to ensure images were in 




Figure 5.5: Peak systolic image of valve leaflets from the atrial view as visulized with 
the video camera. 
 
5.2.4.3 Data Analysis 
 RLL is defined as the amount of leaflet available for coaptation (Fig. 5.6). While 
coaptation length is typically measured clinically it does not give coaptation information 
about each individual leaflet. As this thesis aimed to provide a more detailed mechanistic 
understanding of the valve RLL was measured. 
 
Figure 5.6: Individual residual leaflet length for the septal and anterior leaflets. 
 There were three major steps in the analysis of the RLL data. Step one was to 
extract images from the video, step 2 was to convert the leaflet markers to a matrix and 
step 3 was to measure the RLL. 
 To analyze the acquired images for RLL, static (reference) images were 
downloaded from the camera. The peak systolic image was identified from the video file. 
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Peak systole was determined as the first frame in which the valve was fully closed and 
did not move in the following frames. While multiple cardiac cycles were taken, the peak 
systolic image was chosen from the first cycle in which the image was clear enough to 
identify all dots in a single frame for all leaflets. Each peak systolic image was then saved 
and labeled accordingly. This step was repeated for all conditions and for all valves. 
 Following image identification, a matrix of the leaflet markers was constructed 
using Matlab (7.10.0, MathWorks Inc., Natick MA). The Matlab code which was used to 
generate the matrix and plots can be found in appendix G. First, the dots in each row as 
well as the number of rows were manually counted. This was simplified by printing 
images of both static and peak systolic images. For the static image, all dots were 
counted. For systolic images, only visible dots were counted.  Additional dots were added 
in some cases where there were dots located in wrinkles or close to the annulus and could 
not be seen in coaptation. A matrix was created with this information. The row and 
column in which the references were located was identified within the matrix for all 
conditions (Fig 5.7), and is displayed as an x in the below image.  
 
Figure 5.7: Matrix representation of the leaflet markers. Reference denoted as an X, 
leaflet markers as 1, and spacers (no leaflet) as 0s.  
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 The static image was overlaid on each condition and plotted by aligning the 
matrices with the reference. An example plot is shown below (Fig. 5.8). This was 
repeated for each leaflet, experimental condition, and valve. 
 
Figure 5.8: Plot generated in Matlab of the reference leaflet (hashed line) overlayed 
on the area visible at peak systole (solid line). Axes represent the spacing of the 
markers and are  spaced 2mm apart. 
 To compute RLL, the line of interest was identified as the line of markers that 
intersected the central point of coaptation, as this is where malcoaptation occurs. The 




Figure 5.9: Markers of interest identified on the posterior leaflet (blue line) with 
reference (blue dot), anterior leaflet (red line) with reference (red dot), and septal 
leaflet (green line) with reference (green dot) for the central coaptation region. 
 Next, locating the line of interest on the leaflet plot was aided by using the 
reference as a landmark. Once the line of interest and reference were identified on the 
image the line of interest was identified on the plot of the leaflet.  The distance from the 
reference to the line of interest was identified by counting the number of columns of dots 
between the two. For example with the posterior leaflet (blue) the line of interest is 
adjacent to the reference mark. The corresponding adjacent line on the plot is found in the 





Figure 5.10: RLL visualization (bar) as determined by subtracting static markers 
from peak systolic markers. 
RLL was defined as the number of markers on the line of interest in the static 
image minus the number of visible markers along the same line in the peak systolic 
image, times the marker spacing. For Figure 5.10 above, 16 markers were seen on the 
static image and 7 markers were observed at peak systole for the posterior leaflet. Since 
the markers are spaced at 0.2 cm, the RLL was calculated as 1.8 cm. RLL were then 
determined for all leaflets, for all conditions for all valves. 
5.2.5 Leaflet Mobility 
5.2.5.1 Data Acquisition 
3D echo image acquisition was triggered with by the pulse duplicator by 
attachment of a BNC cable to the ECG leads of the echo machine. Once the signal 
registered on the machine it was adjusted to ensure there was only one distinct rising 
edge, as this was when the machine acquired an image.  The following machine settings 
were used: full volume, Xres, high density, Pen, FV Opt (Frame Rate), resulting in a 
frame rate of 43 Hz. The gain was typically set to 50% but was altered ± 5% as needed 
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for each individual experiment. This method was used to acquire images for a total of 8 
valves. 
5.2.5.2 Data Analysis 
Acquisition of a 3D data set allowed examination of any 2D slice within the 3D 
volume using Philips Qlab software (Philips Healthcare, Andover, MA). Thus, leaflet 
mobility was assessed with 2D slices which were interrogated across all three coaptation 
lines: anterior/posterior, posterior/septal and septal/anterior (Fig. 5.8a). For slices of 
interest, tenting height (TH) was measured as the perpendicular distance from the point of 
coaptation to the annulus plane and tenting area (TA) was measured as the area enclosed 
by tracing the annulus plane and leaflet surfaces (Fig. 5.11b).  Measurements were 
conducted at peak systole, defined as the first image in which the valve was completely 




Figure 5.11 A) Imaging plane of the valve as viewed from the atrium. 
Anterior/posterior (AP, red), septal/anterior (SA, green) and septal/posterior (SP, 
blue) coaptation line are shown in which the B) tenting height and tenting area were 
measured in the resulting anterior/posterior plane. 
 
5.2.6 Chordal Forces 
5.2.6.1 C-ring Instrumentation 
 Force transducers were implemented on individual chordae originating from the 
APM and inserting into both the anterior and posterior leaflets. C-rings were 
implemented on a single PM to investigate the main chordae: marginal, intermediate and 
strut chordae as shown in figure 5.12. Only chordae originating from the APM were 
instrumented with transducers, which allowed for identification of the difference between 
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the forces on individual types of chords. The APM was selected as it was expected that 
chords inserting into the APM would be most affected by the conditions simulated. As 
annular dilatation displaces the anterior and posterior segments of the annulus in which 
the measured chords insert into would indirectly affect the chords, various displacements 
of the APM would directly affect the chords. It was not always feasible to instrument a 
single valve with 6 c-rings to measure each chordae from the APM and hence a total of 
14 valves were used to achieve a minimum sample size of 8 for each type of chord. 
 
 
Figure 5.12: Chordae selected for c-ring attachment: 1-marginal, 2-intermediate, 3-
strut. 
 
Chordae were selected based upon the following criteria: no branching, adequate 
length (> 0.5cm), and diameter (< 0.06 cm), which fit within c-ring grooves. Chords were 
attached using 5-0 silk sutures on either end of the c-ring. The chord was then cut 
between the two ends of the transducer to allow for force transmission to the gauge. 




Figure 5.13: Image of attachment of c-ring to chordae. Image shows attachment of 
c-rings to marginal, intermediate and strut chords from the APM into the anterior 
leaflet. 
 
5.2.6.2 Data Acquisition 
 Each c-ring was set to read zero voltage once the valve was in a normal position 
and prior to initialization of the simulator. The signal from each c-ring was sent to an in-
house data acquisition and analysis program based on the LabVIEW platform (LabVIEW 
5.1, National Instruments, Austin, TX) and measured throughout the cardiac cycle. 
Chordal force was acquired using separate valves as those for echo and RLL 
measurements, as it was not experimentally feasible to run both experiments 
simultaneously: avoiding interference in echo imaging due to the metallic c-rings and 
potential fading of leaflet markers. 
5.2.6.3 Data Analysis 
 Differential force, the difference between diastolic and peak systolic force, were 
measured for each condition (Fig. 5.14). This information aimed at providing an 
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understanding of the combined geometric and hemodynamic influence on chordal force 
distribution.  Chordal force measurements were ensemble averaged over 15 cardiac 
cycles. 
 
Figure 5.14: Representative chordal force measurement results. Both normal (solid 
line) and apical displacement of the APM (dashed line) chordal force measurements 
are shown for the anterior strut chord as an average over 15 cardiac cycles. 
Determination of the diastolic and differential forces are shown. 
 
5.2.7 Experimental Conditions 
Valve dynamics were quantified with isolated annular dilatation starting at a 
normal annular size (6 cm2) and dilated to 100% by increments of 20%. Isolated 
displacement of the PMs was achieved by repositioning the PMs on the septal wall 
simultaneously (PPM/SPM), which simulated left ventricle (LV) dilatation69.  The sole 
displacement of the APM simulated right ventricle (RV) dilatation23, 24.  Combined RV 
and LV dilatation was investigated for normal, 40% and 100% dilated annulus sizes with 
all PM displacements. The APM was displaced both laterally and apically, individually 
and combined. Anterior/posterior displacement was disregarded early on in 
experimentation as it showed no difference and was not physiological, as confirmed by in 
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vivo echo images. The SPM and PPM were displaced anteriorly/posteriorly, (SPM/PPM), 
laterally and apically, as isolated and combined conditions. For combined RV/LV 
dilatation all PMs were displaced in all directions. All PMs were displaced by 10 mm for 
each displacement condition. All experimental conditions both isolated and combined are 
schematically summarized in Table 5.1. 
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Table 5.1: Conditions simulated during experimentation. Dashed lines indicates 
alteration from control. Apical displacment is shown as a smaller circle. 
 
 
Hemodynamics, leaflet coaptation, leaflet mobility and chordae forces were 
investigated for the previously mentioned conditions. While all conditions were 
simulated, not all measurement techniques were used for each condition. Hemodynamics 
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and RLL was quantified for every condition, including isolated and combined disease 
conditions. Echocardiographic images were acquired for all PM displacements, but only 
for dilatations of 40% and 100% for both isolated and combined conditions. Since 
significant TR was first seen at 40%, this amount of dilatation and an extreme case of 
100% were investigated to see if alterations occurred in leaflet mobility which could give 
more information as to why TR occurred. Force measurements were only acquired for 
extreme dilatation of 100%, and displacement of the anterior PM both in the isolated  and 
combined cases. Measurement techniques which were used for specific disease 
conditions can be seen in the table 5.2. 
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Table 5.2: Measurement techniques used for specific disease conditions. X identifies 
conditions which were measured with specific technique, with – denoting technique 
which were not utilized for the specific condition. Note (*): Force was only 
investigated for 100% dilatation and combined PM displacement. 
 
5.2.8 Statistical Analysis 
All statistical analysis was completed using Minitab 15 (Minitab Inc, State 
College, PA) and expressed as mean ± standard deviation. An Anderson Darling test was 
first performed to assess data normality. Each valve served as its own control, such that 
measurements of disease conditions were compared to those made on the same valve for 
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the normal position.  A General Linear Model (GLM) was used for the analysis of all in 
vitro data as the samples were not independent, and involved repeated measures. For this 
reason a standard One Way ANOVA or student’s t-test could not be used. While these 
two tests are a form of GLM, the use of the standard GLM allows for pairing of samples 
on multiple measurements70. 
A GLM was used to investigate the effect of individual and combined annular 
dilatation and PM displacement on TR, RLL, leaflet mobility and chordal force. Pairing 
of repeated measurements on the same valve was implemented in the model by including 
the valve as a random factor. Significance was determined at p ≤ 0.05. If a significant 
difference was present; a Dunnett’s post hoc was used to asses which groups varied from 
control.  
A GLM was also used to assess the difference in RLL across leaflets with various 
disease conditions, with significance at p ≤ 0.05. A Dunnett’s post hoc was used to assess 
which groups were significantly different from control RLL for each leaflet.   
Additionally, a Tukey’s post hoc was used to assess differences within PM displacements 
which resulted in significant TR across leaflets.  A Spearman’s test was used to 
determine correlation between RLL of an individual leaflet and TR. 
5.2.9 Calibration 
Calibrations were conducted for the flow probe, pressure transducer, and c-rings. 
Flow probe and pressure transducer calibrations were conducted approximately every 3 
months, with the c-rings being calibrated before and after every experiment. 
A flow probe (600 Series, Carolina Medical Electronics, North Bend, SC) was 
connected to a flow meter and calibrated with the use of a variable voltage transformer, 
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steady centrifugal pump, a graduated cylinder and a stopwatch using saline solution. The 
ground was placed at the inlet flow of the flow probe. A range of flow rates was created 
by changing the pump voltage via the transformer.  Flow was calculated as the total 
volume emptied into a graduated cylinder for a given time period and calculated in both 
directions.  This was repeated three times and averaged, with a linear regression fit 
providing the calibration factor.  A sample data set is plotted below. 
 
Figure 5.16: Representative calibration curve for the flow probe. 
The pressure transducer (DP9-30, Validyne Engineering Corp., Northridge, CA), 
a dual chamber transducer with an interchangeable diaphragm, was connected to an 
amplifier box, and was calibrated from 0 to 70 mmHg for each chamber with the use of a 
differential water column. A voltmeter was attached to the pressure transducer amplifier 
box to measure voltage for each pressure. Each chamber was exposed to a range of water 
column pressures individually and this was repeated three times and averaged. Pressure 
was converted from cmH2O to mmHg and plotted against the voltage measured, with a 




Figure 5.17: Typical calibration curve for the pressure transducer. 
 
C-rings were calibrated in room temperature saline solution and were zeroed prior 
to calibration. Force transducers were connected to a Wheatstone bridge amplifier to 
complete the circuit.  Known weights, ranging from 10g to 1000g were hung from one 
end of the gauge while the other end was anchored. Weights were used to induce 
deformation causing a variation in voltage. Force was plotted against voltage to 
determine the sensitivity of each c-ring. Calibration was conducted after manufacturing 















This chapter is divided into in vivo and in vitro results. For the in vivo results, the 
characteristics of enrolled patients are presented followed by the comparison of PM 
positions of dilated ventricular patients and control subjects. Measured parameters were 
then assessed for their correlation to TR. For the in vitro section, results have been 
divided into sections based upon disease conditions simulated: a) isolated annular 
dilatation b) isolated PM displacement and c) combined annular dilatation and PM 
displacement. Hemodynamics, residual leaflet length (RLL), chordal forces and leaflet 
mobility data are presented for all conditions. Absolute RLL measurements were 
investigated for isolated annular dilatation demonstrating incremental changes with 
dilatation. For both isolated and combined, percent change in RLL was determined to 
demonstrate relative changes from control. Chordal force data were quantified for both 
diastole and the differential of force between peak systole to diastole for all disease 
conditions simulated. 
 
6.1 In Vivo 
6.1.1 Patient Characteristics 
A total of 64 subjects were enrolled and included both volunteers and Emory 
University Hospital patients.  All patient data can be found in the raw data section A. The 
demographics of the subject group consisted of a mean age of 51 ± 18 years with 58% 
male and 42% females (Table 6.1).  
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TABLE 6.1: Patient Characteristics 
 Study Patients (n = 64) 





Primary Etiology  
Pulmonary Arterial Hypertension 19 (30%) 
Congestive Heart Failure 8 (13%) 
Atrial Fibrillation 6 (9%) 
Cardiomyopathy 7 (11%) 
Coronary Artery Disease 5 (8%) 
Aortic Stenosis 3 (5%) 
Endocarditis 2 (3%) 
Other (Non-Cardiac Related) 5 (8%) 
Normal Volunteer 9 (14%) 
Tricuspid Regurgitation  
Trace 20 (31%) 
Mild 13 (20%) 
Moderate 17 (27%) 
Severe 14 (22%) 
 
 The right ventricular end diastolic area (RVEDA) of patients was plotted against 
left ventricular end diastolic area (LVEDA) to assess appropriate classification of 
patients. These values were used to classify patients based upon normal clinical 4 
chamber echo measurements, RVEDA of 20.1 ± 4.0 cm2 and LVEDA of 32.2 ± 7.7 cm2 
71, with values greater than one standard deviation considered dilated (Fig. 6.1). With 
blinded clinical assessment used to verify classification from measurements, three 
patients were reclassified from their original size classification. Thus while most patients 
fell within one deviation of the size classification, the three reclassified patients were 
placed into the normal, dilated RV and dilated RV/LV groups. As the control group was 
defined by normal ventricular geometry, the group consisted of both healthy volunteers 




Figure 6.1: Assessment of patient classification. RVEDA is plotted against LVEDA 
for each patient, with their classification designated by color and shape of marker. 
Clinically accepted normal values are designated by the dashed line with one 
standard deviation, as shown with a gray bar. 
 
Assessment of patient group characteristics, as compared to control (ie. subjects 
with a  normal sized RV and LV), found the highest levels of clinically significant TR 
(moderate to severe) in patients with RV dilatation, either in isolation (81%) or combined 
with LV dilatation (79%). Only 31% of patients with isolated LV dilatation had clinically 
significant TR (Fig. 6.2). It is interesting to note that 14% (3 patients) of the control 
group presented with clinically significant TR. While these patients did have normal 
sized RV and LVs, one had aortic stenosis, a second had atrial fibrillation, and a third had 
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pulmonary hypertension. The explanation for the presence of severe and moderate TR in 
the control group,  can be explained by the aforementioned etiologies as they are know 
correlates of TR, irrespective of ventricle size.  
 
Figure 6.2: Prevalence of the percentage of patients with TR within the 
classifications: control, dilated RV, dilated LV, dilated RV/LV. The largest 
percentage of clinically significant TR was present patients with isolated RV or both 
RV/LV dilatation. Note that no patients with a dilated RV presented with mild TR. 
 
A significantly higher (p ≤ 0.05) pulmonary arterial (PA) pressure compared to 
normal was observed in patients with a dilated RV and both RV and LV dilation (Fig. 
6.3). These were the same groups which were observed to have the highest levels of 




Figure 6.3: Peak systolic pulmonary arterial pressure for all patient groups. 
Significance (*) defined at p ≤ 0.05 using a One Way ANOVA with Dunnett’s post 
hoc. 
Patients with a dilated RV and those with both ventricles dilated had a 
significantly larger (p ≤ 0.05) normalized annulus area as compared to control when 





Figure 6.4: Annulus area normalized by body surface area, as measured from peak 
systole, for all patient groups. Significance (*) defined at p ≤ 0.05 using a One Way 
ANOVA with Dunnett’s post hoc. 
Additional analysis was conducted to better understand the variation in annulus 
area within both patients groups (Fig. 6.5) and the severity of TR (Fig. 6.6). Similar 
annulus area was seen with both trace and mild TR with 8.7 cm2 and 8.9 cm2.  Patients 
with moderate TR had an average annulus size of 11.4 cm2, with patients with severe TR 






Figure 6.5: Annulus area of patient groups, within the severity of TR. Average TR 






Figure 6.6: Annulus area per severity of TR, within each patient group. Average TR 




6.1.2 Papillary Muscle Position and Leaflet Tethering 
PA pressure, annulus area, PM positions and leaflet tethering data according to 
patient ventricular dilatation grouping are shown in Table 6.1. Schematics depicting 
significant PM displacement from control are shown in each classification section 
(6.1.2.1-6.1.2.4). Raw data measurements for all patients are located in the raw data 
section B. All patients with single or biventricular dilatation had significant (p ≤ 0.05) 





TABLE 6.1: Patient Measurements: Pulmonary Artery Pressure, Annulus Area,  
Papillary Muscle Positions. Annulus area and papillary muscle position normalized 
by BSA. Abbreviations: Setpal/Lateral (sept./lat.), Anterior/Posterior (ant./post.), 
Apical (api.) 4-chamber (4ch), Tenting Area (TA), Tenting Height (TH). 
 Control Dilated RV Dilated LV Dilated RV/LV 
Peak Systolic PA 
Pressure (mmHg) 36.96 ± 20.77 68.98 ± 27.85* 44.68 ± 16.82 52.11 ± 14.84 
Annulus Area 
(cm2/m2) 4.6 ± 1.2 6.2 ± 3.0 #  5.7 ± 2.0 6.1 ± 1.0* 
APM (sept./lat.) 
(cm/m2) -0.2 ± 0.5 -0.5 ± 0.6 #  -0.1 ± 0.7 -0.5 ± 0.5 
APM (ant./post.) 
(cm/m2) -0.4 ± 0.3 0.3 ± 0.5 -0.2 ± 0.5 -0.3 ± 0.6 
APM (api.)  
(cm/m2) 1.5 ± 0.3 1.9 ± 0.8 # 2.0 ± 0.6* 2.0 ± 0.4* 
SPM (sept./lat.)  
(cm/m2) 0.6 ± 0.2 1.0 ± 0.5 # 0.6 ± 0.3 0.7 ± 0.2 
SPM (ant./post.) 
(cm/m2) 0.2 ± 0.3 0.3 ± 0.2 0.3 ± 0.3 0.2 ± 0.2 
SPM (api.)  
(cm/m2) 0.7 ± 0.2 1.1 ± 0.3* 0.8 ± 0.2 1.0 ± 0.2* 
PPM (sept./lat.)  
(cm/m2) 0.5 ± 0.2 0.9 ± 0.5 # 0.6 ± 0.2 0.7 ± 0.2 
PPM (ant./post.) 
(cm/m2) -0.6 ± 0.3 0.4 ± 0.5 -0.5 ± 0.5 -0.7 ± 0.4 
PPM (api.)  
(cm/m2) 0.8 ± 0.3 1.3 ± 0.4* 0.9 ± 0.2 1.0 ± 0.4 
4ch TA (cm2) 0.6 ± 0.2 1.4 ± 0.5* 1.1 ± 0.6* 1.4 ± 0.5* 
4ch TH (cm) 0.3 ± 0.1 0.6 ± 0.2* 0.5 ± 0.2* 0.5 ± 0.1* 
* = p ≤ 0.05, as compared to control group, ANOVA 
# = p<0.05, as compared to normal, Kruskal-Wallis 
 
6.1.2.1 Control (Normal Right and Left Ventricle) 
 Of the 64 subjects, 21 were classified as control by measurement of a normal RV 
and LV area. These subjects were imaged as either volunteers (n = 9) or as requested by 
their physician (n=12). Positions of control PMs were consistent with previously reported 
locations as identified in normal subjects using MRI 72. The findings of the MRI study 
can be found in appendix H, with the measurements in the raw data section C. The 
anterior PM was the most apical of all three PMs and the only PM located on the free 
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wall and was typically more posterior as denoted with the negative measurement of -0.40 
± 0.29 cm/m2. Both the SPM and PPM were located on the septum and were located at a 
similar distance from the annulus, with the SPM located more anterior and the PPM 
located in the posterior direction. 
 
Figure 6.7: Relative location of papillary muscles. SPM: septal papillary muscle, 
PPM: posterior papillary muscle, APM: anterior papillary muscle. 
 
6.1.2.2 Dilated Right Ventricle 
16 of the 64 patients in the study were classified as having only RV dilatation. 
Patients with a dilated RV had significant displacement of all PMs away from the center 
of the annulus, with the APM displaced septally (-0.5 ± 0.6 cm/m2) and the septal and 
posterior PMs displaced laterally, towards the LV. All PMs were also displaced apically 
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in these patients (APM: 1.9 ± 0.8 cm/m2, SPM: 1.1 ± 0.3 cm/m2, PPM: 1.3 ± 0.4 cm/m2). 
Directions of statistically significant displacement are shown in the figure 6.8. 
 
Figure 6.8: Depiction of significant displacement for patients with a dilated RV, as 
compared to control subjects. Both short and long axis views are shown. 
 
Tethering, as measured as both tenting area (TA) and tenting height (TH) was 
significantly (p ≤ 0.05) increased in patients with a dilated RV as compared to control. 
While TH was consistent amongst patient groups, TA was highest with isolated RV 
dilatation (1.4 ± 0.5 cm/m2). 
6.1.2.3 Dilated Left Ventricle 
It was difficult to find patients with isolated LV dilatation as most had a 
pacemaker lead through the tricuspid valve; these patients were excluded from the study 
as this is a known cause of TR 11, 73. Thus, 13 of the 64 patients were classified as having 
only LV dilatation. The only significant PM displacement in these patients was apical 





Figure 6.9: Depiction of signficant displacement for patients with a dilated LV, as 
compared to normal subjects. A long axis view is shown. 
Tethering, as measured as both TA and TH was significantly (p ≤ 0.05) increased 
in patients with a dilated LV as compared to control. While TH was consistent amongst 
groups, patients with a dilated LV did not have the highest levels of TA. 
6.1.2.4 Dilated Right and Left Ventricle 
Of the 64 patents enrolled for this study, 14 had dilatation of both the RV and LV. 
Patients with both ventricles dilated had significant apical displacement of both the APM 
(2.0 ± 0.4 cm/m2) and SPM (1.0 ± 0.1 cm/m2). 
 
Figure 6.10: Depiction of significant displacement for patients with both a dilated 
RV and LV, as compared to normal subjects. A long axis view is shown. 
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Tethering, as measured as both tenting area (TA) and tenting height (TH) was 
significantly (p ≤ 0.05) increased in patients with combined RV and LV dilatation as 
compared to control. While TH was consistent amongst patient groups, in addition to 
isolated RV dilatation, the combination of RV and LV dilatation also resulted in the 
highest TA (1.4 ± 0.5 cm/m2). 
6.1.3 Determinants of Tricuspid Regurgitation 
Once the displacement of the PMs was defined, a more in depth investigation of 
the variables measured was conducted to determine which, if any, of the measurements 
were correlated to the severity of TR of the patients. All measured parameters, as listed in 
the table, were assessed for correlation of the grade of TR. A variable was considered to 
be clinically correlated to TR with a p value greater than or equal to 0.05. Investigated 
variables and their correlation associated with the severity of TR are shown in table 6.2.  
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TABLE 6.2: Determinants of the Grade of Tricuspid Regurgitation. Abbreviations: 
Septal/Lateral (sept./lat.), Anterior/Posterior (ant./post.), Apical (api.) 4-chamber 
(4ch), Tenting Area (TA), Tenting Height (TH), Coefficient (Coeff.). 
 
  Correlation Multivariate 
  r p Coeff. p 
Age (n=57) 0.14 0.293   
PA Pressure (n=62) 0.66 0.000 0.28 0.000 
MR Grade (n=62) 0.21 0.102   
Classification (n=64) 0.46 0.000 0.26 0.001 
RVEDA (n=64) 0.48 0.000   
LVEDA (n=64) 0.24 0.059   
Annulus Area (n=64) 0.51 0.000 1.60 0.027 
APM (sept./lat.) (n=63) -0.11 0.376   
APM (ant./post) (n=63) 0.06 0.656   
APM (api.) (n=63) 0.26 0.038 -4.52 0.061 
SPM (ant./post) (n=58) -0.02 0.867   
SPM (sept./lat.) (n=58) 0.37 0.004   
SPM (api.) (n=58) 0.40 0.002   
PPM (sept./lat.) (n=59) 0.40 0.001   
PPM (ant./post) (n=59) -0.01 0.951   
PPM (api.) (n=59) 0.49 0.000   
4ch TA (n=58) 0.54 0.000   
4ch TH (n=58) 0.49 0.000   
 
 PA Pressure (r = 0.66, p = 0.000) was an independent predictor of the grade of 
TR. When the geometry of the ventricles was investigated, all parameters (Classification: 
r = 0.46, p = 0.000, RVEDA: r = 0.48, p = 0.000) were significantly correlated, with the 
exception of LVEDA (r = 0.24, p = 0.059). Changes in the annular and subvalvular 
apparatus were significantly correlated with the grade of TR, specifically annulus area  
(r = 0.51, p = 0.000) and apical PM displacement of the APM (r = 0.26, p=0.038), SPM  
(r = 0.40, p = 0.002) and PPM (r=0.49, p=0.000). Additionally, displacement of the SPM 
(r = 0.37. p = 0.004) and PPM (r = 0.40, p = 0.001) away from the center of the RV 
towards the LV were correlated with the grade of TR. Both measurements of tethering, 
TA and TH, were correlated with the grade of TR, (r = 0.54, p = 0.000) and (r = 0.49,  
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p =0.000), respectively. It is important to note that PM position and tenting 
measurements could not be obtained for all patients, explaining why the sample size for 
the measurements is less than 64 in all cases. 
Once correlations of individual parameters were determined a multivariate 
analysis was then conducted, to determine if the combination of multiple variables could 
better predict TR. Those variables which had a significant correlation to TR were 
included in the original model: PA pressure, classification, RVEDA, annulus area, APM 
(apical), SPM (anterior/posterior, apical), PPM (septal/lateral, apical), tenting height and 
area. The test was run with all variables and then again with the highest p value 
eliminated. This was repeated until all remaining variables had p ≤ 0.10. While tethering 
area was highly correlated with TR, it dropped out on the 6th step, with a p-value of 
0.794. Two additional steps were completed before all variables in the multivariate 
regression where p ≤ 0.10, leaving four variables. PA pressure (p = 0.000), classification 
(p = 0.001), annulus area (p = 0.027) and apical displacement of the APM (p = 0.061) 
were predictors of the grade of TR in a multivariate regression analysis.  
 
6.2 In Vitro 
The results for the in vitro work are divided into results from experiments with 
isolated annular dilatation, isolated PM displacement, and combined annular dilatation 
and PM displacement. The isolated PM displacement and combined sections are further 
divided by the PM which was displaced in the experiments. Results from isolated anterior 
and septal/posterior PM displacements are first presented and then results for the 
displacement of all three PMs together. Hemodynamic results are presented first followed 
by RLL, chordal force and leaflet mobility data, to assist in explaining differences 
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observed in the amount of TR. All data are shown as mean ± standard deviation, with the 
exception of the RLL data which are expressed as mean ± standard error, to ease 
visualization of data on graphs. 
6.2.1 Isolated Annular Dilatation 
6.2.1.1 Hemodynamics 
When the isolated effect of annular dilatation was investigated on the amount of 
TR, a significant effect (p = 0.000) was found. A significant increase (p ≤ 0.05) in 
regurgitation could be seen with 40% annular dilatation as compared to the control 
(7.9±3.4 mL, n = 8). Further dilatation in excess of 40% resulted in a significant (p ≤ 
0.05) increase in TR from control. The largest amount of TR (20.1 ± 6.2 l) was seen with 





Figure 6.11: Tricuspid regurgitation volume as an effect of annulus area times 
normal with significance (* = p ≤ 0.05), as compared to control (0), n = 8. 
Malcoaptation, as visualized by a hole, first appeared at 40% dilatation of the 
normal annulus area and increased in size with further dilatation.  In all cases the orifice 
was in the central region of the three leaflets, towards the septum. This can be seen in the 





Figure 6.12: Image of representative valve (Expt8_040609) with isolated annular 
dilatation from 0-100%. Central malcoaptation is highlighted with black. Video is 
provided through the link (click image for video). 
In addition to measurement of an increase in TR and visualization of a central 
hole in valve images, a regurgitant jet could be seen with color Doppler imaging using 
3D echo. Peak systolic images of the same valve can be seen for both a normal annulus 
size and 100% dilated annulus. No jet is present with the normal annulus, while a distinct 





Figure 6.13: Color Doppler images of a valve with a normal annulus area and 100% 
dilated annulus. A central regurgitant jet is visible with 100% dilatation (click 
images for videos). 
In addition to showing that dilatation of the annulus had a significant effect on 
TR, it was of interest to determine if the presence of a 3D saddle shape reduced TR. No 
significant difference was seen in the amount of TR when saddle and no saddle were 
compared for 100% annular dilatation (Fig. 6.14). Thus, the presence or absence of a 





Figure 6.14: Plot of TR for control and 100% dilatation with and without a saddle. 
No significance was found between saddle and no saddle conditions. Note: Negative 
volume of control with a saddle was assumed as closing volume and subtracted from 
all measurements. 
 
6.2.1.2 Residual Leaflet Length 
Next, the effect of annular dilatation on RLL was investigated to provide a better 
understanding of the mechanism responsible for TR, by measuring the amount of leaflet 
available for coaptation on each individual leaflet. The individual leaflet, whether 
anterior, septal or posterior in which RLL was measured had a significant (p = 0.000) 
effect on RLL. Likewise, the amount of annular dilatation (p = 0.000) had a significant 
effect on RLL. When the impact of leaflet was investigated further it was found that there 
was an inverse relation of RLL to dilatation, with RLL decreasing with increasing 
annular dilatation, for all leaflets (n = 8) (Fig. 6.15).  A significant difference (p ≤ 0.05) 
was seen in RLL of the posterior leaflet as compared to both the anterior and septal 
89 
 
leaflets, with the posterior having the largest RLL throughout. No difference was seen in 
RLL between the anterior and septal leaflets for any annulus area measured. Next, when 
determining which leaflet was most affected by dilatation, it was found that anterior 
leaflet RLL was most affected, as it decreased from an initial RLL of 1.1 ± 0.4 to 0.2 ± 
0.2 cm. The loss of valve competence and significant TR coincided with a minimum RLL 
of 0.5 ± 0.2 cm, as measured on the anterior leaflet. A negative correlation could be seen 
between RLL and TR for the posterior (r = -0.303) and anterior (r = -0.685) leaflets, but 
not with the septal leaflet (r = -0.423), demonstrating the decrease in RLL as the amount 
of TR increases. 
 
Figure 6.15: RLL as an effect of annulus area times normal, as shown for each 
individual leaflet: posterior (blue), anterior (red), and septal (green). Standard error 
is shown. 
 
6.2.1.3 Chordal Forces 
The force on the chords connecting from the anterior PM to the anterior and posterior 
leaflets was investigated to see if annular dilatation resulted in redistribution of the forces. 100% 
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dilatation of the annulus had a significant effect on all chordae inserting into the anterior 
(marginal: p = 0.005, intermediate: p = 0.027, strut: p = 0.008) and posterior leaflets (marginal:  
p = 0.039, intermediate: p = 0.014, strut: p = 0.021). Both anterior and posterior marginal chords 
experienced the highest percent increase in force from control with 147 ± 34%and 96 ± 52%, 
respectively.  Percent increases in force of the intermediate chords were 91±41% for the posterior 
leaflet and 80±43% for the anterior leaflet. While strut chordae tensions were significantly 
increased, they were the least impacted by dilatation with the lowest level (43±26% and 25±22% 
anterior and posterior) of increase, as compared to marginal and intermediate chordae. Typically, 
the chordae inserting into the anterior leaflet experienced higher percent increases in differential 
force from normal as compared to chordae inserting into the posterior leaflet (Fig. 6.16). Only 
the APM was instrumented with c-rings, as the anterior and posterior leaflets were 
expected to be most affected by dilatation as the anterior and posterior sections of the 
annulus are dilated. 
 
Figure 6.16: Peak systolic chordal force measurements for chords originating from 
the APM. Significance (* = p ≤ 0.05, # = p ≤ 0.01) as determined with a GLM as 
compared to 0% dilatation for the same valve. 
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6.2.1.4 Leaflet Mobility 
Finally, the impact of annular dilatation on leaflet mobility was assessed through 
measurement of tenting height and tenting area along the three coaptation zones. No significant 
difference was seen with tenting height as an effect of annular dilatation for the septal/anterior (p 
= 0.752), anterior/posterior (p = 0.150), and posterior/septal (p = 0.536) coaptation lines.  
Additionally, no significant difference in tenting area could be seen with increased levels of 
dilatation at any coaptation line: SA (p = 0.254), AP (p = 0.173), and PS (p = 0.276). While the 
values for 100% tended to be larger, especially with TA, the difference was not statistically 




Figure 6.17: Peak systolic tenting height and area measurements are shown as an 
effect of annular dilatation, along the coaptation lines: septal/anterior (SA), 
septal/posterior (SP), anterior/posterior (AP). 
 
6.2.2 Isolated Papillary Muscle Displacement 
The effect of PM displacement was investigated through sole displacement of the anterior 
PM and combined displacement of the septal and posterior PM, as these PMs would be expected 
to move together as they are both located on the septum. Combined PM displacement was then 
93 
 
simulated in which all three PMs were displaced. Each PM was displaced in multiple directions 
and is described in further detail in each section. 
6.2.2.1 Anterior Papillary Muscle Displacement 
 The anterior PM was displaced from a control position laterally and apically, both 
separately and combined (Fig. 6.18). Each PM was displaced by 10 mm from its control 
position in each direction. 
 
Figure 6.18: Control position of PMs along with directions of APM displacement. 
Control position is shown with a solid line with displaced positions is shown with a 
dashed line. Note: Apical displacement is shown as displaced into the image, away 
from the annulus, as a smaller circle. 
 
6.2.2.1.1 Hemodynamics 
TR was significantly (p = 0.001) impacted by PM displacement, when annular 
size was maintained at a normal size. Individual APM displacement in the lateral (1.76 ± 
1.89 mL) and apical (4.13 ± 4.35 mL) directions did not result in significant increases in 
TR from control. A significant increase in TR was seen with displacement of the APM 
alone (Fig.6.19). Only combined displacement in the apical and lateral directions resulted 




Figure 6.19: Tricuspid regurgitation as an effect of APM displacement with 
significance (* = p ≤ 0.05), as compared to control, n = 8. Bar colors correspond to 
PM which was displaced: black (no displacement), blue (APM). 
Malcoaptation, defined as the absence of leaflet coaptation, was visibly present in 
the center of the three leaflets with displacement of the APM with combined lateral and 
apical displacement. Lateral displacement of the APM resulted in valve coaptation 
similar to that in the normal valve, with coaptation towards the septal annulus segment. 
Apical displacement of the APM either isolated or combined with lateral displacement 
resulted in a coaptation of the leaflets that was more central as compared to control, 




Figure 6.20: Image of valve with isolated APM displacement. PM displacement 
shown with a dashed line, as compared to control position solid line. 
 
6.2.2.1.2 Residual Leaflet Length 
With significant TR measured in the presence of APM displacement in a 
combined direction (lateral and apical), the effect of APM displacement on RLL was then 
investigated. RLL was measured for all three leaflets as an effect of APM displacement 
in individual apical and lateral and combined directions. When the difference in RLL for 
each leaflet was investigated across all PM displacements, RLL was found to vary 
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significantly on the anterior leaflet (p = 0.004), but not for the posterior (p = 0.342) or 
septal (p = 0.110) leaflets. Anterior RLL was significantly different (p ≤ 0.05, denoted in 
Fig 6.21,#) from control with apical and combined lateral and apical displacement of the 
APM. Percent change in RLL varied significantly by leaflet (p = 0.000). The septal 
leaflet was significantly different than both anterior and posterior RLL. This is observed 
in figure 6.21 with septal RLL consistently decreasing and anterior and posterior RLL 
increasing. Further investigation was conducted with combined lateral and apical 
displacement of the APM, as this was the condition which resulted in significant TR. 
RLL was significantly different across the three leaflets (p = 0.002) with the septal leaflet 
having significantly (p ≤ 0.05,*) less leaflet available for coaptation as compared to the 





Figure 6.21: Percent change in RLL from control as an effect of APM displacement 
as shown for each individual leaflet: posterior (blue), anterior (red), and septal 
(green). Standard error is shown. Significance shown as *, p ≤ 0.05 compared within 
PM displacement, #, p ≤ 0.05 compared to control for the same leaflet. Grey box 
highlights condition with significant TR. 
 
6.2.2.1.3 Chordal Force 
With an understanding of the changes in RLL, the effect of APM displacement on 
forces of the chords branching from the APM and inserting into the anterior and posterior 
PM was investigated. Chordal force was not affected by APM displacement for any of 
the chords measured: Anterior marginal (p = 0.358), anterior intermediate (p = 0.862), 
anterior strut (p = 0.695), posterior marginal (p = 0.360), posterior intermediate (p = 
0.956) and posterior strut (p = 0.072). Force measurements for chordae measured are 




Figure 6.22: Differential chordal force measurements for chordae originating from 
the APM. Bar colors correspond to PM which was displaced: black (no 
displacement), blue (APM). 
6.2.2.1.4 Leaflet Mobility 
Finally, the impact of APM displacement on leaflet mobility was assessed through 
measurement of tenting height and tenting area on the septal/anterior, septal/posterior, 
and anterior/posterior coaptation lines. APM displacement had a significant impact on 
tenting height (p = 0.016) and tenting area (p = 0.009) across the anterior and posterior 
leaflets. There was no difference in tenting height (p = 0.334) or tenting area (p = 0.080) 
at the coaptation of the septal and anterior leaflets. Likewise no difference was seen for 
the septal and posterior coaptation line for tenting height (p = 0.179) or tenting area (p = 
0.803). Investigation into which direction of APM displacement was responsible for 
alterations in leaflet mobility at the anterior/posterior coaptation line found differences in 
both tenting height and tenting area with combined lateral and apical displacement (Fig. 
6.23). It is interesting to note that this is the same condition in which a significant 





Figure 6.23: Peak systolic tenting height and area measurements are shown as an 
effect of APM displacement, along the coaptation lines: septal/anterior (SA), 
septal/posterior (SP), anterior/posterior (AP). Significance shown as *, p ≤ 0.05. 
 
6.2.2.2 Septal and Posterior Papillary Muscle Displacement 
The septal and posterior PM were displaced simultaneously as they are both 
located on the septum and would be expected to move together in a similar direction. The 
septal PM was displaced from a control position anteriorly, laterally and apically, both 
separately and combined. Likewise the posterior PM was displaced from a control 
100 
 
position posteriorly, laterally and apically, both separately and combined (Fig. 6.24). 
Each PM was displaced by 10 mm from its control position. 
 
Figure 6.24: Control position of PMs along with directions of SPM/PPM 
displacement. Control position is shown with a solid line with displaced positions 
shown with a dashed line. Note: Apical displacement is shown as displaced into the 
image, away from the annulus, as a smaller circle. 
6.2.2.2.1 Hemodynamics 
TR was significantly (p = 0.001) impacted by PM displacement, when annular 
size was maintained at a normal size. Specifically, displacement of the septal and 
posterior PMs in the combined direction (anterior/posterior, lateral and apical) resulted in 
significant (p ≤ 0.05) TR when compared to control (Fig.6.25). Additionally, when 
looking at the hemodynamic results one might suspect that lateral displacement of the 
septal and posterior PMs resulted in significant TR, but this cannot be shown statistically. 
The reason for this is due to the high variability in the measurements which resulted in a 
non-normal distribution of the data. When a detailed analysis was conducted of the 
measurements for this condition it was seen that the data fell into two groups, valves (n = 
3) with high levels of TR (11.4 ± 5.4 mL) and valves (n = 5) with insignificant levels (1.7 
± 0.3 mL). Thus, the resulting two groupings of data could not be assessed with statistical 
comparisons, because even the use of a non normal test would rank the data, and result in 




Figure 6.25: Tricuspid regurgitation as an effect of SPM/PPM displacement with 
significance (* = p ≤ 0.05), as compared to control, n = 8. Bar colors correspond to 
PM which was displaced: black (no displacement), red (SPM/PPM). 
Observations were next made as to the effect of septal and posterior PM 
displacement on leaflet coaptation. Differences in leaflet coaptation, as viewed from the 
atrium, were only visible with lateral displacement either isolated or combined, of the 
septal and posterior PMs. When the PMs were displaced only laterally the coaptation line 
was towards the anterior/posterior sections of the annulus, thus the septal leaflet covered 
the majority of the orifice (6.26). With lateral displacement of the SPM/PPMs was 





Figure 6.26: Image of valve with isolated SPM/PPM displacement. PM displacement 
shown with a dashed line, as compared to control position with a solid line. 
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6.2.2.2.2 Residual Leaflet Length 
The effect of SPM and PPM displacement on RLL was investigated as this 
condition resulted in a significant increase in TR when displaced in the combined 
direction (anterior/posterior, lateral and apical) direction. RLL was measured for all three 
leaflets as an effect of SPM/PPM displacement in individual (anterior/posterior, lateral 
and apical) and combined directions. When the difference in RLL for each leaflet was 
investigated across all PM displacements, RLL did not vary significantly across any 
leaflet: anterior (p = 0.229), posterior (p = 0.352) and septal (p = 0.343) (Fig. 6.27). 
Percent change in RLL varied significantly by leaflet (p = 0.006) with the septal leaflet 
being significantly different than the posterior RLL. This is observed in figure 6.19 with 
the septal leaflet RLL consistently decreasing while posterior RLL was increasing. 
Further investigation was conducted with combined anterior/posterior, lateral and apical 
displacement of the SPM/PPM, as this was the condition which resulted in significant 
TR. RLL was not significantly different across the three leaflets (p = 0.247). Additional 
analysis was conducted to determine if there was a difference between RLL across the 
leaflets when the SPM/PPM was displaced laterally as this condition resulted in high 
levels of TR in some valves. However, individual leaflet RLL was not affected (p = 




Figure 6.27: Percent change in RLL from control as an effect of SPM/PPM 
displacement as shown for each individual leaflet: posterior (blue), anterior (red), 
and septal (green). Standard error is shown. Grey box highlights condition with 
significant TR. 
 
6.2.2.2.3 Chordal Force 
Chordal force was not measured with isolated displacement of the septal and 
posterior PMs in any direction. It was assumed that displacement of the SPM and PPM 
would not significantly alter forces on chords originating from the APM hence the force 
transducers were mounted on the APM only. However, displacement of the SPM and 
PPM was investigated in conjunction with APM displacement, with all three PMs 





6.2.2.2.4 Leaflet Mobility 
Lastly, the impact of septal and posterior PM displacement on leaflet mobility 
was assessed through measurement of tenting height and tenting area on the three 
coaptation lines. No difference was seen in tenting height (p = 0.109) or tenting area (p = 
0.166) across the septal and anterior coaptation line. Similarly no difference was seen in 
either tenting height (p = 0.057) or tenting area (p = 0.206) across the septal and posterior 
coaptation line. Finally when leaflet mobility was assessed for the anterior and posterior 
coaptation line, no difference was seen in either tenting height (p = 0.527) or tenting area 
(p = 0.713). Results for leaflet mobility measurements can been seen in the below figure 
(Fig. 6.28). While displacement of the septal and posterior PMs in the combined 
directions (posterior/anterior, lateral and apical) seems to decrease leaflet mobility, as 
seen with an increase in tenting height and tenting area in the septal/posterior and 




Figure 6.28: Peak systolic tenting height and area measurements are shown as an 
effect of SPM/PPM displacement, along the coaptation lines: septal/anterior (SA), 
septal/posterior (SP), anterior/posterior (AP). 
 
6.2.2.3 Combined Anterior, Septal and Posterior Papillary Muscle Displacement 
Finally, a severe PM displacement condition was created in which all three PMs 
were displaced simultaneously with combined directions. The anterior PM was displaced 
with combined lateral and apical directions. This was simulated in conjunction with 
displacement of the septal PM in an anterior, lateral and apical direction while the 
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posterior PM was displaced in a posterior, lateral and apical direction (Fig. 6.29). Each 
PM was displaced by 10 mm from its control position. 
 
Figure 6.29: Control position of PMs along with directions of APM/SPM/PPM 
displacement. Control position is shown with a solid line with displaced positions is 
shown with a dashed line. Note: Apical displacement is shown as displaced into the 
image, away from the annulus, as a smaller circle. 
 
6.2.2.3.1 Hemodynamics 
TR was significantly (p = 0.001) impacted by PM displacement, when annular 
size was maintained at a normal size. A significant increase (p ≤ 0.05) in TR was seen 
with severe displacement of all three PMs (Fig.6.30). Combined displacement of the 




Figure 6.30: Tricuspid regurgitation as an effect of combined APM/SPM/PPM 
displacement with significance (* = p ≤ 0.05), as compared to control, n = 8. Bar 
colors correspond to PM which was displaced: black (no displacement), green 
(APM/PPM/PPM). 
With significant levels of TR observed with combined PM displacement, 
observations were made as to the effect on leaflet coaptation. A difference could be seen 
in the location of leaflet coaptation with the leaflets coapting more towards the anterior 
and posterior section of the annulus, away from the septal segment. This can be seen in 
the below images when compared to the control case (Fig. 6.31). Displacement of all 
PMs results in the septal leaflet covering more of the orifice. This is due to a restriction in 
the anterior and posterior leaflets, with anterior PM displacement and increased septal 





Figure 6.31: Image of valve with combined APM/SPM/PPM displacement. PM 
displacement shown with a dashed line, as compared to control position with a solid 
line. 
While it could be shown that combined displacement of the APM (lateral and 
apical), SPM (anterior, lateral, apical) and PPM (posterior, lateral apical) resulted in 
significant TR, it was of interest to determine the role of a 3D saddle shape on TR. A 
significant difference (p = 0.024) was seen in the amount of TR when saddle and no 
saddle was compared with severe PM displacement (Fig. 6.32). In the case of severe PM 
displacement the presence of a 3D saddle resulted in a reduction in TR from 6.32 ± 7.28 
with a flat saddle to 4.48 ± 7.12 mL with a saddle, for an approximate reduction of 1.40 ± 





 Figure 6.32: Plot of TR for control and all PMs displaced in all directions with 
(grey bar) and without a saddle (black bar). Significance shown as * = p ≤ 0.05. 
 
6.2.2.3.2 Residual Leaflet Length 
Next, RLL was then investigated to determine if the increase in TR could be 
explained with alterations in the leaflet mechanics. RLL was measured for all three 
leaflets as an effect of APM/SPM/PPM displacement in combined directions. Posterior 
RLL was the only leaflet which had a significant difference (p = 0.049, #) from control 
with PM displacement. Neither anterior (p = 0.087) nor septal (p = 0.147) RLL was 
affected by severe PM displacement (Fig. 6.33). Further investigation of RLL across 
leaflets  with displacement of the APM (laterally and apically), SPM (anteriorlly, laterally 
and apically) and the PPM (posteriorlly, laterally, and apically) was conducted as this 
condition resulted in significant TR. RLL was significantly different across the three 
leaflets (p = 0.043). Specifically, septal leaflet RLL was significantly (p ≤ 0.05, *) 




Figure 6.33: Percent change in RLL from control as an effect of APM/SPM/PPM 
displacement as shown for each individual leaflet: posterior (blue), anterior (red), 
and septal (green). Standard error is shown. Significance shown as *, p ≤ 0.05 
compared within PM displacement, #, p ≤ 0.05 compared to control. Grey box 
highlights condition with significant TR. 
 
6.2.2.3.3 Chordal Force 
Next, the impact of multidirectional displacement of the anterior, septal and 
posterior PMs was investigated for the main chords originating from the APM and 
inserting into the anterior and posterior leaflets. Severe PM displacement resulted in a 
significant increase (p = 0.020) of force in the strut chord inserting into the posterior 
leaflet. No additional increases in forces were seen in chords inserting into the posterior 
leaflet: marginal (p = 0.510) and intermediate (p = 0.824). An increase in chordal force 
with severe displacement was not observed for any chords inserting into the anterior 
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leaflet: strut (p = 0.268), marginal (p = 0.430) and intermediate (p = 0.156). Results for 
chordal forces measurements are shown in figure 6.34. 
 
Figure 6.34: Differential chordal force measurements for chords originating from 
the APM/SPM/PPM. Bar colors correspond to PM which was displaced: black (no 
displacement), green (APM/SPM/PPM). 
 
6.2.2.3.4 Leaflet Mobility 
This final step for assessing the impact of isolated PM displacement on the 
tricuspid valve was to investigate changes in leaflet mobility with multidirectional 
displacement of the anterior, posterior and septal PM. Leaflet mobility was assessed 
through measurement of tenting height and tenting area on the septal/anterior, 
septal/posterior and anterior/posterior coaptation lines. A decrease in leaflet mobility was 
observed at the septal and anterior leaflet coaptation line as measured as a significant 
increase in tenting height (p = 0.017) and tenting area (p = 0.013). Additionally, a 
significant increase in tenting height (p = 0.013) and tenting area (p = 0.006) was 
observed across the septal and posterior leaflet coaptation line. While a decrease in leaflet 
113 
 
mobility was seen with coaptation lines of the septal leaflet, no change was seen the 
anterior and posterior leaflet coaptation line: tenting height (p = 0.091) and tenting area 
(p = 0.088) (Fig. 6.35). These results indicate that displacement of the APM (lateral and 
apical), SPM (anterior, lateral, apical) and PPM (posterior, lateral apical) affect only the 





Figure 6.35: Peak systolic tenting height and area measurements are shown as an 
effect of APM/SPM/PPM displacement, along the coaptation lines: septal/anterior 




6.2.3 Combined Annular Dilatation and Papillary Muscle Displacement 
 With investigation of isolated annular dilatation and PM displacement complete, 
the logical next step was to determine the impact of the combined effect of these 
alterations on the mechanics of the tricuspid valve. The next section will be divided in the 
same manner as the isolated PM displacement section, with annular dilatation combined 
with displacement of the anterior PM presented followed by combined septal and 
posterior PM displacement, and finally with the combination of all three PMs displaced.  
6.2.3.1 Anterior Papillary Muscle Displacement 
 Annular dilatation was combined with displacement of the anterior PM from a 
control position laterally and apically, both separately and combined (Fig. 6.36). The 
APM was displaced by 10 mm in each direction from its control position. 
 
Figure 6.36: Control position of PMs along with directions of APM displacement. 
Control position is shown with a solid line with displaced and dilated positions 
shown with a dashed line. Note: Apical displacement is shown as displaced into the 
image, away from the annulus, as a smaller circle. 
 
6.2.3.1.1 Hemodynamics 
As dilatation alone resulted in significant TR beyond 40% dilatation, it was of 
interest to determine if PM displacement further increased the amount of TR. No 
significant increase in TR from isolated annular dilatation when combined with APM 
displacement (laterally, apically or combined) were observed (Fig. 6.37). APM 
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displacement only played a role in the creation of TR without the presence of annular 
dilatation as reported previously. 
 
 
Figure 6.37: Tricuspid regurgitation as an effect of APM displacement with 
significance (* = p ≤ 0.05), as compared to control, n = 8. Bar colors correspond to 
PM which was displaced: black (no displacement), blue (APM). 
As was seen with isolated dilatation, in the combined case, the anterior and 
posterior leaflets covered a majority of the orifice as they attached to the sections of the 
annulus which were dilated. Similar coaptation characteristics as observed with isolated 
APM displacement were seen in the combined case, with apical displacement restricting 




Figure 6.38: Image of valve with combined 100% annular dilatation and APM 
displacement. PM displacement shown with a dashed line, as compared to control 
position solid line. 
 
6.2.3.1.2 Residual Leaflet Length 
With no significant change in TR with combined annular dilatation and APM 
displacement, it was not expected that there would be significant alterations in RLL. A 
combination of 40% dilatation and displacement of the APM did not have a significant 
impact on RLL for any leaflet: anterior leaflet (p = 0.051), posterior (p = 0.566) or septal 
(p = 0.506) leaflets (Fig. 6.39). However, investigation of combined 100% annular 
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dilatation and APM displacement had a significant impact on anterior RLL (p = 0.002) 
for all directions displaced. This was not significant for the posterior (p = 0.487) and the 
septal (p = 0.320) leaflets. A difference in RLL was observed with APM displacement 
and combined annular dilatation, however, it was found to have less of a reduction in 




Figure 6.39: Percent change in RLL from control (y axis) as an effect of annular 
dilatation (x axis) for APM displacement for all individual leaflets. Standard error is 




to the anterior 
leaflet. Chordal force measurements are shown in the below figure 6.40.   
3 Chordal Force 
Next, it was of interest to determine if chordal forces were redistributed with 
combined annular dilatation and APM displacement. As the forces were increased on all 
chords with isolated annular dilatation but not with isolated APM displacement it was of 
interest to see the results of the combined case. Combined annular dilatation of 100% and 
APM displacement had a significant impact on forces measured on all main APM chords 
inserting into the anterior leaflet: marginal (p = 0.016), intermediate (p = 0.006), strut (p 
= 0.010). Both isolated lateral and combined apical/lateral directional displacement of the 
APM resulted in significant increases (p ≤ 0.05) in chordal force as compared to normal 
for the anterior chords. APM displacement had a significant impact on the posterior strut 
(p = 0.032) chord, but not for the posterior marginal (p = 0.063) or intermediate (p = 
0.210) chords. Forces measured on strut chords inserting into the posterior leaflet had a 
significant increase in force only with apical displacement of the APM with 100% 
annular dilatation. Thus, combined annular dilatation and apical displacement of the 
APM only affected strut chords. Additionally, lateral displacement both isolated and 




Figure 6.40: Differential chordal force measurements for chordae originating from 
the APM. Bar colors correspond to PM which was displaced: black (no 
displacement), blue (APM). 
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6.2.3.1.4 Leaflet Mobility 
Tenting height and tenting area were then measured to assess the impact of 
combined annular dilatation of 100% and APM displacement on leaflet mobility. Leaflet 
mobility was measured across the coaptation of the leaflets: septal/anterior, 
septal/posterior and anterior posterior. Combined dilatation and APM displacement had a 
significant impact on tenting height (p = 0.000) and tenting area (p = 0.000) on the 
coaptation line of the anterior and posterior leaflets. There was no difference seen at the 
SA coaptation line in tenting height (p = 0.619) or tenting area (p = 0.128). Additionally, 
no difference was seen at the SP coaptation line for tenting height (p = 0.935) or tenting 
area (p = 0.265). It was found that combined annular dilatation and displacement of the 
APM  apically, both isolated and combined with lateral displacement, resulted in 
significant increase (p ≤ 0.05) in tenting height and area at the AP coaptation line (Fig. 
6.41). Thus it can be stated that the mobility of the anterior and posterior leaflets was 




Figure 6.41: Peak systolic tenting height and area measurements are shown as an 
effect of APM displacement, along the coaptation lines: septal/anterior (SA), 
septal/posterior (SP), anterior/posterior (AP). Significance shown as *, p ≤ 0.05. 
 
6.2.3.2 Septal and Posterior Papillary Muscle Displacement 
The septal and posterior PM were displaced together as they are both located on 
the septum and would be expected to move together in a similar direction. The septal PM 
was displaced from a control position anteriorly, laterally and apically, both separately 
and combined. Likewise the posterior PM was displaced from a control position 
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posteriorly, laterally and apically, both separately and combined (Fig. 6.42). Each PM 
was displaced by 10 mm from its control position. 
 
Figure 6.42: Control position of PMs along with directions of SPM/PPM 
displacement. Control position is shown with a solid line with annular dilatation and 
displaced positions shown with a dashed line. Note: Apical displacement is shown as 
displaced into the image, away from the annulus, as a smaller circle. 
 
6.2.3.2.1 Hemodynamics 
Once again, as dilatation alone resulted in significant TR beyond 40% dilatation, 
it was of interest to determine if displacement of PMs on the septum further increased the 
amount of TR. No significant increase from TR levels as observed with dilation was seen 
with the addition of simultaneous displacement of the SPM (anteriorly, laterally, apically 
or combined) and PPM (posteriorly, laterally, apically or combined) (Fig. 6.43).  
Displacement of the septal and posterior PMs only played a role in the creation of TR 
without the presence of annular dilatation as discussed previously. As was discussed in 
section 6.2.2.2.1, a statistical analysis could not be performed for the case of lateral 
displacement when combined with 40% dilatation as the data were not normally 
distributed and resulted in two distinct groups, valves (n = 3) with high levels TR (22.5 ± 
5.6 mL) and valves(n = 5) with insignificant levels (1.9 ± 1.9 mL). However, 100% 
dilated condition was normally distributed. Thus, lateral displacement was statistically 




Figure 6.43: Tricuspid regurgitation as an effect of SPM/PPM displacement with 
significance (* = p ≤ 0.05), as compared to control, n = 8. Bar colors correspond to 
PM which was displaced: black (no displacement), red (SPM/PPM). 
As with all other conditions tested, observations were made as to the effect of 
combined annular dilatation and septal and posterior PM displacement on leaflet 
coaptation. Aside from the increase in surface area of the anterior and posterior leaflets 
with annular dilatation, differences in leaflet coaptation were only visible with lateral 
displacement of the septal and posterior PMs. When the PMs were displaced only 
laterally, the coaptation line was towards the anterior/posterior sections of the annulus, 
thus the septal leaflet covered the majority of the orifice.  When the septal and posterior 
PMs were displaced in a combined direction (anterior/posterior, lateral, apical) coaptation 
was more towards the center of the annulus as compared to the normal and annular 
dilated conditions (6.44). The coaptation mimicked a combination of the isolated cases, 
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with lateral displacement of the anterior and posterior PMs moving the coaptation line 





Figure 6.44: Image of valve with isolated SPM/PPM displacement. PM displacement 




6.2.3.2.2 Residual Leaflet Length 
While no significant increases were observed with the addition of septal and 
posterior PM displacement to annular dilatation, it was still necessary to assess RLL as 
changes were observed in leaflet coaptation. RLL was measured for all three leaflets as 
an effect combined annular dilatation and SPM/PPM displacement in individual 
(anterior/posterior, lateral and apical) and combined directions. A combination of 40% 
dilatation and displacement of the SPM/PPM did not have a significant impact on RLL 
for any leaflet: anterior leaflet (p = 0.051), posterior (p = 0.497) leaflet. While SPM/PPM 
displacement had a significant effect on the septal (p = 0.031) leaflet mobility, further 
investigation showed there was no difference  when  disease conditions where compared 
to control, thus the difference was between the disease conditions. This is evident in the 
below figure where the RLL is much different with apical displacement as compared to 
control and the other disease conditions. Additionally, investigation of the combination of 
100% annular dilatation and SPM/PPM displacement did not have a significant impact on 
RLL for any of the leaflets: anterior (p = 0.126), posterior (p = 0.227) and septal (p = 




Figure 6.45: Percent change in RLL from control (y axis) as an effect of annular 
dilatation (x axis) for S/PPM displacement for all individual leaflets. Standard error 




6.2.3.2.3 Chordal Force 
Chordal force was not measured with combined annular dilatation and 
displacement of the septal and posterior PMs in any direction. The rational is the same as 
stated for isolated displacement of the septal and posterior PM, that since the force 
transducers were mounted on the APM, it was assumed that displacement of the SPM and 
PPM would not affect forces on chords originating from the APM. However, 
displacement of the SPM and PPM was investigated in conjunction with APM 
displacement, with all three PMs displaced in the combined directions with combined 
annular dilatation. See section 6.2.2.3.3 for detailed results. 
6.2.3.2.4 Leaflet Mobility 
Lastly, the impact of combined annular dilatation and septal and posterior PM 
displacement on leaflet mobility was assessed through measurement of tenting height and 
tenting area on the three coaptation lines: septal/anterior, septal/posterior, and 
anterior/posterior. A significant difference was observed at the septal/anterior coaptation 
line for both tenting height (p = 0.004) and tenting area (p = 0.002). It was determined 
that apical and combined (anterior/posterior, lateral, apical) directional displacement 
resulted in significant increases (p ≤ 0.05) in both tenting height and area. No difference 
was seen in either tenting height (p = 0.433) or tenting area (p = 0.834) across the anterior 
and posterior coaptation line. While septal and posterior PM displacement had a 
significant impact on both tenting height (p = 0.034) and tenting area (p = 0.013), further 
investigation showed there was no difference  when  disease conditions where compared 
to control, thus the difference was between the disease conditions. This is better 
understood by visualizing the data in figure 6.46. It is evident that while the directions 
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measured in the S/A line did not vary from control they may have varied between the 
different directions of PM displacement, with lateral displacement appearing to be 
smallest. Results for leaflet mobility measurements can been seen in the below figure 
(Fig. 6.46). Displacement of the septal and posterior PMs in both apical and combined 
(posterior/anterior, lateral and apical) directions decrease leaflet mobility, at the 
coaptation line of the septal and anterior leaflets. 
 
Figure 6.46: Peak systolic tenting height and area measurements are shown as an 
effect of combined 100% annular dilatation and SPM/PPM displacement, along the 





6.2.3.3 Combined Anterior, Septal and Posterior Papillary Muscle Displacement 
Finally, a severe PM displacement condition was created in which all three PMs 
were displaced simultaneously with combined directions and implemented in conjunction 
with annular dilatation. This condition was the most severe simulation of disease in the 
model. For combined PM displacement, the APM was displaced with combined lateral 
and apical directions with the SPM in an anterior, lateral and apical direction while the 
PPM was displaced in a posterior, lateral and apical direction (Fig. 6.47). Each PM was 
displaced by 10 mm from its control position. 
 
Figure 6.47: Control position of PMs along with directions of APM/SPM/PPM 
displacement. Control position is shown with a solid line with annular dilatation and 
displaced positions shown with a dashed line. Note: Apical displacement is shown as 
displaced into the image, away from the annulus, as a smaller circle. 
 
6.2.3.3.1 Hemodynamics 
When combined, both annular dilatation (p = 0.000) and PM displacement (p = 
0.000) had a significant effect on TR as compared to annular dilatation alone. Severe PM 
displacement, all PMs displaced in all directions, was the only displacement which 
resulted in further increases (p ≤ 0.05) in TR from annular dilatation, of 40% and 100%. 
The largest levels of TR were reached at 100% dilatation with all PMs displaced in all 




Figure 6.48: Tricuspid regurgitation as an effect of combined APM/SPM/PPM 
displacement with significance (* = p ≤ 0.05), as compared to control, n = 8. Bar 
colors correspond to PM which was displaced: black (no displacement), green 
(APM/PPM/PPM). 
While it could be shown that annular dilatation of 40% and 100% and combined 
displacement of the APM (lateral and apical), SPM (anterior, lateral, apical) and PPM 
(posterior, lateral apical) resulted in significant TR, it was unknown as to the role of a 3D 
saddle shape on TR in this disease state. No significant difference was seen in the amount 
of TR when saddle and no saddle were compared with combined annular dilatation and 




Figure 6.49: Plot of TR for control and 100% dilatation with all PMs displaced in all 
directions with and without a saddle. No significance was found between saddle and 
no saddle. 
Malcoaptation occurred at the junction of the three leaflets for all combined 
disease conditions, as was expected as annular dilatation alone resulted in malcoaptation. 
The largest levels of TR, where seen when the annulus was dilated by 100% and all PMs 
were displaced in all directions. In this condition, the area of no coaptation was located 
more towards the anterior and posterior annulus segments. A large hole can be seen 





Figure 6.50: Image of valve with 100% dilatation and combined APM/SPM/PPM 
displacement. PM displacement shown with a dashed line, as compared to control 
position with a solid line. 
 
6.2.3.3.2 Residual Leaflet Length 
Next, RLL was assessed to determine if any information could be gained from the 
assessment in changes in the amount of leaflet available for coaptation, as to why 
significant TR occurred. RLL was measured for all three leaflets as an effect of combined 
annular dilatation and APM/SPM/PPM displacement in combined directions. It was first 
determined if RLL for an individual leaflet varied with disease as compared to control. 
Next, within a given dilatation, 40% and 100%, RLL of the disease case was compared to 
control. A significant difference in RLL was only observed for the anterior leaflet with 
40% (p = 0.004) and 100% (p = 0.012) dilatation. No significance difference was seen for 
40% dilatation for the posterior (p = 0.629) and septal (p = 0.361) with the same 
observations for 100% dilatation for the posterior (p = 0.531) and septal (p = 0.519) 




Figure 6.51: Percent change in RLL from control (y axis) as an effect of annular 
dilatation (x axis) for All PM displacement for all individual leaflets. Standard error 
is shown. * = p ≤ 0.05 as compared to control for same level of dilatation.  
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6.2.3.3.3 Chordal Force 
Next, the impact of combined annular dilatation and displacement of the anterior 
(lateral and apical), septal (anterior, lateral and apical) and posterior (posterior, lateral, 
apical) PMs was investigated for the main chords originating from the APM and inserting 
into the anterior and posterior leaflets. Combined annular dilatation and severe PM 
displacement resulted in a significant increase in force for strut chords inserting into the 
anterior (p = 0.047) and posterior (p = 0.013) leaflets. Displacement of all PMs and 
combined annular dilatation did not have an impact on chordal force for the anterior 
marginal (p = 0.0.68), anterior intermediate (p = 0.103), posterior marginal (p = 0.117), 
and posterior intermediate (p = 0.209) chords. Results for chordal forces measurements 




Figure 6.52: Differential chordal force measurements for chordae originating from 
the APM/SPM/PPM. Bar colors correspond to PM which was displaced: black (no 




6.2.3.3.4 Leaflet Mobility 
This final step for assessing the impact of combined annular dilatation and PM 
displacement on the tricuspid valve was to investigate changes in leaflet mobility with 
multidirectional displacement of the anterior, posterior and septal PMs. This was 
completed through measurement of the tenting height and tenting area on the 
septal/anterior, septal/posterior and anterior/posterior coaptation lines. Tenting height was 
significantly increased across the septal/anterior (p = 0.001), septal/posterior (p = 0.036) 
and anterior/posterior (p = 0.001) coaptation lines. The same trends were seen with 
tenting area across the septal/anterior (p = 0.000), septal/posterior (p = 0.007) and 
anterior/posterior (p = 0.001) coaptation lines (Fig. 6.53). These results demonstrate that 
combined annular dilatation (100%) and displacement of the APM (lateral and apical), 
SPM (anterior, lateral, apical) and PPM (posterior, lateral apical) severely affects the 




Figure 6.53: Peak systolic tenting height and area measurements are shown as an 
effect of APM/SPM/PPM displacement, along the coaptation lines: septal/anterior 




The implication of these results and how they are used to explain the impact of 
alterations in the annular and subvalvular apparatus on tricuspid valve mechanics will be 
discussed in detail in the following chapter. Additionally, the clinical implications of this 






This thesis provides a detailed understanding of the mechanics of the normal 
tricuspid valve, as well as insights into how the valve is altered in a diseased state. Details 
of these mechanisms are provided through both in vivo and in vitro investigations. This 
work is supported by the belief that providing a better understanding of how the tricuspid 
valve is altered from normal to disease, may provide valuable knowledge to the clinical 
community target and improve TV repairs.  
The first specific aim used 3D echo imaging in vivo to determine if the RV 
papillary muscles were displaced with ventricular dilatation as has been theorized 13, 24, 45, 
69 and as is seen in the MV 74, 75. It was seen that both RV and LV dilatation result in PM 
displacement. The analysis was extended to determine correlation to the severity of TR to 
the geometry of the ventricle, specifically annular area and various PM displacements.  In 
addition, PA pressure was seen to be a predictor of the severity of TR. 
 The in vitro set up allowed a precise determination of the specific geometric 
mechanisms responsible for TR, through investigation of RLL, leaflet mobility, and 
chordal forces. It was determined that with annular dilatation, the anterior leaflet extends 
to compensate for the larger orifice area, and reduced mobility of the septal and posterior 
leaflets. However, it can only successfully do so up to a 40% increase in annular area.  
Interestingly, it was shown that TR can be present with isolated PM displacement. More 
specifically, multidirectional displacement of a single or multiple PMs, results in extreme 
changes in leaflet mobility and loss of coaptation. A combination of annular dilatation 
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and PM displacement showed the highest levels of TR. This combined increase in 
annular orifice area and PM restriction, drastically alters leaflet mobility, coaptation, and 
chordal force distribution. 
 Unfortunately, it was not possible to investigate the specific PM displacements 
found in patients using the in vitro set up as these studies were done in parallel. However, 
information from both studies remains essential. In vivo studies were used to determine of 
pathological PM displacement, while in vitro studies provided a controlled environment 
to investigate specific disease conditions and their resulting mechanics. The development 
of a tool to measure PM position in vivo using 3D echocardiography will enable future 
studies to investigate more specific patient populations. In addition, the development of 
the in vitro model provides a test bed for further investigation into the mechanics of 
disease and eventually assessment of TV specific repairs. 
7.1 In vivo 
Prior to initiating the 3D echo measurements for specific aim one, it was first 
determined if RV PMs could be identified using MRI 76.  This study was the first report 
describing the specific locations of all three RV PMs. This was done in control subjects 
and patients with a dilated LV using cardiac MRI. While all three PMs could be 
identified, a difference was only seen in the septal PM when compared between RV PM 
position in normal patients and patients with a dilated left ventricle. These data showed 
that left ventricular dilatation resulted in the inward displacement of the septal PM 
towards the centroid of the three PMs. This may be due to the displacement of the septal 
wall into the RV with the increased left ventricular volume (Appendix H). While LV 
dysfunction has typically been related to RV dysfunction through pulmonary 
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hypertension 16, 18, 77, others believe changes in the LV geometry may be directly linked to 
the RV though the interventricular septum 2. Additionally, Anyanwu et al. proposed LV 
dysfunction or dilatation as a mechanism of TR with normal pulmonary hypertension 24. 
Weber and Janicki discuss in detail interventricular septum effects and the displacement 
of the septum into the RV with acute LV distention 69. These results clearly show the 
interplay of the dilated left ventricular volume and the right ventricle and the effect of the 
resulting septum displacement into the RV on the PMs. This motion of the septal wall 
into the RV may affect the septal leaflet as it is attached to the septal and posterior PMs 
located on the septum through chordae tendineae. It is speculated that the PM 
displacement observed in the diseased group may have contributed to the TR present in 
five of the 7 patients. With this in mind the echo study was developed to specifically look 
at the effect of ventricular geometry on the TV apparatus and its relation to the grade of 
TR.  
With the findings using MRI, 3D echo was then investigated as it is more widely 
used in clinical practice as opposed to MRI. Overall, 3D echo proved to be useful in this 
study to identify the PMs, as it allowed for offline analysis of the entire TV geometry. 
Previous methods used to identify TV PM position include, MRI25, 2D 
echocardiography78, 79 and sonomicrometry35, 36. While MRI may provide a more detailed 
geometrical description of the TV apparatus, it is not typically acquired in standard of 
care procedures, as it is a more expensive and longer procedure. Sonomicrometry is a 
useful tool but has only been used in in vivo animal studies and is not suitable for patient 
care. While 2D echo is the most commonly used modality for patient imaging, it requires 
the technician to identify the three PMs at the time of image acquisition. With recent 
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advancements and greater availability, 3D echocardiography is becoming more widely 
used clinically. 3D acquisition allows the offline interrogation of the entire TV geometry 
as the entire 3D volume is captured during the patient scan. Additionally, 3D 
echocardiography can be very useful in identifying leaflet motion, PM locations and 
presence of malcoaptation (Appendix I). Patients with a dilated RV were the easiest to 
image, with the viewing window adjusted to focus on the RV. The same adjustments 
were made for patients with both RV and LV dilation. The APM was the easiest to 
visualize in all patients, as it is the most well defined because of its protrusion from the 
free wall 43. 
 In vivo 3D echocardiography provided a unique investigation of the determinates 
of TR by utilization of an increasingly relevant clinical technique. Knowledge of the 
changes in ventricular geometry and their effect on TR were expanded by collecting 
measurements of the annulus, leaflet tethering and the individual PMs. The technique of 
using 3D echo to measure PM positions may also prove helpful for clinicians to 
determine which PM is contributing to the TR and target their repair efforts. It is 
impossible to know the initial position of any given PM, as patients do not routinely 
undergo echo examination until the disease has already manifested. For this reason it may 
be important to determine the location of the PMs in the diseased state relative to a 
reference, in which the normal relative distance of the PMs to the reference is known. 
This normal distance may be possibly discovered from a large scale clinical study. 
Furthermore the clinician could determine if the PM displacement observed as a result of 
disease could be used to explain the presence or grade of TR. The most relevant 
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reference in this case may be the annulus, as displacement of the PMs away from the 
annulus may result in leaflet tethering and prevent proper coaptation. 
With regards to displacement of the PMs, patients with isolated RV dilatation had 
significant displacement of all PMs. As would be expected, all PMs moved away from 
the annulus. Although previous studies have speculated displacement of the APM on the 
free wall, this is the first study demonstrating movement of the PMs on the septum: SPM 
and PPM moving towards the LV as a result of RV dilatation (Fig. 7.1).  
The resulting RV geometry observed is most likely due to the restricted space 
within the pericardial sack. The combination of displacement of all PMs and annular 
dilatation may account for the patients with isolated RV dilatation having the largest 
percentage of severe TR. We can conclude that the APM, SPM and PPM are moving 
away from the center of the annulus. Even though the annulus is dilated, we expect that 
the center of the annulus, the reference, would remain in a similar location, as the septum 
is being displaced into the LV and the free wall is moving out. It is however possible that 
while the septal and posterior PMs may have moved from their original position in the 
patients with a dilated LV and both ventricles dilated, no difference was seen from 
control because the relative position to the annulus remained the same. In the patients 
with a dilated LV it may have been that while the annulus size remained the same, the 
original position of the annulus was displaced along with the septal and posterior PMs as 
the septum is pushed into the RV with LV dilatation. Additionally, with combined RV 
and LV dilatation both the annulus center may moves along with the all PMS, resulting in 




Fig. 7.1: Depiction of RV dilatation and resulting PM displacement away from the 
center of the RV as compared to control. Blue line depicts lateral reference, with 
grey showing annulus.  
While displacement of the SPM towards the RV was observed in patients with a 
dilated LV using MRI, there were no changes observed in the lateral direction using echo. 
The explanation for this may be manifested in the difference in patients, or with the 
differences in references. While the MRI study used the centroid of the three PMs as a 
reference; the reference in the echo analysis was the center of the annulus. As a result of 
LV dilatation, the center of the annulus may be displaced when the septum moves 
towards the RV. Thus, no difference may be seen in the displacement of the SPM and 
PPM as they would move relative to the reference. This is depicted in the below figure 





Fig. 7.2: Depiction of LV dilatation and resulting lateral PM displacement. Control 
is shown with a solid line and disease is shown with a dashed line. Blue line depicts 
lateral reference, with grey showing annulus.  
The same cannot be said for patients with combined RV/LV dilatation, as their 
reference may be moved, as the LV pushes against the expanding RV. While it may have 
been that the reference (annulus) and septal wall were moving together, the resulting 
distance from the reference to the PMs remained the same in the control patients as in 




Fig. 7.3: Depiction of combined RV and LV dilatation and resulting lateral PM 
displacement. Control is shown with a solid line and disease is shown with a dashed 
line. Blue line depicts lateral reference, with grey showing annulus.  
If this is true, it cannot be conclusively stated that the SPM and PPM have moved 
into the LV. It is however important to point out, that it is most likely the relative position 
between the PMs and the annulus which matters the most. For instance, if the annulus 
was moving in the same direction and magnitude as the PMs, it should not affect proper 
valve closure, as the relative distances would be the same. It is important to observe that 
while the lateral displacement of the PMs to the reference remained constant, the apical 
distance did not. As the PMs are pulled away from the center of the annulus, tethering 
may be induced in conjunction with the increased orifice size due to annular dilation and 
further exacerbate TR. Previous studies have quantified this both in the tricuspid20-22, 33 
and mitral valves 27. 
 Apical displacement of APM was seen in all patient groups with dilatation of the 
RV, LV or both. This indicates that either the PM is moving away from the annulus 
plane, which is the z reference, or the reference annulus plane is moving. Previous studies 
150 
 
by Ton-Nu et al.12 and Fukuda et al.33 demonstrated that the annulus plane becomes more 
planar in patients with annular dilatation, as opposed to saddle shape in normal subjects. 
Unfortunately both studies used a plane of best fit to the annulus as their reference; 
therefore it cannot be determined if the points on the saddle were moving towards the 
apex or atrium. If, in fact, the PMs are being displaced apically, the rationale behind their 
movement may be due to the remodeling and shape change of the ventricles, which are 
yet to be characterized.  Thus it cannot be determined which is moving, the annulus plane 
or the PMs. However, as pointed out previously, it is the relative position that is most 
important, as apical displacement of the PMs, away from the annulus is likely to result in 
leaflet tethering.  
When investigating annulus area it was seen that patients with RV dilatation 
whether isolated or in addition to LV dilatation had the largest annulus area. 
Additionally, it was shown that while the size of the annulus with patients with trace and 
mild TR was similar, patients with moderate to severe TR had much larger annulus areas. 
This further strengthens our belief that annulus area does in fact play a role in 
determining the severity of TR. 
Next, the investigation of the role of PA pressure found it to be the highest 
amongst patients with a dilated RV. This patient group also demonstrated the highest 
levels of TR, thus it was not unexpected that PA pressure and TR were highly correlated 
in all statistical comparisons.  Although it has long been accepted that pulmonary 
hypertension may result in TR, clinical correlations are difficult to find in the literature. 
Not only was this study able to correlate the two, it may also provide an explanation as to 
why this happens. PA pressure was found to be correlated with RV geometry (RVEDA, r 
151 
 
= 0.51). RV geometry was correlated with annular dilatation (r = 0.60), as well as PM 
displacements, which were also shown to be correlated to TR (Fig. 7.4).  
 
Fig. 7.4: Relation of increases in PA pressure to clinically significant TR through the 
dilatation of the RV resulting in annular dilatation. 
This can be explained by understanding that increases in PA pressure result in RV 
dilatation, which dilates the annulus and displaces the PMs. Increases in PA pressure may 
explain this high interdependence and the cause of the geometric alterations. This study 
has shown that increased PA pressure alters the geometry of the ventricle; whether these 
geometric changes can be reversed when the PA pressures are decreased to normal levels 
is yet to be proven.  
 Additionally, a significant correlation between the size of the ventricles and the 
grade of TR was found.  This can be explained by the changes in the valvular and 
subvalvular apparatus as a result of ventricular dilatation which may prevent the valve 
from forming a proper seal. Furthermore, the correlation of RV size to tricuspid annulus 
area shows that patients with a dilated RV are more likely to have a dilated annulus. This 
information has been shown before13, 23, however, it is interesting to note that not all 
patients with a dilated RV had significant increases in annulus area. Although the number 
of patients was small, it is still important to note that the RV may become dilated without 
the annulus being affected. Annulus area was also correlated with TR (r = 0.51) which is 
consistent with many previous studies 22, 23, 38.  
This study, as well as previously published studies20-22, have shown leaflet 
tethering to be a contributor to the presence of TR. Displacements in the PMs would be 
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expected to contribute to leaflet tethering, which may explain why both were correlates to 
the grade of TR. Interestingly our study was able to show apical displacement of the 
APM to be a better predictor of TR, as tethering measurements dropped out of the 
multivariate regression. While tethering remains a clinically important metric in TR, 
attempts to identify and quantify the position of the APM may provide more insight.   
The initial MRI investigation and 3D echo study was essential as they showed 
that changes in the PM positions may also play an important role in TR. If PM 
displacement impacts TV function and lead to TR, residual TR may result after the repair. 
This may result if the PM positions were altered and not addressed with the repair. 
Traditionally, the most common surgical intervention for non-rheumatic disease focuses 
on reducing the dilated annulus to its original size with the placement of an annuloplasty 
ring. Studies have found that restoring the annulus to a normal size may not eliminate TR 
completely and in many cases it returns 26, 33. Hence, solely reducing the annulus may be 
insufficient to permanently correct TR 26, 55. While papillary muscle displacement may be 
one contributor to this recurrence of TR, this study also demonstrates that it may be 
important to assess the impact of the LV size and septal motion on RV function, even 
before surgery is attempted. These outcomes suggest that the underlying pathophysiology 
associated with TR is perhaps not well understood. Previous studies have attempted to 
correlate RV PM displacement to TR and found tethering and restriction of leaflet 
mobility caused by PM displacement to be an independent predictor of TR after TV 
annuloplasty 26, 55. Although the relation of LV dilatation to durability of TV repairs has 
yet to be proven, this study demonstrates the geometric relation between the two 
ventricles. Futures studies may aim to determine pre and post operative PM position and 
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determine the relation to patient outcome. For the first time, this study demonstrates the 
3D echo as a useful tool in locating and measuring PM positions which can be 
implemented on both normal and disease patients. 
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7.2 In vitro 
The in vitro part of the thesis sought to investigate the effects of disease on the 
tricuspid valve annular and subvalvular apparatus in a controlled environment. In this 
section, quantitative measurements were made to understand the changes in TR and 
attempt to explain these changes by analyzing residual leaflet length, leaflet mobility and 
finally chordal force distribution. 
7.2.1 Model Development 
 A large portion of the initial thesis was devoted to development of the in vitro 
model for the TV in vitro studies. Based on previous experience with mitral valves, it was 
hypothesized that a modification of the left heart simulator for mitral valve studies with 
an additional PM muscle and annular geometry would suffice for TV studies. While the 
implementation of the third PM was simple, the simulation of physiologic and pathologic 
annular geometry was more complex. Dilatation of the TV is not symmetric and only 
occurs along the anterior and posterior sections12, 13. While the plate construction was 
similar to that of the MV annulus plate with a spring and internal wire, a rigid tube was 
added to the septal section to ensure it did not dilate. In conjunction with dilatation, the 
TV annulus also adjusts from a triangular to circular shape29, 32. Thus, initial design of the 
annulus plate required an additional wire between the anterior and posterior sections to 
control the amount of triangulation. With the second-generation annulus plate, this was 
no longer needed as the wire and spring alone were able to simulate accurate geometries 
when the wire exited the plate on the septal/posterior segment, as opposed to 
septal/anterior segment. In addition, the second generation plate replaced the rigid tube 
with a separate spring to allow for implementation of a physiological saddle shape. 
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Measurements of the annular plate at normal and dilated sizes were within acceptable 
ranges for in vivo human measurements. 
The implementation of a saddle shape was added to the second-generation 
annulus plate to make the normal condition more physiologic. Addition of the saddle 
shape did not have a significant impact on TR even though it was used as a control for 
comparison to disease conditions. Further investigation of the saddle shape was 
conducted to investigate its effects on the stretch of the leaflets. The findings from the 
study can be found in the appendix J. This additional study was motivated by the 
introduction of the MC3 (Edwards Lifesciences, Irvine, CA) tricuspid specific 3D ring. 
Interestingly, the saddle shape significantly increased the stretch of the anterior leaflet of 
the TV but not the posterior leaflet. This trend differed from that observed in the MV, 
where a saddle was shown to decrease the stretch on both leaflets80. This may be 
attributed to the inherent 3D geometrical differences between the tricuspid and mitral 
valves. In the MV, the apical motion of the commissures results in a saddle, and each 
leaflet is flanked by two annular high points81, 82. However in the TV, the posterior leaflet 
is flanked by two annular points with apical motion (low points) similar to the MV, while 
the anterior leaflet is flanked by one annular point with apical motion (low point) and one 
annular point with basal motion (high point)12, 33. The result of two adjacent annulus 
points moving in opposite directions resulted in more tethering and deformation of the 
anterior leaflet than the posterior leaflet. Thus the stretch configuration of the anterior 
leaflet is not comparable to the MV. 
Since the tricuspid valve has three leaflets, the saddle applied at two points may 
affect each leaflet’s curvature differently. Additionally, the TV is in a lower pressure 
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environment, which may cause the leaflets to possess different material properties than 
the MV. For the posterior leaflet, two high points exist on either side of the leaflet, 
similar to what is seen in the mitral valve. However, there was no significant impact on 
the stretch of the posterior leaflets with a saddle shape as compared to flat, where it has 
been observed with the mitral valve. When comparing the effect of the saddle on the TV 
to the MV, it is important to understand that the annular height to commissural width 
ratio (AHCWR) observed in the TV is approximately 10% whereas the MV is 20%. The 
saddle which is present in the TV has not been investigated as rigorously as compared to 
the MV81, 82, as the importance, if any, of the saddle in the TV is still not well understood. 
Previous studies investigating the effect of saddle on MV leaflet strains, reported no 
differences with 10% AHCWR, and it was not until the AHCWR was increased to 20% 
that the strains were significantly decreased with a saddle shape as compared to flat68, 80. 
 Once the flow simulator was adapted to account for geometric differences, 
between the TV and MV, alterations to the loop configuration from the MV set up were 
necessary to maintain a cardiac output of 5 liters/minute with a much lower driving force 
of only 40 mmHg from the right ventricle. It was necessary to minimize the length of all 
tubing and increase the diameter to 1.5 inch to reduce the resistance to all flow within the 
system. Another major change involved the atrial and pulmonary compliance. It was 
essential to make it as easy as possible for the ventricle to expel its volume within the 
allotted time. This was achieved by increasing the size of the pulmonary reservoir 
container, as detailed in the materials section. The pulmonary reservoir overflowed into 




7.2.2 Isolated Annular Dilatation 
Investigation of annular dilatation, found that TR was highly dependent on 
annular dilatation with significant TR occurring at only a 40% increase in annular area. 
This was seen at 75% dilatation in in vitro mitral valve studies59.  It may be the increased 
mechanical complexity of bringing three flexible surfaces together which causes the TV 
to leak earlier. A central zone of leaflet malcoaptation was consistently seen in all valves 
with annular dilatation, demonstrating the dependence on the three leaflets coapting 
simultaneously. Previous studies of TR repair have determined varying thresholds for 
deciding when to clinically repair the annulus. In a study by Dreyfus et al., they repaired 
any TV that was larger than 70 mm in diameter by direct measurement 9 and Carpentier 
et al. repaired the valve if the surgeon could insert 3 fingers width into the annulus 8. In 
the present study, annular dilatation of 40% corresponded to an annulus area of 88 ± 2 
mm2 and septal lateral diameter of 23 ± 0. 5 mm, which is less dilatation then previously 
recommended for repair. 
While annular dilatation has been shown to cause TR, it was important to 
understand the mechanism behind it in order to gain insight as to why some patients with 
annular dilation have TR and others do not. As the annulus dilates the anterior and 
posterior sections are displaced, causing the posterior and anterior leaflets to be pulled 
away from the central coaptation line. This results in the reduction of RLL at the point of 
coaptation. When the RLL is reduced to an insufficient length, the three leaflets cannot 
properly coapt, resulting in gaps, wrinkles, and leaflet mismatch (Fig. 7.5).  
A significant increase in TR coincided with a visible gap and an RLL of 5 mm as 
such a minimum RLL of 5 mm or less of any leaflet may be a predictor of tricuspid 
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regurgitation. Even if the leaflets have RLL available for coaptation, the complexity of 
coaptation may require more than 5 mm of tissue from each leaflet to form a seal and 
prevent regurgitation. This study found anterior leaflet RLL to be most affected by 
annular dilatation. It may be because the anterior leaflet extends to compensate for the 
increase in the orifice area, created by dilatation of the annulus. It is interesting to note 
that multiple studies have reported the anterior leaflet to be the longest and largest in area 
as compared to the posterior and septal leaflets 32, 40. This ratio may be the body’s attempt 
to compensate for annular dilatation up to a certain level. In contrast to the anterior 
leaflet, the septal leaflet experienced little change in RLL as an effect of dilatation83. This 
may be explained by previous studies which have commented on the large number of 
chordae inserting into the septal leaflet from the septum32 and thus the possibility for 
restricted motion. When these findings are compared to the mitral valve it is the posterior 
section of the annulus which dilates, with the anterior leaflet covering the increased 
orifice 84. Thus whereas it is the leaflet on the annulus segment that is dilating (anterior) 
which is effected with TV dilatation it is the opposite with the MV (anterior). It is 
however interesting to point out that the leaflets of both the MV and TV which 
compensate for the dilatation are both the largest leaflets. 
Next, the leaflet mobility and coaptation geometry were investigated with the use 
of 3D echo, in which measurements of tenting height and tenting area were taken at the 
three coaptation lines. Dilatation of the annulus did not significantly alter leaflet mobility 
or coaptation geometry. This may be because the leaflets are free to adjust and adapt as 
no PM displacement if present, to the changes although the annular diameter is increased. 
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It is only the residual leaflet length that displays a significant change, not the leaflet 
coaptation geometry. 
Although the coaptation geometry did not change with dilatation, investigation of 
the chordal forces showed an increase in forces in all six measured chords: anterior 
marginal, anterior intermediate, anterior strut, posterior marginal, posterior intermediate, 
posterior strut. This may be due to many factors at play. As the annulus dilates, the 
surface area of the leaflet exposed to pressure increases, as force is proportional to 
pressure and area. Thus, the maximum chordal force required to prevent billowing of the 
leaflets increases. In addition, it is believed that the marginal and intermediate chordal 
forces increased with dilatation as they were no longer in the coaptation zone and were 
engaged. This is compared to a normal configuration where these chordae were within 
the coaptation region and may have been slack.  This explains the findings that marginal 
and intermediate chords had the largest increases in force as compared to control. Finally, 
the relative position of the point of leaflet insertion to PM attachment of the chord is 
altered. The annulus is moved, however the PMs remain in their normal position. Similar 
trends were seen with dilatation above 40%, with the most extreme case at 100% 
dilatation. The below schematic depicts significant alterations from normal when the 





Figure 7.5: Schematic of significant alterations in the leaflets and chords as 
observed with dilatation. The schematic shows leaflet mobility, residual leaflet 
length and chordal forces along the three coaptation lines. Specific significant 
alterations are shown in bright red. 
 
7.2.3 Isolated Papillary Muscle Displacement 
While it is accepted that annular dilatation may result in TR, it is not the only 
mechanism which can cause TR. The effect of PM displacement on valve function has 
been investigated on the left side of the heart, both in vivo and in vitro, but has only 
recently been investigated on the right side. While this has been shown through in vivo 
studies in this thesis, previously published studies have yet to correlate PM displacement 
to TR. However, studies have correlated changes in RV geometry to increases in TR21, 23, 
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24. It is believed that as the RV dilates, the PMs become displaced and this results in 
leaflet tethering20, 22. 
In the previously discussed in vivo MRI study, it was found that dilatation of the 
LV can affect RV PM positions. The septal PM displaced towards the center of the RV in 
patients with a dilated LV25.  Although the previous study was unable to specifically 
correlate the presence of TR in these patients to the PM displacement, the results 
presented may give us an idea of how the lateral displacement reported in patients may 
cause TR. Additionally, the in vivo portion of this thesis provided a direct correlation of 
PM displacement to the grade of TR. 
Through the in vitro investigation of PM displacement, it was demonstrated that 
PM displacement alone may lead to significant TR. As with the case of isolated PM 
displacement, significant levels of TR in the presence of the displacement of the APM, 
PPM/SPM and all PMs could be seen. While numerous PM displacements were 
investigated, severe displacement with the APM, S/PPM and all PMs displaced in 
multiple directions simultaneously was the only condition which resulted in significant 
TR. Although lateral displacement of the SPM/PPM resulted in significant TR in some of 
the cases, the high variability did not allow for a statistical comparison of the group to 
control. This variability may be a result of the high variability in chordae insertion into 
the septal leaflet. In addition, septal leaflet RLL was highly affected by all PM changes as 
it experienced a reduction for all PM displacements. It is believed that the septal leaflet is 
most impacted by changes in PM displacement since it has many chordal insertions, with 
those coming from the septal PM being the shortest32. While displacement of the PMs 
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without concurrent annular dilatation is rare, it is important to understand what may 
happen if the annulus is repaired and the PMs are left displaced. 
In addition to the creation of TR, multidirectional PM displacement also affected 
proper coaptation of the leaflets. Changes in coaptation were most significant when all 
PMs were displaced in all directions corresponding to increased mobility of the septal 
leaflet and restriction of the other leaflets. With this increased mobility, the coaptation 
line of the three leaflets was more towards the center of the annulus, thus the septal 
leaflet covered more of the orifice, but was not long enough to do so, as it is the shortest 
leaflet 32, 40, which resulted in a central zone of malcoaptation.  
With evidence that PM displacement in the presence of a normal sized annulus 
may result in TR, the impact of these alterations on leaflet mobility and coaptation was 
used to better understand valve mechanics. With PM displacement, the only changes in 
septal/anterior and posterior/septal coaptation geometry were seen with multidirectional 
displacement of all PMs. This may be due to the small length of the chords from the 
septal PM. Observationally, it was found that the septal PM is not always well defined 
and often fused, and thus the chords are often the shortest and thinnest. Because of this 
phenomenon, small changes in PM position may result in large changes in leaflet 
mobility, especially since all chordae are displaced by the same amount (10 mm) for all 
PMs. Additionally, combined displacement in the apical or lateral directions of the APM 
resulted in tethering at the AP coaptation zone, while isolated directional displacement of 
the APM did not. This suggests that tethering is a local phenomenon, in that changes at a 
given coaptation zone are a direct result of the PM at that location. For example, 
alterations in the AP coaptation line would be indicative of displacement of the APM. 
163 
 
This may be useful, in that while it is possible to clinically visualize the PMs, it may not 
always be feasible. Thus one could potentially use the coaptation geometry to assess 
which PM or multiple PMs are displaced. 
Finally the investigation of PM displacement on chordal forces revealed increases 
only in the forces on the posterior strut chordae. While force tended to increase with 
apical APM displacement, significant increases were observed with severe PM 
displacement. Thus, significant alteration in the coaptation geometry of the valve is 
needed in order to redistribute forces in the case of isolated PM displacement. These 
findings are important, as they emphasize that in the case of PM displacement the 
mechanics of the valve and subvalvular apparatus are altered. Thus an annuloplasty 
procedure may not be sufficient to restore the valve mechanics to normal. The below 
schematics showcase the conditions in which isolated PM displacement resulted in 
significant differences in leaflet mobility, as assessed with echo, leaflet coaptation, as 
assessed with RLL, and chordal forces. This is depicted for apical (Fig. 7.6), combined 
lateral and apical (Fig. 7.7) displacements of the APM, and for all PMs displaced (Fig. 
7.8). Only conditions which resulted in  significant alterations from control are shown. 
With isolated apical displacement of the APM the anterior leaflet length available 
for coaptation increased as the leaflet was restricted apically. No further changes were 
observed in any other conditions measured. Thus, these alterations were not drastic 




Figure 7.6: Schematic of significant alterations in the leaflets and chords as 
observed with apical displacement of the APM. The schematic shows leaflet 
mobility, residual leaflet length and chordal forces along the three coaptation lines. 
Specific significant alterations are shown in bright red. 
 
With the addition of lateral displacement to apical displacement of the APM, the 
mobility of the anterior and posterior leaflets was decreased. Apical displacement 
restricts the mobility of the anterior leaflet initially. However, the combined lateral 
displacement moves the APM away from the center of the valve, further restricting 
mobility of the anterior leaflet resulting in tethering. Changes in leaflet tethering were 
only observed at the anterior/posterior coaptation line as this is where the chords from the 




Figure 7.7: Schematic of significant alterations in the leaflets and chords as 
observed with combined lateral and apical displacement of the APM. The schematic 
shows leaflet mobility, residual leaflet length and chordal forces along the three 
coaptation lines. Specific significant alterations are shown in bright red. 
 
Finally, with displacement of the anterior (lateral and apical), septal (anterior, 
lateral and apical) and posterior (posterior, lateral and apical) PMs the most drastic 
changes in valve mechanics with isolated PM displacement were observed. The leaflet 
tethering observed with lateral and apical displacement of the APM, was no longer seen. 
The coaptation line was moved more towards the anterior and posterior sections of the 
annulus due to displacement of the septal and posterior PMs. This resulted in a reduction 
in the leaflet mobility across both coaptation lines for the septal leaflet. As a result, the 
posterior leaflet contributed more to coaptation, as the length of the posterior leaflet 
which was available for coaptation increased since it was restricted. Furthermore, 
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displacement of all three PMs was the only condition of isolated PM displacement which 
resulted in a significant increase in chordal forces. Combined PM displacement resulted 
in severe changes in the coaptation geometry. Consequently, the posterior strut chord 
restricted the motion of the posterior leaflet as measured as an increasing force, resulting 
in an increased RLL and leaflet tethering. The numerous alterations in the valve 




Figure 7.8: Schematic of significant alterations in the leaflets and chords as 
observed with combined displacement of the APM, SPM and PPM. The schematic 
shows leaflet mobility, residual leaflet length and chordal forces along the three 




7.2.4 Combined Annular Dilatation and Papillary Muscle Displacement 
The next logical step was to combine these two disease manifestations, to 
investigate the combined effect of annular dilatation and PM displacement. It was shown 
that in the combined case of annular dilatation, greater than or equal to 40%, and all PMs 
displaced in all directions the highest levels of TR were achieved. It is a combination of 
multiple mechanisms that results in the increased levels of TR.  The anterior and 
posterior leaflets are pulled away from the central line of coaptation due to annular 
dilatation, increased leaflet mobility of the septal leaflet with SPM and PPM 
displacement (as discussed previously), and restriction of the anterior leaflet mobility 
with displacement of the APM  all contribute to the high levels of regurgitation. 
When these two conditions, annular dilatation and PM displacement, were 
combined, more information as to the role of these disease states was obtained. 
Combined cases were observed to have more impact on the leaflet geometry. This is most 
likely true because with annular dilatation the orifice area is increased, and with PM 
displacement the leaflet mobility is restricted. Consequently, the leaflets are no longer 
free to coapt normally as was the case with annular dilatation. Multidirectional 
displacement of the PMs resulted in significant changes in leaflet coaptation which was 
evident by the alterations in leaflet geometry across all coaptation lines. In the case of 
apical displacement of the APM with dilatation, only the AP coaptation line was affected, 
resulting in local restriction of the anterior and posterior leaflet mobility.  By adding 
further displacement of the APM in the lateral direction the SA coaptation line was 
affected. This may be due to the lateral restriction of the anterior leaflet. At the same 
time, the anterior leaflet still attempts to compensate for the dilatation and thus it was 
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pulled away from the SA coaptation line. When all three PMs were displaced in all 
directions, leaflet mobility was affected at all coaptation lines, which is evident by 
significant changes in the coaptation geometry. There was never a case in which changes 
were observed in tenting height and not in tenting area. This suggests that measurements 
of tenting area alone may provide enough information as to alterations in leaflet 
geometry, thus it may not be of additional value to measure tenting height. 
With an understanding of the combined role of annular dilatation and PM 
displacement on leaflet coaptation and leaflet mobility, the final step was to investigate 
chordal forces. Alterations in chordal forces will be discussed by condition and explained 
in conjunction with the altered mechanics for each condition.  
Overall combined conditions of annular dilatation and PM displacement resulted 
in the most severe alterations in valve mechanics. The following images depict the 
alterations in valve mechanics as seen with the combination of annular dilatation and 
each type of PM displacement (Fig.7.9-7.14). 
While no change was observed in valve mechanics with isolated lateral 
displacement of the APM, when combined with annular dilatation significant changes 
were observed. With lateral displacement of the APM away from the center of the 
annulus the anterior leaflet became restricted as is evident with an increase in RLL. As 
the anterior leaflet attempts to assist in covering the enlarged orifice due to dilatation, it 
cannot as it is tethered. This results in an increase in force in all the chords inserting into 





Figure 7.9: Schematic of significant alterations in the leaflets and chords as 
observed with combined annular dilatation and lateral APM displacement. The 
schematic shows leaflet mobility, residual leaflet length and chordal forces along the 
three coaptation lines. Specific significant alterations are shown in bright red. 
Combined annular dilatation and apical displacement of the APM affected valve 
mechanics across all three coaptation lines. This resulting combination displaced the 
anterior/posterior coaptation zone apically, resulting in an increase in anterior RLL, as the 
anterior leaflet mobility was decreased as a result of tethering. Finally the chords from 
the APM inserting into both the anterior and posterior leaflets were affected. The strut 
and marginal chordal forces increased. The increase in strut chord forces may be due to 
the apical displacement. The increase in marginal chordal force may have been observed 
only on the anterior leaflet as this leaflet attempted to cover the enlarged orifice, due to 




Figure 7.10: Schematic of significant alterations in the leaflets and chords as 
observed with combined annular dilatation and apical APM displacement. The 
schematic shows leaflet mobility, residual leaflet length and chordal forces along the 
three coaptation lines. Specific significant alterations are shown in bright red. 
When the APM was displaced both laterally and apically and combined, with 
annular dilatation, a combination of the alterations seen in apical and lateral displacement 
was observed. Only the coaptation lines of the anterior and posterior leaflet were 
observed to be altered. Apical and lateral displacement restricted the mobility of the 
anterior leaflet with an increase in leaflet tethering at the anterior/posterior coaptation and 
an increase in RLL. As the leaflet was restricted, less of the leaflet covered the orifice, 
leaving more leaflet available for coaptation. As with lateral APM displacement and 
annular dilatation, forces on all chords from the APM inserting into the anterior leaflet 




Figure 7.11: Schematic of significant alterations in the leaflets and chords as 
observed with combined annular dilatation and combined lateral and apical APM 
displacement. The schematic shows leaflet mobility, residual leaflet length and 
chordal forces along the three coaptation lines. Specific significant alterations are 
shown in bright red. 
While apical displacement of the septal and posterior PMs had little effect on 
leaflet mechanics, it did result in a decrease in leaflet mobility at the septal/posterior 
coaptation line. The reason this was observed at the line of coaptation between the septal 
leaflet and anterior leaflet and not the posterior leaflet may be due to two reasons. First, 
with annular dilatation, the anterior leaflet is responsible for covering a majority of the 
orifice, thus restriction in the mobility of the leaflet may drastically alter coaptation. 
Secondly, it is important to note that the chords inserting into the septal PM are the 
shortest. Thus as the septal PMs is displaced by 10 mm, the septal/anterior zone may be 
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more affected since this is the location of the SPM and insertion of the chords into the 
anterior and septal leaflets.  
 
Figure 7.12: Schematic of significant alterations in the leaflets and chords as 
observed with combined annular dilatation and apical SPM and PPM displacement. 
The schematic shows leaflet mobility, residual leaflet length and chordal forces 
along the three coaptation lines. Specific significant alterations are shown in bright 
red. 
Similar observations were made with displacement of the septal and posterior 
PMs in the anterior/posterior, lateral and apical directions as with isolated apical 
displacement. The decrease in mobility at the septal/anterior coaptation line may be 




Figure 7.13: Schematic of significant alterations in the leaflets and chords as 
observed with combined annular dilatation and combined anterior, lateral and 
apical SPM and combined posterior, lateral and apical PPM displacement. The 
schematic shows leaflet mobility, residual leaflet length and chordal forces along the 
three coaptation lines. Specific significant alterations are shown in bright red. 
As expected the most severe alterations in the annular and subvalvular apparatus 
resulted in the most severe changes in leaflet mechanics, as observed with changes along 
all three coaptation lines. Leaflet mobility was decreased along all three coaptation lines. 
As was reported with isolated displacement of all three PMs the line of coaptation was 
more towards the anterior/posterior annulus segment. The septal leaflet mobility was 
increased with lateral displacement of the septal and posterior PMs and the anterior 
leaflet mobility was decreased with lateral and apical displacement of the APM. 
Coaptation is further altered with the addition of annular dilatation as the anterior and 
posterior annular segments are displaced and the septal leaflet attempts to cover the 
increased orifice size since the anterior leaflet is restricted. The greatest levels of TR are 
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seen in this condition, both for annular dilatation of 40% and 100% because the septal 
leaflet is too short to cover the increasing orifice. Both anterior and posterior strut chordal 
forces increased, which can be attributed to the apical displacement of the APM and not 
the lateral displacement. The reason for this is that the lateral displacement when 
combined with annular dilatation reorients the APM with the annulus to a more normal 
state. 
 
Figure 7.14: Schematic of significant alterations in the leaflets and chords as 
observed with combined annular dilatation and APM, SPM and PPM displacement. 
The schematic shows leaflet mobility, residual leaflet length and chordal forces 





7.3 In Vivo/In Vitro Comparison 
 Since the in vivo (specific aim1) and in vitro (specific aims 2 and 3) sections were 
done simultaneously, it was not feasible to test PM positions which were found to be 
significant in aim 1 in both aims 2 and 3. For this reason, the relevance and comparison 
between the in vivo findings and in vitro simulations will be discussed here. Assumptions 
were made for in vitro simulations of PM displacement as no previous studies had been 
conducted to define actual PM displacement. In vitro experiments were done to 
systematically explore the effect of PM displacement, which cannot be done in patients. 
Displacement of the PMs was simulated by displacing the PMs on the septal wall 
simultaneously (PPM/SPM), simulating left ventricle (LV) dilatation69, and the sole 
displacement of the APM to simulate right ventricle (RV) dilatation23, 24.  Combined RV 
and LV dilatation was combined displacement of the anterior, septal and posterior PMs. 
Completion of the in vivo study revealed different PM displacements than those 
simulated in vitro. Figure 7.15 demonstrates the overlap between the conditions 




Figure 7.15: Overlapping in vivo and in vitro PM displacements. 
While RV dilatation was simulated in vitro with only APM displacement, SPM 
and PPM displacement was measured in vivo. This was based on the assumption that RV 
dilatation would not result in displacement of the septal wall into the LV. It was believed 
that even with elevated RV pressures, the LV pressure remains higher than the RV 
pressure. In vivo echo measurements disproved this theory demonstrating displacement of 
the septal and posterior PMs towards the LV. As pointed out previously in the discussion, 
it may be an artifact of the x-reference, which is the center of the TV annulus, which may 
have moved laterally. This may account for the significant changes in SPM/PPM 
displacement, but not lateral APM displacement. As seen in the above figure apical 
displacement of the APM was observed for all in vivo cases, and was simulated in vitro 
but not in conjunction with apical displacement of other PMs as was observed in vivo. 
There was however a condition in which all PMs were displaced apically, but it was 
combined with displacement of the PMs in multiple other directions. While isolated LV 
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dilatation was simulated with SPM and PPM displacement, as it was assumed that the LV 
would dilate into the RV, only apical displacement was observed in vivo. Both the SPM 
and PPM were displaced apically in vitro but did not result in significant TR alone, which 
is consistent with in vivo findings of patients with dilated LVs having lower levels of TR. 
In vitro simulation of combined RV/LV dilatation was more severe than was seen in vivo 
as only the APM and SPM were displaced apically.  
Comparison of the in vivo to in vitro results can help to provide a better 
understanding of the data. For example, in vivo results showed that patients with 
significant levels of TR were patients with a dilated RV or both ventricles. Interestingly 
these patients had a dilated annulus as well as PM displacement. When dilatation and PM 
displacement were combined in vitro, significant levels of TR were always observed 
irrespective of the type of PM displacement. Although displacement of the septal and 
posterior  PM differed in vivo as compared to in vitro, in vivo studies demonstrated that 
TR was very sensitive to displacement of the septal and posterior PPM, as seen in both 
echo and MRI studies 72.  
 While differences did exist in the conditions found in vivo and those created in 
vitro, it is important to point out that all possible PM displacements may not have been 
observed in the patient population. Additionally, the in vivo results of PM displacements 
are show as an average of the population sampled and any deviations from the mean may 
have been lost with averaging. Thus, future in vivo studies may aim to target more 
specific patient populations with various types of dilatation and papillary muscle 
positions. Furthermore, the in vitro simulations demonstrate what conditions, both in 
isolation and combination, may result in TR but do not include all possibilities.  
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 Comparing the annulus sizes measured in vivo and those simulated in vitro shows 
that the annulus size of patients with trace and mild TR, 8.7 cm2 and 8.9 cm2 is 
comparable to approximately 40% dilatation of the in vitro annulus, resulting in an 
annulus area of 8.4 cm2. While this was the level of dilatation at which statistically 
significant TR was observed, it was not necessarily clinically significant, with levels of 
TR similar to those of mild TR in vivo. While the annulus size found in patients with 
moderate TR (11.4 cm2) was similar to in vitro levels of TR measured with isolated 
dilatation of 100% (12 cm2), the annulus size measured in patients with severe TR was 
much larger than what was simulated in vitro. With isolated annular dilatation of 100% as 
our max we were only able to create mild to moderate levels of TR in vitro. Based upon 
the in vivo findings, the creation of more dilatation would have resulted in higher levels 
of TR. Future studies should investigate annular dilatation greater than 100%. 
7.4 Clinical Relevance 
 First and foremost it is important to understand a problem before it can be 
accurately corrected. For this reason the information presented in this thesis is of 
importance not only to the scientific community, to fill a gap in knowledge, but the 
clinical community as well. This thesis provides clinicians with a better understanding of 
how the tricuspid valve mechanics are altered with disease and an explanation of the 
resulting TR. If one were to look through the literature they would find some information 
on the tricuspid valve, but mostly about its anatomy, and little to nothing on the 
mechanics of the valve. As our lab has been instrumental in providing the clinical 
community with in depth information on the mitral valve for close to 20 years, this thesis 
serves as the first step in doing this for the tricuspid valve. 
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There is an increasing interest in the changes that occur in the anatomy of the 
tricuspid valve apparatus and the correlation of these changes with the severity of 
tricuspid regurgitation.  In our study with the use of 3D Echocardiography the position of 
the RV PMs was identified for the first time and reported how their position was altered 
with ventricular dilatation. This study also showed the presence of leaflet tethering with 
PM displacement resulting in significant TR in patients. A detailed investigation of the 
parameters responsible for clinically significant TR, as presented here, can guide the 
clinician to target repairs to the direct cause of TR and thus may result in more durable 
repairs. In addition to highlighting the importance of geometry and pulmonary pressures 
in TR, this study also presented a reliable non-invasive technique which may serve to 
provide more patient-specific diagnosis and treatment. These findings help to change the 
future diagnosis and therapies of clinically relevant TR.  
While this study consistently found that dilatation of the annulus area by 40% 
resulted in significant TR, the valves were of relatively similar size. Clinically, not all 
patients with annular dilation have regurgitation, and it is believed that this may be due to 
variations in leaflet and sub-valvular anatomy, with some patients’ valves being larger to 
begin with and tolerate more dilatation. Additionally, some believe that the leaflets may 
possibly remodel in vivo to compensate for the altered environment, which cannot be 
simulate in vitro. This study showed that the anterior leaflet is responsible for 
compensating for an increase in orifice area as a result of annular dilatation in most cases. 
Thus, it may be important for the clinician to not only look at annulus size, but also at 
RLL to determine the potential for regurgitation. Although it may be difficult to measure 
RLL in vivo with current 2D and 3D echocardiograph techniques, leaflet length as 
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measured just before coaptation and coaptation length may be used to assess the valve. 
Future studies should be conducted to determine if in fact patients with annular dilatation 
but no TR have longer leaflets, specifically the anterior leaflet. 
This has already begun to take place as knowledge and understanding of the 
tricuspid valve increase, changes are being made to clinical standards to incorporate this 
information. For example, AHA/ACC guidelines recommend repair for patients with 
tricuspid annular dilatation, specifically recommending annuloplasty to correct annular 
dilatation during left-side repair when mild TR is present14. Currently this decision only 
requires the consensus of clinicians and does not state the size at which the tricuspid 
valve annulus is considered dilated as with the mitral valve. Current repairs for functional 
TR focus mainly on reducing the size of the annulus to normal. This study shows that it 
may also be important to restore the available leaflet length for coaptation, providing as 
much overlap as possible, specifically in the central region. Repairing the annulus to its 
true size with a ring annuloplasty may not be enough in the presence of PM displacement, 
if the PMs are displaced enough to severely affect the mechanics of proper leaflet 
closure. With evidence that PM displacement alone can lead to TR, it may be important 
to investigate PM position and ventricular size, both RV and LV, in addition to annulus 
area when deciding to treat a patient. Potential adjunct procedures in the setting of leaflet 
tethering and PM displacement could include downsizing ring annuloplasty (a mainstay 
repair strategy in functional mitral regurgitation), or leaflet augmentation57 to increase the 
amount of leaflet area available for coaptation.  More specifically, evidence-based 
guidelines are ultimately needed to ensure patients are treated appropriately. 
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Furthermore, it is interesting to note that not all patients with RV dilatation had a 
dilated annulus. Annulus size within this patient group ranged from a very small sized 
annulus (4.3 cm2) to an extremely dilated annulus (23.4 cm2). While it cannot be 
elucidated from this data it is of interest to determine if in fact RV dilatation occurs first 
with remodeling of the ventricular, along with annular dilatation occurring secondary. 
The converse may also be true in that patients may first present with isolated annular 
dilatation, possibly due to enlargement of the right atrium, which may then result in 
remodeling of the RV. Thus, the combination of both annular dilatation and RV dilatation 
is most likely a more chronic condition. 
Additionally, the alterations reported in tricuspid valve mechanics, through 
measurements of leaflet mobility, residual leaflet length and chordal force may help to 
provide clinicians with a road map to target repairs. This thesis used 3D echo for the first 
time, not only to identify and measure the PMs in vivo, but also to interrogate leaflet 
mobility across the three coaptation lines. By taking a closer look at the alterations in 
individual leaflet geometry and understanding displacement of which PMs are 
responsible, clinicians may be able to correct leaflet tethering with repairs to the PM 
responsible for tethering. Leaflet tethering continues to be a clinical relevant metric as 
studies correlate leaflet tethering to TR. Additionally, leaflet tethering is easily measured 
in the clinic and assessed by the clinician. The chordal force data are important to 
clinicians to better understand the role of individual chords to better guide repairs which 
reposition or even cut different chords. All cases of severe TR also experienced 
significant alterations in valve mechanics. For this reason to restore the valve to its 
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normal state, which is the ultimate goal, not only should regurgitation be addressed but an 
attempt made to restore valve mechanics to their original state. 
7.5 Limitations 
7.5.1 In Vivo 
While the MRI study was limited to the effects of LV dilatation on the posterior 
and septal PMs, as they are located on the septal wall, the echo study was able to include 
both isolated and combined RV and LV dilatation. In addition, the 3D echo study allowed 
for direct correlations of alterations in the tricuspid valve annular and subvalvular 
apparatus to the grade of TR. 
With the 3D echo study, the small number of patients within each group resulted 
in high variability within the group classifications. Future studies should aim to recruit 
additional patients and look at PM displacements in specific disease patterns, as those 
with different disease manifestations would be expected to have different remodeling 
characteristics. In addition, it would be interesting to determine if the severity of 
ventricular dilatation correlates to the magnitude of PM displacement. As noted in the 
discussion, although relative position of PMs to the annulus plane is important, it would 
be of interest to determine if the reference (annulus plane) or the PMs are moving in these 
patients, as it is difficult to identify a reference that does not move with disease. For 
example, the annulus plane was used as a reference in the study, but was found to be 
dilated and thus the center of the annulus in the diseased patients was not in the same 
relative position as in the normal patients. 
It is important to point out the fact that in this study and in typical clinical 
practice, PA pressure is determined directly from the TR jet velocity. Although TR was 
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determined from the size of the TR jet, this is not completely independent of the velocity 
of the jet. The TR jet is dependent on both the orifice size and velocity; thus, the higher 
the PA pressure, the higher grade of TR. Previous studies which measured PA pressure 
both indirectly and directly, found PA pressure to be correlated with TR 16, 19. Although 
not ideal, to truly investigate the correlation between TR and PA pressure, direct high 
fidelity catheter measurement of PA pressure should be conducted to confirm these 
findings. 
 It was not always feasible to identify all three PMs in a single patient as the septal 
and posterior PMs were often difficult to view. In addition it was often difficult to see the 
PM protruding from the wall, particularly in the case of the SPM and PPM. If the PM 
was not visible, the insertion point of the chordae into the wall was taken instead. 
Although the direct insertion of the chordae into the wall may not be evidence of the 
existence of a PM, it is the changes in the attachment location (chordae insertion) that are 
important, not necessarily the existence of a PM. Previous classifications of PM types 
have reported some PMs to be “fused”, in which the chordae attached directly into the 
wall 42. The same study reported there to be several PMs tips and chordae insertions for 
both the SPM and PPM, whereas the APM is usually one distinct PM 42, 43. 
7.5.2 In Vitro 
Although the rigidity of the right ventricle is not physiologic, it does not 
significantly impact the results of this study as this analysis is focused on the valve itself.  
Interactions between the right ventricle and valve apparatus are simulated by 
displacement of the PMs themselves. Many previous mitral studies60, 61, 68, 85 have been 
published using a rigid ventricle box and have been instrumental in providing a better 
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mechanistic understanding of the valve under both physiological and pathologic 
conditions.  With regards to the rigid annulus model used, it is believed that this is 
essential since these PM holders maintain a rigid position, thus the relative position 
between the two remains constant, which is supported by the literature 35. Since 
measurements were made during systole, this system is maintained in a systolic state, for 
both the annulus and PMs. This is an accepted limitation of the study, and thus the impact 
of the results may be limited by the static nature of the ventricle and annulus. 
Measurement of RLL reported here is an estimate of the leaflet available for 
coaptation as it does not take into account any curvature, stretching or compression which 
may occur when the leaflet surfaces join and thus may underestimate the actual length. 
The common technique which is currently practiced is to measure coaptation length, a 
surrogate of RLL, which provides a global measurement for the coapting leaflet length, 
but cannot distinguish individual leaflets. The method used here allowed us to determine 
each individual leaflets contribution to coaptation. The technique cannot be directly 
applied to clinical applications but only as a method to provide further information about 
leaflet mechanics. 
Echo measurements for assessment of leaflet mobility were made across the three 
coaptation lines, whereas the location of malcoaptation was centrally located at the three 
leaflets. As it was of interest to understand how  each individual leaflet was affected by 
disease it was impossible to take measurements as the center of the annulus as this is the 
point where the three leaflets come together, and therefore impossible to distinguish 
between the leaflets, specifically the anterior and posterior leaflets.   
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Finally, while a saddle shaped annulus similar to that reported in humans 12, 33 was 
used on the control conditions for the PM displacement and combined cases, isolated 
annular dilatation studies had a flat annulus. It is believed that the presence or absence of 
a saddle in this study did not affect the results as the closing volume between valves (n = 
8) with and without a saddle in a control position (normal annulus size and PM location) 






Through both in vivo and in vitro investigations, the mechanics of the tricuspid 
regurgitation and the role of annular and subvalvular alterations were investigated. In 
vivo analysis was able to determine PM displacements of disease patients as compared to 
controls and correlate them and annulus area to TR. In vitro investigations extended this 
analysis and provided detailed mechanics responsible for TR. 
The in vivo study showed that 3D echocardiography can be used to identify and 
measure the position of all three PMs of the tricuspid valve for normal and diseased 
patients. This study found that dilatation of both ventricles results in displacement of the 
RV PMs. Apical and lateral displacement of all PMs was significantly correlated to the 
grade of TR and leaflet tethering, with the exception of lateral displacement of the APM. 
PA pressure, classification based upon RV and LV size, annulus area, and apical 
displacement of the APM were all predictors of the severity of TR. Increases in PA 
pressure lead to geometric changes in the ventricles, which results in alterations to the TV 
apparatus including both the annulus and PMs. A complete investigation of the 
parameters responsible for clinically significant TR as presented here can help the 
clinician to target repairs to the direct cause of TR and thus may result in more durable 
repairs. In addition to highlighting the importance of geometry and pulmonary pressures 
in TR, this study also presented a reliable non-invasive technique which may serve to 
provide more patient-specific diagnosis and treatment. 
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  The in vitro study demonstrates that while annular dilatation can alone lead to 
TR, isolated PM displacement can also cause TR, with the most severe TR achieved with 
a combination of these conditions. Alterations in either the annulus size or PM position 
result in the distortion of proper coaptation mechanics. With annular dilatation the 
anterior leaflet attempts to compensate for the dilatation since it is the section which is 
most commonly dilated. While no changes were observed in leaflet mobility, marginal 
chords were engaged as a result of dilatation as they were no longer in the coaptation 
zone and assisted in preventing leaflet prolapsed. With isolated PM displacement the 
septal leaflet has the largest reduction in RLL, which may be attributed to numerous 
chordae insertions into the leaflet. Overall, severe displacement of the PMs, with all PMs 
displaced simultaneously in multiple directions, was necessary to cause alterations in 
leaflet mobility. In addition the strut chordal forces increased with multidirectional 
displacement of the PMs. In combined cases of annular dilatation and PM displacement, 
the increased annulus diameter (annular dilatation) and leaflet tethering (PM 
displacement), drastically changed leaflet coaptation and altered chordal forces.  
 This study showed that with disease, as simulated with annular and subvalvular 
geometric alterations, leaflet coaptation is initially altered which results in redistribution 
of chordal forces. This study helps to identify situations in which the valve mechanics are 
significantly altered and may provide insight for targeting repairs of the tricuspid valve. 
In conclusion, addressing annular size and PM location may be important for 






 With regards to the in vivo study, the small number of patients within each group 
resulted in high variability within the group classifications. Future studies should aim to 
recruit additional patients and look at PM displacements in specific disease patterns, as 
those with different disease manifestations would be expected to have different 
remodeling characteristics. In addition, it would be interesting to determine if the severity 
of ventricular dilatation correlates to the magnitude of PM displacement. As noted in the 
discussion, relative position of PMs to the annulus plane is important. Thus, it would be 
of interest to determine if the reference (annulus plane) or the PMs are moving in these 
patients, as it is difficult to identify a relevant reference that does not move with disease. 
 It is important to point out the fact that in this study, and in typical clinical 
practice, PA pressure is determined directly from the TR jet velocity. Although TR was 
determined in this study from the size of the TR jet, this measurement is not completely 
independent of the velocity of the jet. The TR jet is dependent on both the orifice size and 
velocity; thus, the higher the PA pressure, the higher grade of TR. Previous studies which 
measured PA pressure both indirectly and directly, found the values to be correlated with 
TR 16, 19. Although not ideal, to truly investigate the correlation between TR and PA 
pressure, direct high fidelity catheter measurement of PA pressure should be collected to 
confirm these findings. 
 The logical next step for the in vivo and in vitro work is to investigate the effects 
of pulmonary hypertension of TR, as this is of particular interest to the clinical 
community. While PA pressure is accepted as a contributor to TR and was confirmed 
with the in vivo findings in this thesis, the mechanisms by which this occurs are still 
unknown. In vivo studies may aim to determine which PA hypertension patients present 
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with severe TR, and if there are any geometrical correlations. Furthermore, it would be of 
interest to see if current treatment for PA hypertension also results in a reduction of TR, 
and if so by what mechanism. Long term studies may be important to determine the 
outcome of patients in which the TR is reserved with PA hypertension treatment. If in 
fact patients in which the TR remains have poor outcomes repair for the tricuspid valve 
may be necessary. The in vitro flow loop provides an ideal system to isolate parameters 
to see if it is the increase in pressure, providing a greater force on the TV apparatus, or 
the secondary change in geometry, or a combination of the two which contributes to TR.  
 Additional conditions of PM displacement which were identified in vivo should 
be investigated in vitro. For example, in vitro studies assumed only the APM was 
displaced with RV dilatation, but in vivo findings showed that in addition to the APM, the 
SPM and PPM are also displaced. While no significant increase in TR was seen with 
APM displacement alone in vitro, significant TR was created when all PMs were 
displaced, although the SPM and PPM were displaced in the opposite direction, towards 
the RV, as reported in vivo. Combined displacement of the APM, SPM, and PPM away 
from the RV, would be expected to further exacerbate TR. 
 While the role of a saddle shaped annulus was not shown to have a significant 
effect on the TR as well as leaflet strain, future studies may look to investigate the effect 
of chordal forces. Saddle shape may result in a redistribution of chordal forces as it would 
alter the distance from the annulus to the PMs at certain locations of the annulus.  
 This thesis focused solely on functional tricuspid regurgitation and did not 
investigate any of the many congenital abnormalities with result in significant TR. For 
example, Ebstein’s is a disease in which the leaflets of the tricuspid valve are often 
attached directly to the ventricle wall or septum, resulting in severe TR. While tricuspid 
valve alterations occur with many congenital defects the resulting geometries are widely 
variable. Any information into the mechanism behind the TR in these cases may further 




COMPARISON OF HUMAN AND PORCINE TRICUSPID VALVES 
 
 A study was completed to investigate to compare the anatomy of human tricuspid 
valves to those of porcine valves. Porcine measurements were taken of the annulus, 
leaflets, chords and papillary muscles. These measurements were compared to similar 
measurements found in literature for human tricuspid valves. 
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AN APPROPRIATE MODEL FOR THE HUMAN TRICUSPID 
VALVE: THE PORCINE TRICUSPID VALVE 
 
INTRODUCTION 
Interest in the tricuspid valve and its role in tricuspid regurgitation (TR) are on the 
rise. TR was previously thought of as benign, but recent studies have found it to affect 
morbidity and mortality 1. With an increased interest, research studies are being 
conducted to understand the valve in vivo for both human and animal subjects. Although 
in vivo studies have provided us with initial insight into the disease, to truly understand 
the mechanics of the valve, animal testing and in vitro studies are necessary. Such studies 
would allow the investigator to understand the valve in a controlled environment.  
Acquisition of disease free human hearts for research purposes is often challenging as 
normal hearts are typically allocated for transplant recipients, and those typically used for 
research purposes have heart disease. In addition, the source of the human hearts is most 
often limited and inconsistent. Since the acquisition of human valves is difficult, we must 
first determine an appropriate animal model for the human tricuspid valve to be studied in 
vitro. 
Studies have looked at both ovine 35, 36 and porcine 42, 43 specimens to serve as a 
model for the human tricuspid valve. However, these studies did not focus in detail on the 
size and shape of the annulus or leaflets. Although many studies have looked at various 
components of the TV, no study exists that both looks at the valve in its entirety and 
compares an alternative species to a human valve. Although the porcine heart is typically 
accepted as a good model for the human heart 31, 43 it has not been investigated in detail 
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for the tricuspid valve and its valvular and subvalvular components, which has been done 
for the mitral valve 86, 87. This study will compare the annulus, leaflets, chordae tendineae 
and papillary muscles of the human tricuspid valve to the porcine valve to demonstrate 
that the porcine valve is an appropriate model for the human tricuspid valve. 
 
MATERIALS AND METHODS 
Porcine specimens were obtained from a local abattoir (Holifield Farms, 
Covington GA) from female non pregnant pigs ages 6-12 months, 600 lbs.. Porcine hearts 
had an average weight of 941 + 86 grams. Measurements were taken on fresh hearts 
within 4 hours of slaughter. Hearts were selected which had an approximate annulus area 
of 10 cm2.  Hearts were removed from the study if there was damage to the TV as a result 
of slaughter. The various measurement methods used for porcine hearts were comparable 
to those used to obtain the reference human data. Specific descriptions as to why each 
method was selected for comparison are detailed below. 
Annulus: The right atria was removed from the flaccid porcine hearts (n = 10) to expose 
the tricuspid valve and the ventricle was statically pressurized to 40 mmHg to simulate 
normal systolic ventricular pressure. Pressurization was achieved by placing a tube in the 
RV through the pulmonary valve.  A bucket was then attached to the end of the tube and 
elevated to a height to achieve a static pressure head of 40 mmHg when filled with water. 
A ruler was placed in the annulus plane for reference. Pictures were then taken of the 
pressurized valve. The annulus area and diameter were measured both in the septal/lateral 
(SL) and posterior/anterior (AP) directions. The annulus was traced in Matlab R2007a 
(Mathworks, Natick, MA) to determine the area. The centers of the anterior and posterior 
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annulus segments were selected and the distance was measured using Matlab to 
determine AP diameter.  This same procedure was repeated for the SL diameter with the 
center of the septal and anteroposterior segments. Human measurements of diameter (SL 
22, 33, 37 and AP 22, 33) and annulus area 34, 37, 38  were taken from studies that used 2D and 
3D in vivo measurements. Human measurements during diastole were used since they are 
most similar to the statically pressurized porcine hearts, as they are not contracted. 
Porcine annulus segment length and circumference measurements were performed 
on intact flattened hearts (n = 10) in which an incision was made through the right 
ventricle at the free wall connection between the septal and posterior leaflets. Pictures 
were then taken of the valve with a reference ruler at the annulus. Segment lengths were 
traced in Matlab along the annulus between the posteroseptal (PS) and anteroseptal (AS) 
commisures, and along the septal leaflet for the septal segment and the anterior and 
posterior leaflets for the anteroposterior (AP) segment (Fig. 1a) to determine distance.  
 
Figure A.1: Schematic of annulus and leaflet measurements. a) Segment length 
measurements: septal segment (S Seg.) measured from the posterior/septal (PS) 
commisure to the anterior/septal (AS) commisure across the septal leaflet, 
anteroposterior segment (AP Seg.) measured from the anterior/septal commisure 
(AS Comm.) to the posterior/septal commisure (PS Comm.) across the anterior and 
posterior leaflets. b) Location of width (W) and height (H) measurement of each 
leaflet. 
Circumference was calculated as the addition of the two segments. This method 




Leaflets: Porcine leaflet measurements were made using the same methods as previously 
described to measure segment lengths with intact flattened hearts. Leaflet height and 
width were measured with a ruler (Fig. 1b).  Leaflet area was calculated by analyzing 
images in Matlab by identifying the reference distance on the ruler to determine pixel 
spacing and tracing the leaflet perimeter to define the analysis area. Human leaflet height, 
width and area data from fixed hearts 31, 40 was used for comparison as there have been no 
accurate methods of in vivo quantification of leaflet length and width. In order to account 
for changes due to fixation, normalization was also investigated in which the values of 
the measurements were normalized by the circumference of the fixed hearts. Relative 
leaflet size was compared to 3D echocardiographic human findings of Shah 39 and Anwar 
37. 
Papillary Muscles: Porcine observations of the papillary muscles (PM) were made on 
intact flattened hearts (n = 10) ensuring that all PM structures were maintained. The PMs 
were defined using relative leaflet position, with the anterior PM located between the 
anterior and posterior leaflets, septal PM, also known as the medial or conus muscle, 
between the septal and anterior leaflets, and posterior PM located between the septal and 
posterior leaflets.  The size of the PMs was also noted and whether the PM had multiple 
heads or was fused to the wall. In addition to the three main PMs, observations were 
made as to the presence and location of the moderator band, which extends from the free 
wall to the septal wall. Comparison to human PMs were made to observations of cadaver 
hearts by Crick et al. 43. 
Chordae Tendineae: Valves were exposed as previously described for annulus 
measurement and then excised with annulus, leaflets, chords and PMs intact. Porcine 
195 
 
chordae tendineae were classified into similar groups as seen in humans based upon 
insertion location: 1 - Free Edge/Marginal (n = 26), 2 - Rough Zone/Supplemental (n = 
27), 3 - Deep/Strut (n = 24) for each leaflet (Fig. 2).  
 
Figure A.2: Insertion location of chordae tendineae, with classification based upon 
insertion location into leaflet.1) marginal/primary - inserting into the free edge of 
the leaflet, 2) rough zone/supplemental - inserting between the marginal and 
intermediate chords, and deep/secondary - inserting into the belly of the leaflet. 
Chordae were cut at the PM tip and leaflet insertion location. Laser micrometry was used 
to obtain chordae diameter along the entire length of the chord and an average diameter 
was then calculated. Human chordae measurements were taken from Silver et al. 31 and 
normalized by leaflet width to account for fixation. 
Statistical Analysis: All statistical analyses were completed in Minitab 15 (Minitab Inc., 
State College, PA). A 2 sample t-test with summarized data was used for comparison.  
Summarized data, which included sample size, mean, and standard deviation, was used as 
raw values were not available from previously published data.  Results are presented as 
mean + standard deviation.  A significant difference was determined at a 99% confidence 
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level, to minimize the differences due to chance since the comparisons are across studies, 




Minimal significant differences were seen between porcine and human anatomy 
when normalized.  The comparison is divided into annulus, leaflet, PM and chordae 
tendineae measurements. 
Annulus: Results for the comparison between human and porcine for annulus 
measurements can be found in Table A.1.  
Table A.1: Annulus measurements for both human and porcine specimens. Both 
absolute and normalized values are shown. 
 Absolute Value  Normalized by Annulus Area  
 Human Porcine  Human Porcine  
 Mean ± SD Mean ± SD  Mean ± SD Mean ± SD  
Diameter (cm)           
   SA (SL) 3.28 0.64 3.19 0.25  0.32 0.06 0.32 0.03  
   AP 3.58 0.49 4.70 0.41 * 0.35 0.05 0.47 0.04 * 
Area (cm2) 10.34 2.55 9.99 1.33       
Circumference (cm) 11.80 1.27 15.50 0.98 * 1.15 0.12 1.55 0.10 * 
Segment Lengths (cm)      Normalized by Circumference  
   AnteroPosterior 8.54 0.83 9.60 0.53 * 0.72 0.07 0.62 0.03 * 
   Septal 3.20 0.85 5.90 0.53 * 0.27 0.07 0.38 0.03 * 
* = p<.01 as compared to human 
 
There were no significant differences between human and porcine when comparing 
annulus area as this was used for inclusion criteria. Human circumference (11.8 + 1.27 
cm) was significantly (p < 0.01) smaller than porcine valves (15.5 + 0.98 cm).  
Comparison of normalized human measurements of the SL (n = 52) 22, 33, 37 diameter to 
measured porcine valves found no significant difference, while comparison of the AP (n 
= 22) 22, 33 diameter to measured porcine valves found a significant difference (p < 0.01) 
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when normalized by annulus area for comparison. There was a significant difference (p < 
0.01) between the anteroposterior and septal segment lengths for porcine when compared 
to human measurements on  flattened hearts (n = 30) 88.  Human and porcine segment 
length measurements were normalized by the circumference for comparison.  
Leaflets: Results for the comparison between human and porcine leaflet measurements 
can be found in Table A.2.  
Table A.2: Leaflet measurements for both human and porcine specimens, including 
length/height, width and area for all leaflets. Both absolute and normalized values 
are shown. 
 Absolute Value  Normalized by Circumference  
 Human Porcine  Human Porcine  
 Mean ± SD Mean ± SD  Mean ± SD Mean ± SD  
Length/Height 
(cm) 
       
   Anterior 2.90 0.44 3.20 0.38 * 0.24 0.04 0.21 0.02 * 
   Septal 2.33 0.39 2.70 0.81 * 0.19 0.03 0.17 0.05  
   Posterior 2.55 0.41 3.20 0.23 * 0.20 0.03 0.21 0.01  
 Width (cm)        
   Anterior 3.42 0.85 3.80 0.63 * 0.28 0.07 0.25 0.04  
   Septal 3.37 0.85 4.20 0.57 * 0.28 0.07 0.27 0.04  
   Posterior 2.59 0.91 2.80 0.23 * 0.21 0.07 0.18 0.01 * 
 Area (cm2)        
   Anterior 4.53 1.72 7.90 1.23 * 0.37 0.14 0.51 0.08 * 
   Septal 4.04 1.74 7.70 3.09 * 0.33 0.14 0.50 0.20  
   Posterior 3.11 1.73 4.80 1.36 * 0.25 0.14 0.31 0.09  
* = p<.01 as compared to human 
 
Minimal differences were seen in porcine leaflet geometry when compared to human 
leaflet height and width measurements on intact fixed hearts 31, 40 and in vivo 3D real-time 
echo measurement of height22 and area 37, 40. When normalized by circumference, 
significant differences (p < 0.01) were seen in posterior leaflet width, with human (0.21 + 
0.07) wider than porcine (0.18 + 0.01) and anterior leaflet length, with human (0.24 + 
0.04) being larger than porcine (0.21 + 0.02) and anterior leaflet area, with human (0.37 + 
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0.14) larger than porcine (0.51 + 0.08). A further comparison between groups was 
completed to better understand the relative dimensions of the leaflets to each other (Fig. 
3).  
 
Figure A.3: Relative comparison within human and porcine specimens for leaflet 




The septal leaflet was the shortest for both human and porcine. The posterior leaflet was 
the smallest in width for both human and porcine.  For both human and porcine the 
posterior leaflet had the smallest area. 
Papillary Muscles: The comparison between human and porcine PMs on flattened hearts 
was qualitative. A representative image from a porcine heart and a normal human heart, 
obtained for this study, are shown in figure 4.  
 
Figure A.4: Representative images of a flattened human tricuspid valve and porcine 
tricuspid valve comparing papillary muscle morphology and insertion location. 
Abbreviations: A-Anterior Leaflet, P-Posterior Leaflet, S-Septal Leaflet, APM-
Anterior papillary muscle, PPM-Posterior papillary muscle, SPM-Septal papillary 
muscle. 
Observations in the porcine PMs were similar to those previously reported by Joudinaud 
42 on 50 porcine hearts. Both human and porcine hearts had similar PM insertion location 
into the ventricle, with the anterior PM on the free wall and the posterior and septal PMs 
on the septum. Porcine and human PMs are of similar type, with protruding, fused and 
multiple muscle heads and can be classified in the same manner, by location. The anterior 
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PM is the largest and most well defined 43, with the posterior PM having many 
attachments, and the septal PM the smallest and often fused to the wall 42, with chordae 
inserting directly into the free wall. Relative location was similar in both species. 
The moderator band was present on all porcine hearts analyzed. Diameter of the 
moderator band was variable but consistent with attachment from the free wall to the 
septal wall was observed. A previous study comparing human to porcine anatomy 
reported the moderator band to be present in both porcine and human hearts 43.  They 
reported the structure to be more prominent in the porcine heart and located further from 
the apex as compared to humans.  
Chordae Tendineae: Porcine chordae tendineae were observed for all groups which 
have previously been reported in the human TV 31, with the  marginal/primary, inserting 
into the free edge of the leaflet, rough zone/supplemental inserting between the marginal 
and strut chords, and deep/strut inserting into the belly of the leaflet.  A representative 




Figure A.5: Representative image of chordae tendineae classification for both 
human and porcine tricuspid valves. Free Edge/Marginal (1), Rough 
Zone/Supplemental (2), and Deep/Strut (3) chordae are shown. 
Variation exists between chords from valve to valve, but the main chordae groups were 
present 32. Human measurements taken from Silver et al. 31 were compared to porcine 
measurements of all chordae and found a significant difference (p < 0.01) between 
chordae diameter was only seen in rough zone/supplemental for the septal leaflet when 
normalized by anterior leaflet width (Table 3).  
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Table 3: Chordae tendineae measurements for both human and porcine specimens, 
including free edge/marginal, rough zone/supplemental and deep/intermediate for 
all leaflets. Both absolute and normalized values are shown. 
 Absolute Value  Normalized by Ant. Leaflet 
Width 
 
 Human Porcine  Human Porcine  
 Mean ± SD Mean ± SD  Mean ± SD Mean ± SD  
Diameter (mm)           
Anterior Leaflet           
   Free Edge/Marginal 0.80 0.20 1.12 0.36  0.23 0.06 0.30 0.09  
   Rough 
Zone/Supplemental 
1.10 0.40 1.09 0.18  0.32 0.12 0.29 0.05  
   Deep/Strut 1.00 0.40 1.37 0.45  0.29 0.12 0.36 0.12  
Posterior Leaflet           
   Free Edge/Marginal 0.80 0.20 1.03 0.25  0.23 0.07 0.27 0.07  
   Rough 
Zone/Supplemental 
0.90 0.20 0.96 0.34  0.26 0.07 0.25 0.09  
   Deep/Strut 0.90 0.30 1.12 0.44  0.26 0.10 0.29 0.12  
Septal Leaflet           
   Free Edge/Marginal 0.80 0.30 0.62 0.17  0.23 0.10 0.16 0.04  
   Rough 
Zone/Supplemental 
0.90 0.20 0.62 0.09  0.26 0.07 0.16 0.02 * 
   Deep/Strut 0.80 0.30 0.87 0.23  0.23 0.10 0.23 0.06  
* = p<.01 as compared to human        
 
DISCUSSION 
The main difference in the human and porcine heart is the position in the body as 
the human stands upright while porcine specimens are on all fours. While this may affect 
the naming of the leaflets, this study demonstrated that the structure of the tricuspid valve 
is similar between porcine and human species, irrespective of the orientation of the heart 
in the body. In this study, the leaflets were named as if the heart was sitting on its apex 
(septal, anterior and posterior) 89 and not as if anatomically oriented in the heart (septal, 
antero-superior, and inferior). Controversies over the proper naming of the leaflets 
continue to exist 90. The leaflets in this study were named as such to be consistent with 
recent publications in the field 9, 39, 42, 88. 
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Comparisons of the annulus indicated a difference in the AP diameter. This may 
be due to the fact that human measurements were completed using echocardiography, and 
the difference seen may be due to the low echo resolution. Also, determining the AP 
diameter in vivo is subjective as it is very difficult to determine the exact center of the 
anterior and posterior annulus segments. The measurements performed on the porcine 
hearts may be more accurate than what is possible with echocardiography. It is important 
to note that although the annulus area measurements were similar the circumference was 
not. The study in which the circumference data was extracted did not report the annulus 
or heart size; it only stated that the hearts were from adult cadavers, thus they may have 
differed in size than the human hearts used to determine annulus area. The difference 
seen in the circumference between species is most likely due to the difference in size of 
the porcine hearts used in this study and the typical adult human heart. For this reason the 
circumference was used as a normalization factor throughout the study. Segment lengths 
also differed for human and porcine. Since segment lengths were determined between the 
commissures, there is variability in choosing the center of the commissure accounting for 
this difference.  
The leaflet geometry was in overall agreement.  Although there were differences 
seen between species in length, width and area, further investigation found no difference 
in the relative sizes when compared within the species.  It is the relative sizes that are 
most important when the valve as a whole is used to study mechanics, since investigation 
is conducted to understand how the entire valve works together. Comparison of leaflets 
was restricted to the main leaflets and did not include the scallops due to the large 
variability in number and size of the scallop leaflets as reported in both humans and 
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porcine valves 42. Measurements in this study were conducted on the three main leaflets, 
although studies have reported a variable number of leaflets, with 2 to 7 leaflets present 
32, 91. 
This study also provides a baseline for porcine valve selection for in vitro studies.  
In this study the difference in the specimens were minimized when normalized to account 
for the difference in size of the hearts. It may be possible to select for valves that are 
more similar in size to humans and to exclude those with large structural differences.  
Valves should be selected to minimize differences in annulus area, leaflet height and 
width, with similar PM structure and chordae insertion location. 
Human vs. Porcine Measurement Method Comparison 
The human hearts that were used in reported studies were normal, with no clinical 
implication of tricuspid valve disease. Human measurements, which were used for 
comparison, were taken from several literature sources. 
Justifications for comparisons of reported human measurements to measured 
porcine valves can be made. Human measurements taken from Silver et al. 31 which were 
used to compare chordae tendineae diameter were normalized by leaflet width as this was 
the only appropriate normalization parameter provided in the human study. We expect 
similar effects in structure due to fixation on chordae as to leaflet width, due to similar 
collagen alignment. Diastolic measurements were used for all in vivo human data, as this 
is most similar to an excised heart which is in a relaxed state.  Despite best efforts to 
mimic measurement techniques used on existing human data, some of the difference may 
be attributed to measurement discrepancy. Indexing was used for comparison, as there are 
not only variations across species but within the species themselves. It is not uncommon 
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for a normalization factor to be utilized when analyzing clinical data, thus we have 
chosen to do so in this study. Ideally it would be best to obtain human hearts and porcine 
hearts of similar size for a direct comparison. Even with this method, some differences 
are to be expected due to the fact that there is a large amount of variability within each 
species. 
Accounts of human observations on the TV and its components are limited, 
especially with respect to PMs. It is necessary for future studies to do an exhaustive 
analysis of the human TVs which includes the location and structure of the PMs. Most 
studies of the human TV have been limited to the annulus 22, 29, 33-36, 38, 88, which may 
coincide with recent attempts to surgically repair the annulus. Studies of the annulus in 
vivo have not only looked at size, but shape as well 12, 33 and have commented on the 3D 
nature of the annulus. This amount of detail as to 3D shape was not completed in this 
study as the porcine hearts were excised and as such would not be expected to retain its 
natural 3D geometry. 
  In conclusion, this investigation provides a complete and thorough examination of 
the porcine tricuspid valve and its similarities to the human valve. We found the porcine 
tricuspid valve to be an appropriate model for the human valve due to minimal significant 
differences in valvular and subvalvular anatomy. The porcine tricuspid valve may thus be 
used as a model for in vitro testing as the relative structure of the valve is maintained 
within the two species. The specimens share similar geometric measurements of the 
annulus, leaflets, chordae tendineae and papillary muscles. 
The identification of an appropriate model for in vitro investigation will greatly 
aid research as it is not always feasible to obtain human valves, due to cost and 
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availability of healthy valves.  It is important to note that the purpose of this study was to 
identify an acceptable model for in vitro testing and the authors make no claims for a 
replacement to a native human valve in vivo. 
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 Form completed for every valve prior to experimentation. Valves which passed all 




Valves will be selected which best represent the human anatomy 
Pass/Fail 
 
  1 Begin by selecting a valve which is small and has minimal gashing.  
Ensure that the TV is intact.  
  Estimation of annulus size can be achieved by comparing to TV ring sizer 
32. 
  Do not select a heart if the RV is distended. 
  2 Examine the PMs to ensure that there are no abnormalities and three 
distinct groups are present  
  Septal  
  Anterior    
  Posterior  
  3 Ensure chords insert into PM groups. 
  4 Examine the leaflets. 
  3 Main Cusps - Anterior, Posterior, Septal 
  Post Smallest Leaflet 
  5 Pressurize the heart. Ensure there is no/minimal leakage. If there is a 
distinct regurgitant jet the valve will not be chosen for experimentation.  
  6 Take a picture of the pressurized valve with a reference ruler placed on 
the plane of the annulus.  
  7 Measure the Annulus 
  Perimeter (10.5 ± 1.27 cm)   
  Septal Segment (3.06 ± 0.37 cm)   
   Anteroposterior Segment (7.4 ± 0.94 cm)   
 8 Open the RV.  Prior to excising the valve measure the leaflets. 
  Anterior:  
  Height (2.16 ± 0.44 cm)   
  Width (3.42 ± 0.85 cm)   
  Septal: 
   Height (1.74 ± 0.39 cm)   
  Width (3.37 ± 0.85 cm)   
  Posterior: 
  Height (1.90 ± 0.41 cm)    
  Width (2.59 ± 0.91 cm)   
 9 Excise valve and subvalvular apparatus. Ensure no damage to leaflets, 





VENTRICULAR CHAMBER DRAWINGS 
 
 The right ventricle consisted of multiple parts which were assembled to make the 
complete chamber. All necessary drawings needed to manufacture the chamber are 























































PAPILLARY MUSCLE DISPLACEMENT SHEET 
 
 An excel sheet was used to input the current position of the three papillary muscle 







IN VIVO IRB PROTOCOL 
 




IRB Study: IRB00013027 
Protocol – Version Date: 10/2009 
Title of Study: Echocardiographic study of Right Ventricular Papillary Muscle position in 
normal, dilated RV, dilated LV and dilated LV/RV patients 
Short Title: Echocardiographic Right Ventricular Papillary Muscle Displacement Study 
 
Principle Investigator: Stamatios Lerakis, M. D. 
Emory Department: Cardiology 
Phone Number: 404-778-5414 
Co-Investigators: Erin Spinner, B.S. 
Abstract: 
 Although recent advancements have been made for the specific repair of tricuspid 
regurgitation (TR), many patients are still left with residual TR or later develop recurrent 
TR.  Current repairs seek to fix the valvular apparatus but do not attempt to restore 
subvalvular function, such as papillary muscle (PM) position. It is believed PM 
displacement is a common result of ventricular dilatation, in addition to the annular 
dilatation.  This displacement may cause leaflet tethering and improper leaflet coaptation, 
thus contributing to the latent TR. 
 This study will seek to identify and quantify the amount of papillary muscle 
displacement that occurs in patients with TR.  We will use echocardiographic images to 
examine quantitative changes in patient anatomy with left ventricular (LV) and right 
ventricular (RV) dilatation. Anatomical measurements can be made once the images are 
acquired using commercially available software 
 Patients will be assigned to one of four categories:  1) those with normal sized and 
functioning right and left ventricles (RVEDV < 110 ml and LVEDV < 130 ml); 2) those 
with RV dilation or (RVEDV > 110 ml); 3) those with LV dilation (LVEDV > 130ml); 
and 4) those with combined RV and LV dilation.  The normal patient group may have 
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trace TR while the dilated group will have mild to severe grade TR. We will use 
echocardiographic data to take specific measurements of the placement of the three 
papillary muscles in the RV with respect to the annulus plane.  Eight patient data sets 
from each group (normal, LV dilatation, RV dilatation, and RV/LV dilatation) will be 
analyzed for a total of 32 patients. The distance for all three PMs will be recorded and 
compared between the groups to determine if dilatation has a significant impact on RV 
PM location. 
 This information will provide insight into the mechanism of how PM 
displacement may cause tricuspid regurgitation.  We can then begin to understand if there 
are additional changes that affect proper closing of the leaflets. 
 
1. Introduction – Background 
 Currently, 16.8  million people in the US (5.6% of the population) have tricuspid 
valve regurgitation (TR) 7, which results in back flow of blood from the right ventricle to 
the right atrium. Out of this population, 8,000 per year go on to receive some type of 
treatment 8, either complete valve replacement or repair such as an annuloplastry, which 
reduces the size of the valve opening to its original size. Current repairs offer limited 
success, with 10% of surgeries unsuccessful, and a majority of reoperations due to 
returning levels of TR 47.  This number of unsuccessful repairs may be due to the 
incomplete understanding of the cause of the TR. 
 In most cases, TR is caused by annular dilatation, in which the fibrous ring that 
attaches the valve to the heart wall becomes enlarged so that the leaflets cannot 
completely cover the orifice in order to prevent regurgitation.  In conjunction with a 
dilated annulus, the ventricle also dilates.  Fixing the annulus size does not eliminate TR 
completely and in many cases it returns 26, 33. Studies that found recurring TR after 
annuloplasty have concluded that reducing the annulus may not be enough to correct TR 
26, 55. Thus, additional mechanisms have been investigated, specifically the effects of PM 
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displacement. It has been shown that TV tethering, restriction of leaflet mobility, caused 
by PM displacement is an independent predictor of TR after tricuspid valve annuloplasty 
26, 55, but the amount of displacement has yet to be quantified. The proposed mechanism 
for this relationship is that as the free wall dilates the anterior papillary muscle, which is 
located on the free wall of the ventricle and attaches through chordae tendineae to the 
valve leaflets, moves outward, thus tethering the leaflets 92.  In addition to the proposed 
motion of the anterior PM in RV dilation, it is of interest to determine if the PMs on the 
septal wall, the posterior and septal PMs, move in conjunction with RV or LV dilation.  
Although it is possible for the septal and posterior PMs to be affected by LV dilation 
since the two ventricles are connected, it has not yet been identified.  If in fact there is an 
effect on the PMs in the RV due to LV dilatation, this may further support the belief that 
the dynamics on the left side of the heart affect the right side of the heart.  
 
2. Objectives 
 The purpose of this study is to utilize echocardiography to examine anatomical 
changes in patients with dilated right and left ventricles in association with tricuspid 
regurgitation. 
The specific aims of this project are as follows: 
1. Determine RV papillary muscles displacement due to isolated RV and LV 
dilatation and combined RV/LV dilatation, from patient Echocardiographic 
images 
2. Compare RV papillary muscles location in normal, RV dilated, LV dilated 
and RV/LV dilated patients and determine effect of papillary muscles 
displacement on TR 
 




 Echocardiographic images of the heart will be acquired following the standard 
clinical procedures, including 4 chamber and RV views.  Procedures that differ from 
standard practice are limited to the subsequent additional data analysis. The 
echocardiographer will maintain a spreadsheet in which they will identify eligible 
patients for the study and assign a reference number to protect patient privacy. All 
echocardiographic patient images will be stored according to current hospital practice on 
secure servers.  Images will then be analyzed using commercially available software to 
measure the distance of all three RV PM tips to the annulus plane. Results from data 
analysis will also be stored, but no patient data will be contained on these files, only the 
assigned reference number.  
 Since this study is purely data analysis and requires no additional involvement as 
far as the patients is concerned, there are no risks to the patient.  At the same time the 
patient will receive no immediate benefits from participating in the study. 
 
4. Participant Selection 
 Patients who come in for an echocardiography which fit into one of the four 
categories listed below will be asked for verbal consent to participate. The 
echocardiographer will ask the patients when they are in the echo suite prior to beginning 
the exam if they are interested in participating in a research study.  The technician will 
then inform them of the study and read the verbal consent script.  If the patient says yes, 
their information will be noted in the list stating they have consented, and the exam will 
proceed according to standard operating procedure.  If the patient says no, their name will 
not be placed on the eligible patient list and the will proceed with their exam. 
Eligibility Criteria 
a. Physician Ordered Echocardiogram 
b. Age >18 years of Age 
c. Normal Patients:  
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a. N = 25 patients 
b. Normal LV : LVEDV< 130 ml 
c. Normal RV: RVEDV  <  110 ml 
d. Maximum TR Grade: Trace 
d. RV Dilatation Patients: 
a. N = 25 patients 
b. Normal LV: LVEDV< 130 ml 
c. Dilated RV: RVEDV > 110 ml 
d. TR Grade: Mild - Severe 
e. LV Dilatation Patients:  
a. N = 25 patients 
b.  Dilated LV: LVEDV> 130 ml 
c. Normal RV: RVEDV < 110 ml 
d. TR Grade: Mild- Severe 
f. RV/LV Dilatation  patients:  
a. N = 25 patients 
b.  Dilated LV: LVEDV> 130 ml 
c. Dilated RV: RVEDV > 110  ml 
d. TR Grade: Mild - Severe 
Ineligibility Criteria: 
 During data analysis if we are unable to accurately identify and measure all three 
RV PMs the patient data will be removed from the study. 
 
5. Statistical Analysis 
 Measurements will need to be normalized by body surface area (BSA) to 
minimize error due to various sized anatomies. All data will first be accessed for 
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normality, and then based upon normality the data will be assessed for statistical 
difference from the normal patients measurements and additionally between the groups. 
 
6. Adverse Event Reporting 
 Although, the likelihood of an adverse event is negligible, any events that may 
occur will be reported in writing to the IRB board, as per standard procedure. 
 
7. Data and Safety Monitoring Plan (DSMP) 
 A list will be maintained by the echocardiographer as to which patients are 
eligible for the study and what group they are in.  This spreadsheet will also be used to 
assign a reference number to the patient in order to protect patient privacy.  The 
spreadsheet will be stored in a locked cabinet. The safety of the patients involved will not 
be addressed in this IRB since the echo is part of the standard of care for these patients 
and no additional protocols will be needed. 
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IN VIVO CONSENT FORM 
 
 All patients were consented prior to admittance into the research study. A script 
was provided to the technician to read to the patients. 
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IRB Study: IRB00013027 
Verbal Consent Script – Version Date: 11/13/2008 
Title of Study: Echocardiographic study of Papillary Muscle position in normal, dilated 
RV, dilated LV and dilated LV/RV patients 
Short Title: Echocardiographic Papillary Muscle Displacement Study 
 
Principle Investigator: Stamatios Lerakis, M.D. 
Emory Department: Cardiology 
Phone Number: 404-778-5414 
 
You are being asked to participate in a study which will seek to identify and quantify the 
amount of right ventricle papillary muscle displacement which occurs in patients with 
TR.  In this study, we will use echocardiographic images to examine the changes in 
patients with left ventricular (LV) and right ventricular (RV) dilatation. There is no 
difference in the time or procedure of acquisition of your echocardiogram.  This study 
will simply use your echo images, which are taken as standard procedure as have already 
been ordered by your doctor, to take measurements afterward. 
 
Your participation and data is strictly confidential. Your data will be assigned a reference 
number in order to protect patient privacy. Since this study is purely data analysis and 
requires no additional involvement as far as you, the patients is concerned, there are no 
additional risks involved.  At the same time you will receive no immediate benefits from 
participating in the study. 
 
Your participation in this study is voluntary.  It is entirely your choice.  If you 
decide to take part, you can change your mind later on and withdraw from the 
research study. The decision to join or not join the research study will not cause you to 
lose any medical benefits.  If you decide not to take part in this study, your doctor will 
continue to treat you. 
Do you give verbal consent to participate in this study? 
If, yes state yes and your data will be included as part of this study.  




RLL MATLAB CODE 
 
 A Matlab code was written to transpose the marker data into a matrix and then 






1. Increase contrast in all 42 pictures (includes static images). Save. 
2. Crop all 42 pictures. Save as file_cropped.jpg in a new folder. 
3. Places cropped pictures in ppt template. Save as date. 
4. EITHER: 
o Place cropped pictures (3 on each page) in word doc. Print and connect-
the-dots for each leaflet with a pen/pencil. 
o Open each of the 42 pictures in Photoshop, or similar program. Connect-
the-dots for each leaflet with a thin paintbrush. 
o TIP: darken the dots first to make it easier to connect-the-dots. 
5. Start with one leaflet. Count the dots on each row for each of the 14 conditions 
(includes static).  Write the numbers down next to the picture to make it easier for 
step 6. 
6. Enter this info in the leaflet’s corresponding makeMatrix.m file.  
o DO NOT CHANGE anything in this file. Just run it, and fill in the blanks 
in the command window. 
o TIP: Must do all 40 entries for the one leaflet in one sitting. So, be sure 
you’ve done step 5 in its entirety (and clearly), so you can do this quickly 
without any mistakes. 
7. Open the areaPlotInitial.m file for that leaflet and run it. That’s it. 
o DO NOT CHANGE anything in this file. 
8. Open the plotAll.m file for that leaflet and run it.  
o DO NOT CHANGE anything in this file. 
o Save all the newly formed jpgs in a new folder. 
9. Places these newly formed jpgs in the ppt. 
10. Make a line showing the residual leaflet length on the jpg in ppt, and enter the 
data in the table. Do this for each of the 39 experimental conditions. 
11. Repeat 5 – 9 for the other two leaflets. 
 
Matlab CodeL: makeMatrix.m 
 
% User Status Information 
fprintf('When there are no more rows, just press enter.\n') 
fprintf('Enter row info as a vector.\n'); 
fprintf('Example: [0 14 0] would be one empty spot, 14 markers, and 
then one empty spot\n\n'); 
  
% Get the bottom row and create the empty matrix 
counter = 30; 
fprintf('Input ant_1_0\n'); 
row = input('Enter bottom row info: '); 
mat = zeros(counter,row); 
mat(end, :) = 1; 
  
% Ask for each row 
while length(row) > 0 
   row = input('Enter row info: '); 
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   firstOne = find(mat(counter,:),1); % finds the first occurance of a 
marker in the previous row 
    
   zerosBefore = find(row,1) - 1  ;
   markers = row(zerosBefore+1); 
   zerosAfter = find(row(end:-1:1),1) - 1; 
    
   lastOne = length(mat(counter,:)) - find(mat(counter,end:-1:1),1) + 
1;  
   totalOnes = lastOne - firstOne + 1; 
    
   if isempty(zerosBefore) 
       zerosBefore = 0; 
   end 
   if isempty(markers) 
       markers = 0; 
   end 
   if isempty(zerosAfter) 
       zerosAfter = 0; 
   end 
        
        
  if      totalOnes ~= (zerosBefore + markers + zerosAfter) && 
length(row) > 0 
          row = input('WRONG INPUT.  TRY AGAIN. Enter row info: '); 
          firstOne = find(mat(counter,:),1); % finds the first 
occurance of a marker in the previous row 
          zerosBefore = find(row,1) - 1; 
          markers = row(zerosBefore+1); 
          zerosAfter = find(row(end:-1:1),1) - 1; 
   end 
    
   counter = counter-1; 
   mat(counter,firstOne+zerosBefore:firstOne+zerosBefore+markers-1)=1; 
end 
  
status = 'Now adding reference point...' 
xcor = input('What is the X coordinate of the reference point: '); 
ycor = input('What is the Y coordinate of the reference point: '); 
mat(end-ycor+1,xcor) = 2; 
  
while length(find(mat(1,:),1)) == 0 
    mat(1,:) = []; 
end 
  
status = 'Finished.' 
  
ant1_0 = mat 
 
Matlab Code: areaPlotInital.m 
 
function [x, y, refx, refy] = areaPlotInitial(sample, color1) 
% septal, initial, 10/07/08, 100708_full.jpg 
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  sample = [ 0     0     0     0     0     1     1     1     0     0     
0     0     0     0     0 
     0     0     0     0     0     1     1     1     1     1     1     
1     1     0     0 
     0     0     0     0     1     1     1     1     1     1     1     
1     1     0     0 
     0     0     0     0     1     1     1     1     1     1     1     
1     1     0     0 
     0     0     0     0     1     1     1     1     1     1     1     
1     1     0     0 
     0     0     0     0     1     1     1     2     1     1     1     
1     1     0     0 
     0     1     1     1     1     1     1     1     1     1     1     
1     1     0     0 
     0     1     1     1     1     1     1     1     1     1     1     
1     1     0     0 
     0     1     1     1     1     1     1     1     1     1     1     
1     1     0     0 
     0     1     1     1     1     1     1     1     1     1     1     
1     1     0     0 
     1     1     1     1     1     1     1     1     1     1     1     
1     1     1     0 
     1     1     1     1     1     1     1     1     1     1     1     
1     1     1     1 
     1     1     1     1     1     1     1     1     1     1     1     
1     1     1     1]; 
tempTitle = 'Anterior Leaflet'; 
%% sample leaflet adjustments 
% separate leaflet into positive and negative slopes 
max = find( sample(1,:), 1); 
% size the original leaflet 
[rows cols] = size(sample); 
% add a border of zeros around it 
sample = [zeros(1,cols+2) 
          zeros(rows,1) sample zeros(rows,1) 
          zeros(1,cols+2)]; 
% flip it vertically for proper graphing 
sample = sample(end:-1:1,:); 
  
%% sample leaflet locations 
% find bottom left corner of leaflet 
x = [find(sample(2,:),1,'first')]; 
y = [find(sample(:,2),1,'first')]; 
% find bottom right corner of leafle  t
xend = [find(sample(2,:),1,'last')]; 
yend = [find(sample(:,2),1,'first')]; 
% find reference X point of leaflet 
[refy refx] = find(sample==2,1); 
  
%% plotting 
% plot the base of leaflet  
plot([x xend], [y yend],color1); 






% iterate through left side (positive sloping) 
for c=1:max+1 
    for r=1:rows+1 
        if sample(r,c) == 1 
            if sample(r+1,c) == 0 || (sample(r,c-1)==0 && sample(r-1,c-
1)==1) 
                x = [x c]; 
                y = [y r]; 
            end 
            plot(c,r,'r.'); 
       nd  e
    end 
end 
  
% iterate through right side (negative sloping) 
for c=max+1:cols+1 
   for r=rows+1:-1:1 
       if sample(r,c) == 1 
           if sample(r+1,c) == 0 || (sample(r,c+1)==0 && sample(r-
1,c+1)==1) 
               x = [x c]; 
               y = [y r]; 
           end 
           plot(c,r,'r.'); 
       end 
   end 
end 
  
% add the bottom right corner 
x = [x xend]; 
y = [y yend]; 
  
% plot reference poin  t
plot(refx,refy,'kx'); 
  
% plot black border of leaflet 
plot(x,y,color1) 
  
xlabel('Distance (mm/2)'); ylabel('Distance (mm/2)'); 
title(tempTitle); 
 
Matlab Code: plotAll.m 
Code shown for Anterior Leaflet (plotAllAnterior.m) code is modified for each 
leaflet by altering the leaflet name. 
 
%%Plot Static Leaflet 
leafletName = 'Anterior Leaflet'; 
  
date = '031909'; 
  
color1 = 'k'; 
color2 = 'b'; 
color3 = 'g'; 
color4 = 'c'; 
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color5 = 'm'; 
color6 = 'r'; 
color7 = 'y'; 
  
colorName1 = 'Black'; 
colorName2 = 'Blue'; 
colorName3 = 'Green'  ;
colorName4 = 'Cyan'; 
colorName5 = 'Pink'; 
colorName6 = 'red'; 
colorName7 = 'yellow'; 
  
leftTextCoor = -1; 




colorAll = 56; 
colorNameAll = {colorName1 colorName2 colorName3 colorName4 colorName5 
colorName6 colorName7}; 
  
[rows cols] = size(ant_S); 
[x1, y1, refx1, refy1] = areaPlotInitial(ant_S,colorAll{1}); 
%% Plot Ant_1_0 
[x2, y2, refx2, refy2] = areaPlot(ant_1_0); 
%plot(refx2+(refx1-refx2),refy2+(refy1-refy2),'go'); % plot the ref 
point 
plot(x2+(refx1-refx2),y2+(refy1-refy2),colorAll{2}); % plot the border 
plot([x2(1) x2(end)]+(refx1-refx2),[y2(1) y2(end)]+(refy1-
refy2),colorAll{2}); % plot the base 
%% Plot Ant_1_40 
[x3, y3, refx3, refy3] = areaPlot(ant_1_40); 
plot(x3+(refx1-refx3),y3+(refy1-refy3),colorAll{3}); % plot the border 
plot([x3(1) x3(end)]+(refx1-refx3),[y3(1) y3(end)]+(refy1-
refy3),colorAll{3}); % plot the base 
%% Plot Ant_1_100 
[x4, y4, refx4, refy4] = areaPlot(ant_1_100); 
plot(x4+(refx1-refx4),y4+(refy1-refy4),colorAll{4}); % plot the border 
plot([x4(1) x4(end)]+(refx1-refx4),[y4(1) y4(end)]+(refy1-
refy4),colorAll{4}); % plot the base 
%% Plot Ant_2_0 
[x5, y5, refx5, refy5] = areaPlot(ant_2_0); 
plot(x5+(refx1-refx5),y5+(refy1-refy5),colorAll{5}); % plot the border 
plot([x5(1) x5(end)]+(refx1-refx5),[y5(1) y5(end)]+(refy1-
refy5),colorAll{5}); % plot the base 
  
%% Plot Ant_2_40 
[x6, y6, refx6, refy6] = areaPlot(ant_2_40); 
plot(x6+(refx1-refx6),y6+(refy1-refy6),colorAll{6}); % plot the border 
plot([x6(1) x6(end)]+(refx1-refx6),[y6(1) y6(end)]+(refy1-
refy6),colorAll{6}); % plot the base 
  
%% Plot Ant_2_100 
[x7, y7, refx7, refy7] = areaPlot(ant_2_100); 




refy7),colorAll{7}); % plot the base 
%% Plot Ant_3_0 
[x8, y85, refx8, refy8] = areaPlot(ant_3_0); 
plot(x8+(refx1-refx8),y8+(refy1-refy8),colorAll{8}); % plot the border 
plot([x8(1) x8(end)]+(refx1-refx58),[y8(1) y8(end)]+(refy1-
refy8),colorAll{8}); % plot the base 
  
%% Plot Ant_3_40 
[x9, y9, refx9, refy9] = areaPlot(ant_3_40); 
plot(x9+(refx1-refx9),y9+(refy1-refy9),colorAll{9}); % plot the border 
plot([x9(1) x9(end)]+(refx1-refx9),[y9(1) y9(end)]+(refy1-
refy9),colorAll{9}); % plot the base 
  
%% Plot Ant_3_100 
[x10, y10, refx10, refy10] = areaPlot(ant_3_100); 
plot(x10+(refx1-refx10),y7+(refy1-refy10),colorAll{10}); % plot the 
border 
plot([x10(1) x10(end)]+(refx1-refx10),[y10(1) y10(end)]+(refy1-
refy10),colorAll{7}); % plot the base 
  
  
strTop = [colorNameAll{1} ' = Static ... ' colorNameAll{2} ' = Normal 
... ' colorNameAll{3} ' = Dilated 20% ... ' colorNameAll{4} ' = Dilated 
40%']; 
strBottom = [colorNameAll{5} ' = Dialated 60% ... ' colorNameAll{6} ' = 














MRI ASSESSMENT OF RIGHT VENTRICLE PAPILLARY 
MUSCLE POSITION 
 
 MRI was used to investigate the right ventricle (RV) PM position in normals and 
patients with a dilated left ventricle (LV). A significant difference was seen in the septal 
PM position, towards the center of the RV, in patients with a dilated LV as compared to 
normal subjects. Dilatation of the LV was shown to impact the geometry of the RV 
through the septum.  
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Objective: To investigate the impact of left ventricular (LV) dilatation on right 
ventricular (RV) papillary muscle (PM) displacement.  
Methods: Thirteen patients underwent high resolution cardiac magnetic resonance 
imaging (CMR) at Emory University Hospital: 7 patients with congestive heart failure 
and a dilated LV composed the Dilated LV Group and 6 normal subjects were used as a 
control. 120 CMR slices were acquired in a short axis view at end-diastole for each 
subject. CMR slices were used to identify the papillary muscle tip position in 3 
dimensional coordinates for the septal, posterior and anterior PMs. The centroid of the 
PM coordinates was used as the reference point for comparison between subjects. The 
relative orientation between the right ventricular papillary muscles was evaluated and 
compared between the Dilated LV Group and normal subjects.  
Results: Dilatation of the LV resulted in a significant (p=0.05) displacement of the septal 
RV PM towards the centroid, Normal group: 0.0285+0.036 mm/mm vs. Dilated LV 
Group: 0.1437+0.026 mm/mm. More specifically the septal PM significantly (p=0.03) 
moved away from the septal wall (Normal Group: 0.61+0.09 mm/mm, Dilated LV 
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Group: 0.379+0.037 mm/mm). Specific locations of all three RV PMs were reported for 
normal subjects and patients with a dilated LV. 
Conclusions: Patients with a dilated LV have significantly increased displacement of the 
septal RV PM away from the septum when compared to normal controls. This 
demonstrates pathophysiologic contribution of the LV to specific papillary muscle 
alterations within the RV.   
 
Left sided heart disease is traditionally thought to impact the right side of the 
heart through pulmonary hypertension 16, 93 and increased after load on the right ventricle 
(RV). LV dilatation and dysfunction, even in the absence of pulmonary hypertension, can 
have a detrimental impact on the RV and may be a potential mechanism for high 
occurrence of TR in patients with MR. In this study, it is hypothesized that in addition to 
pulmonary hypertension geometric changes on the left side may also directly affect the 
right side as the RV and LV are connected through the interventricular septum 69. The 
volume in which the LV and RV can fill is restricted by the pericardial sack, thus, a 
dilated LV may not only enlarge into the pericardial space but also into the RV as it is a 
lower pressure chamber. Changes in RV geometry induced from LV geometric changes 
may contribute to secondary tricuspid regurgitation through papillary muscle 
displacement, improper muscle contraction or other complications. 
Changes in RV geometry may lead to alterations in the positions of the PMs of 
the tricuspid valve as they are directly connected to the ventricle. Studies by Jouan et al. 
and Hiro et al. investigated the RV PM position in sheep over the cardiac cycle, but did 
not report how these positions may change in a diseased state 35, 36. Studies have 
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implicated RV dilatation as a cause of anterior PM displacement 23, 24. The speculated 
mechanism for pathological PM displacement is that as the free wall of the right ventricle 
dilates, the anterior PM, located on the free wall of the ventricle and attaching through 
chordae tendineae to the valve leaflets, moves outwardly, thus tethering the tricuspid 
valve leaflets 92. In addition to the proposed motion of the anterior PM due to RV 
dilation, it is of interest to determine if the PMs on the septal wall, the posterior and 
septal PMs, are displaced due to LV dilation. Although it is probable that the septal and 
posterior PMs are affected by LV dilation through the interventricular septal motion, it 
has yet to be demonstrated in human subjects. The specifics of which PMs are displaced 
with specific etiologies, the direction of displacement, and how much they are displaced 
remain unknown.  
If in fact there is an effect on the PMs in the RV due to LV dilatation, this may 
further support the belief that the dynamics on the left side of the heart affect the right 
side of the heart. We hypothesize that geometric changes in the left ventricle (LV), as a 
result of LV dilatation, may also alter RV geometry and displace the PMs located on the 
septal wall. 
In this study, we identify and compare the position of RV PMs in normal subjects 
and patients with LV dilation to quantitatively establish the RV PM positions and the 
influence of LV dilation on RV PM displacement. Magnetic Resonance Imaging (MRI) 
was the imaging modality chosen for this study because it has the potential to image 







A total of 13 subjects were scanned as part of a high resolution geometric protocol 
at Emory University Hospital Midtown, Atlanta GA. Of these, 7 were congestive heart 
failure patients (Dilated LV Group) with the following implications: mild (n=2) to severe 
(n=5) mitral valve regurgitation, a dilated left ventricle (LVEDV 234.7 + 70.8 ml), mean 
age of 65 ± 14, NYHA class 2(n=2), 3(n=4), 4(n=1), pulmonary regurgitation (n=3), 
pulmonary hypertension mild(n=3) to moderate(n=3), normal systolic function(n=6), and 
mild tricuspid regurgitation(n=5). The remaining 6 were normal subjects, with no known 
heart conditions and used as controls for the study (Normal Group), mean age(n=5) 25 ± 
2.5. The study was approved by the Emory University Institutional Review Board for 
human subjects, and patient privacy was protected according to HIPPA regulations and 
all patient identifiers were removed from data used in this study. Informed consent was 
obtained from all participants in the study. 
Image Acquisition 
All scans were acquired on a Philips Intera CV 1.5 T system using a cardiac coil. 
High resolution, ECG and navigator echo gated ‘whole heart’ gradient echo sequence 
was used in the short axis orientation spanning both the right and left ventricles during 
end-diastole 94. Pixel size ranged from 0.53 – 0.70 mm, slice thickness from 1.5 – 2.0 
mm, and echo time from 1.3 – 2.1 ms. Approximately 120 slices were acquired at end-






XnView 1.92 was used for visualization and post processing. References in the x, 
y, and z direction were identified to compare the PMs in 3D space. An annulus reference 
slice was identified in order to calculate the z distance relative to the annulus reference 
plane (ARP). The annulus plane was selected as a reference plane so the relative 
proximity and change could be related to the annulus plane. The ARP was identified as 
the slice in which the right coronary artery and aortic leaflets were visible. The diameter 
of the ascending aorta was measured and recorded in the ARP. Papillary muscle tip 
position was manually identified in the various images by identifying the regions of low 
intensity (the PM) among regions ofhigh intensity (blood), in the right ventricle (RV) 
(Fig H.1).  
 
Figure H.1: MRI visualization of papillary muscles. a) Septal PM, b) Anterior PM, 
c) Posterior PM 
 
 
The first slice in which the PM was visible was recorded to obtain the z distance 
with respect to the ARP. The x and y coordinates of the center of the PM tip was 
recorded to give the full 3D position. 
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3D coordinates were recorded for all three papillary muscles: septal, posterior and 
anterior in all subjects. All images were registered to the MRI coordinate system for 
purposes of position and orientation 95.  
The centroid of the three PM coordinates was calculated for the three PMs for 
each patient and used as a reference point. All distances were normalized by ascending 
aortic diameter to minimize patient variability. X, y and z distances from the centroid 
(Fig H.2a) were calculated for each PM as well as the distance from each PM to the 
centroid (Fig H.2c). In addition, the triangle formed by the 3 PMs was used to investigate 
the relative position of the PMs. The distance of each triangle side length (Fig H.2b) and 




Figure H.2: Schematic of measurements of PMs. X-direction = (+) septal/(-) lateral, 
Y- direction = (+) anterior/(-) posterior, Z-direction: distance from annulus 
reference plane. 
 
Papillary muscles were classified into groups based upon their location; (i) 
anterior: located on the free wall (ii) septal: located on the anterior portion of the septum; 
and (iii) posterior: located on the posterior portion of the septum. 
Statistical Methods 
An Anderson Darling test was used to test for normality. A two-sample student’s 
t-test was performed to determine statistically significant differences between normal and 
diseased patients at a significance level of p < .05. Values are expressed as mean + 
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standard error. A post hoc power analysis was conducted on groups in which a significant 




All measurements for normal PM position can be found in Table H.1.  
Table H.1: Numerical Measurements of PMs for Normal and Dilated LV groups. 
List of abbreviations: LV (Left Ventricle), Avg. (Average), SE (Standard Error), 
Dist. (Distance), Ant. (Anterior), Post. (Posterior), Sept. (Septal). 
 Normal Group Dilated LV Group  
 Avg.  SE Avg.  SE p-value 
X Dist. – Ant. PM 0.61 ± 0.09 0.38 ± 0.04 0.06 
Y Dist. – Ant. PM 0.20 ± 0.04 0.30 ± 0.04 0.11 
Z Dist. – Ant. PM 0.20 ± 0.05 0.15 ± 0.03 0.44 
X Dist. – Post. PM 0.00 ± 0.07 0.03 ± 0.06 0.76 
Y Dist. – Post. PM -0.35 ± 0.04 -0.33 ± 0.06 0.83 
Z Dist. – Post. PM 0.65 ± 0.03 0.62 ± 0.03 0.48 
X Dist. – Sept. PM -0.61 ± 0.08 -0.41 ± 0.07 0.09 
Y Dist. – Sept. PM 0.14 ± 0.03 0.03 ± 0.04 0.03* 
Z Dist. – Sept. PM 0.85 ± 0.07 0.74 ± 0.05 0.24 
Dist. Ant. PM 0.69 ± 0.08 0.49 ± 0.06 0.07 
Dist. Post. PM 0.76 ± 0.04 0.65 ± 0.10 0.32 
Dist. Sept. PM 1.07 ± 0.08 0.76 ± 0.11 0.05* 
Triangle Area 0.13 ± 0.02 0.09 ± 0.02 0.23 
Dist. Sept.-Ant. PM 1.40 ± 0.15 1.04 ± 0.08 1.08 
Dist. Sept.-Post. PM 0.84 ± 0.10 0.63 ± 0.11 0.19 
Dist. Post.-Ant. PM 0.99 ± 0.07 0.90 ± 0.07 0.35 
*=p ≤ 0.05 as compared to normal 
It is notable that the sides of the triangle formed by the PMs were of similar 
length. The Septal PM was the furthest from the centroid with a normalized distance of 
1.07+ 0.08 mm/mm. The anterior PM was the most apical and furthest from the ARP of 
the three PMs (0.20 + 0.04 mm/mm) with the septal PM the closest to the ARP (0.85 + 
0.07 mm/mm). A 3D depiction of normal PMs and their position in the heart can be seen 




Figure H.3: Anatomical representation of PM position in the right ventricle. 
Dilated LV Group 
All measurements for diseased PM position can be found in Table H.1. The same 
relative position and orientation of all three PMs was noted in the diseased patients as in 
normal patients. The septal PM was furthest from the centroid (0.76 + 0.11 mm/mm). 
The anterior PM was furthest away from the ARP (0.15 + 0.03 mm/mm) while the septal 
PM was the closest (0.74 + 0.05 mm/mm). 
Differences 
Significant differences between normal and diseased patients were only detectable 
with the septal PM. The differences were observed in the y distance (p = 0.03) of the 
septal PM (Diseased 0.38 + 0.04 mm/mm, Normal 0.61 + 0.09 mm/mm) and thus 
displaced in a posterior direction. In addition the septal PM was also displaced towards 
the centroid (p = 0.05) in diseased patients (Dilated 0.029 + 0.04 mm/mm, Normal 0.144 
+ 0.03 mm/mm), and therefore away from the septum. Significant differences of PM 




Figure H.4: Visualization of triangle formed by normal (blue) and diseased (red) 
patients. a) Y displacement of the Septal PM in diseased patients b) Displacement of 
the Septal PM towards then centroid in diseased patients. 
 
DISCUSSION 
To our knowledge this is the first report describing the specific locations of all 
three RV PMs in normal and patients with a dilated LV using cardiac MRI. Comparison 
between RV PM position in normal patients and patients with a dilated left ventricle 
revealed a significant difference in the relative position of the septal PM. In this study, 
we found that left ventricular dilatation resulted in the inward displacement of the septal 
PM towards the centroid of the three PMs, which may be due to the displacement of the 
septal wall into the RV with the increased left ventricular volume. LV dysfunction has 
typically been related to RV dysfunction through pulmonary hypertension 16, 18, 77, but 
changes in the LV geometry may be transferred to the RV though the interventricular 
255 
 
septum 2. Anyanwu et al. proposed LV dysfunction or dilatation as a mechanism of TR 
with normal pulmonary hypertension 24. Weber and Janicki discuss in detail 
interventricular septum effects and the displacement of the septum into the RV with acute 
LV distention 69. Our results clearly show the interplay of ventricle volume and the effect 
of the septum displacement into the RV on the PMs. In addition, we believe that motion 
of the septal wall into the RV, may translate to the septal leaflet as it is attached to the 
septum through chordae tendineae and the septal an posterior PMs. Specific identification 
of the effects of the septal PM displacement on the leaflets was outside the scope of this 
study and therefore we cannot conclude if this displacement leads to tricuspid valve 
tethering or prolapse of the leaflets. However, there is evidence that prolapse and 
tethering of the leaflets result in TR 20, 22, 65. As the PMs are displaced, the tension in the 
chordae may be decreased, but this study only investigated the PM motion. We speculate 
that the PM displacement observed in the diseased group may have contributed to the TR 
present in five of the 7 patients. Our analysis is a first step in demonstrating that left sided 
disease has a direct impact on right sided anatomic structures, resulting in a configuration 
that may lead to tricuspid valve leaflet prolapse and tethering. Further studies are needed 
to investigate the direct impact of PM displacement on valve function. Such studies are 
currently underway to confirm these phenomena.  
In addition to the role of annular dilatation in TR, which is widely accepted, we 
believe changes in the PM positions may also play an important role in TR. If PM 
displacement does in fact impact TV function and lead to TR, this may lead to residual 
TR after repair, if the PM positions were altered and not addressed with the repair. 
Traditionally, the most common surgical intervention for non-rheumatic TV focuses on 
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reducing the dilated annulus to its original size with the placement of an annuloplasty 
ring. Studies have found that restoring the annulus to a normal size may not eliminate TR 
completely and in many cases it returns 26, 33. Hence, solely reducing the annulus may be 
insufficient to permanently correct TR 26, 55. While papillary muscle displacement may be 
one contributor to this recurrence of TR, this study also demonstrates that it may be 
important to assess the impact of the LV size and septal motion on RV function, even 
before surgery is attempted. These outcomes suggest that the underlying pathophysiology 
associated with TR is perhaps not well understood. Previous studies have attempted to 
correlate RV PM displacement to TR and found tricuspid valve (TV) tethering and 
restriction of leaflet mobility caused by PM displacement is to be an independent 
predictor of TR after TV annuloplasty 26, 55. Although the relation of LV dilatation to 
durability of TV repairs has yet to be proven, this study demonstrates the geometric 
relation between the two ventricles. Futures studies may aim to determine pre and post 
operative PM position and determine the relation to patient outcome. This study 
demonstrates a useful tool which can be implemented to measure PM position in both 
normal and disease patients. 
 
LIMITATIONS 
This study was limited to the effects of LV dilatation on the posterior and septal 
PMs, as they are located on the septal wall. Due to the retrospective nature of this study, 
only PM positions at end-diastole were acquired, while future studies of the dynamic 
position of the PMs through the cardiac cycle are required. Although the images used for 
this study were at end-diastole, after careful observation of the ventricle throughout the 
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cardiac cycle we found the position of the PMs did not move from the time at which 
analyzed until beginning systole when the ventricle began to contract. It is of importance 
to note that while TR is a systolic phenomenon, the displacement of the PMs elucidated 
in this study are expected have an effect on the TV apparatus during systole and may 
even be further exacerbated. This can be determined by future studies which investigate 
the PMs not only at peak systole but throughout the entire cardiac cycle. 
 
CONCLUSION 
 Dilatation of the left ventricle resulted in a significant displacement of the septal 
papillary muscle position. This change in PM position is due to change in geometry of the 
LV with dilatation and movement of the septal wall into the RV. Implications the 
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UTILITY OF 3D ECHOCARDIOGRAPHY FOR VISUALIZATION 
OF THE TRICUSPID VALVE 
 
 As the interest in repairing the tricuspid valve (TV), to correct tricuspid 
regurgitation (TR) is increasing, so are attempts to better visualize the TV.  Recent 
advances in 3D echocardiography provide for optimal visualization of both normal and 
diseased TVs, including the valvular and subvalvular apparatus.  Previous 2D methods 
were restricted to only the planes acquired, whereas 3D provides the entire geometry for 
analysis. By acquiring a 3D transthoracic image focusing on the right ventricle one can 
visualize TV leaflet motion and identify the papillary muscles (PM).  While the leaflet 
motion can be visualized in the 3D image, it is necessary to interrogate the 3D images 
along the long axis to identify the PMs. All images were acquired at Emory University 
Hospital using a GE Vivid 7, under an IRB approved protocol. 2D slices along the apical 





Figure I.1: Visualization of the tricuspid valve leaflets from the ventricle during 
diastole (A1) and systole (A2), and the atrium during diastole (B1) and systole (B2). 
Three distinct leaflets can be identified and are labeled: anterior (A), posterior (P) 




Figure I.2: 3D echocardiography can be utilized to interrogate the TV apparatus of 
diseased patients. Regurgitation jets can be visualized in the four chamber view and 
are seen above in patients with severe pulmonary hypertension, with severe (A) and 





Figure I.3: With acquisition of the complete 3D geometry, a more detailed 
description of the valve as compared to traditional 2D methods can be obtained. 
Post processing can be conducted to visualize the three leaflets by taking a cross 
section of the valve, whereby the 2D coaptation lines of the three leaflets can then be 
interrogated. Coaptation images of the A) septal and anterior; B) anterior and 
posterior; and C) posterior and septal leaflets are shown. Quantitative 




Figure I.4: Through interrogation of the 3D image, with 2D planes in the long axis 
view of the RV, the PMs can be identified. Visualization of the chordae, which can 
be traced back to their PM insertions, is used to locate the PM tip. Images of the A) 





MEASUREMENT OF STRAIN ON THE TV LEAFLETS 
 
 The following manuscript investigates the effect of both disease and a saddle 
shape annulus of the strain on the anterior and posterior leaflets. 
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Tricuspid regurgitation (TR) is present in trace amounts or more in 85% of the 
population and is greater than mild in 14% of the population. In severe cases, it can 
contribute to right heart failure and adversely affects mitral valve repair durability. One 
major cause of TR is the dilation of the tricuspid annulus, which alters the geometry of 
the annulus from a saddle-shape to a more planar profile. Another cause of TR is the 
displacement of the papillary muscles, which results from right ventricular dilation. The 
objective of this study was to identify the effect of a saddle annulus on native tricuspid 
leaflets stretch mechanics and TR. In addition, the effects of geometric alterations, 
including annular dilatation and PM displacement, on leaflet stretch was investigated. 
  Fresh porcine tricuspid valves (n=8) were excised and sutured to an adjustable 
three-dimensional annulus plate (allowing for dilatation and saddle-shape) and three PM 
attachment rods. The valve was then placed in the in vitro Georgia Tech right heart 
simulator. Dual-camera photogrammetry, was used to quantify the stretch ratio 
experienced by the valve leaflets at peak systole for the following conditions: 
physiologically normal, 100% annular dilatation, displaced papillary muscles, and a 
combination of annular dilatation and papillary muscle displacement. In addition, a 
saddle and flat annulus was implemented for each of the four conditions.  Papillary 
muscle displacement was simulated by displacing all papillary muscles by 10 mm in all 
directions (laterally, apically, posteriorly/anteriorly). The physiologically normal 
condition - normal annulus area, saddle-shaped annulus with PMs in a normal position, 
was used as a control.  
The results showed that the posterior leaflet exhibited significantly (p ≤ 0.05) 
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higher stretch ratios than the anterior leaflet at peak systole for all conditions tested in 
both the major and areal directions. While no significant (p ≤ 0.05) difference was seen in 
stretch when a flat annulus was compared to saddle in any disease simulated, there was a 
significant (p ≤ 0.05) difference in the normal condition. The posterior leaflet stretch was 
increased with saddle as compared to a flat annulus for both major (1.22 ± 0.12) and areal 
directions (1.19 ± 0.09). Investigation of the impact of disease found a significant 
increase in stretch in the posterior leaflet with a combination of annular dilatation and PM 
displacement (2.01 ± 0.68) as compared to the normal condition with a saddle annulus 
(1.43 ± 0.20).  In addition to the impact of a saddle shaped annulus on the stretch of the 
leaflets, a significant (p ≤ 0.05) reduction in TR was also observed in the presence of PM 
displacement, although the actual volume reduced was minimal (1.2 mL). 
 Stretch values were measured for the anterior and posterior leaflet under both 
physiologic and pathologic conditions for the first time. Further, these results provide an 
understanding of the effects of geometric parameters on valve mechanics and function, 






The tricuspid valve (TV) is one of two atrioventricular valves, and of the two, it is 
the least understood. It has, however, been shown that in severe cases, tricuspid 
regurgitation (TR), can negatively impact mitral valve (MV) repairs1,2 and contribute to 
right heart failure3.  Severe TR is also associated with an increased mortality rate4. TR is 
surprisingly common, and is detectable in 82 – 86% of the US population, with 14 – 18% 
of this population having clinically severe TR5.  
The tricuspid valve consists of an annulus, three leaflets, numerous chordae and 
three main papillary muscle (PM) groupings. These components work together to provide 
proper coaptation and maintain unidirectional blood flow.  Alterations in this balance 
may result in improper closure of the leaflets, altering valve mechanics and leading to 
TR. Specifically, stretch on the leaflets may be impacted when this balance is disturbed.  
Previous studies on the MV concluded that stretch in the central region of the 
anterior and posterior leaflet was reduced with increasing annular saddle curvature6,7 
Thus, saddle was thought to be an important component of mitral valve annular 
restoration. Additionally, studies have shown that as with the MV, alterations in the 
three-dimensional geometry of the tricuspid valve are present in patients with TR8,9. 
Recent clinical studies using 3-dimensional echocardiography have shown the TV 
annulus in healthy patients has a saddle-shape9,10. More specifically, the posteroseptal 
and anterolateral segments of the annulus were shown to be more apical, (low points), 
and the anteroseptal and posterolateral segments were more basal (high points). These 
studies also showed that with functional TR, the annulus became more planar. This 
information may not be similarly applied to the TV as the saddle shape differs as well as 
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the presence of an additional leaflet. It is however, it is unclear whether saddle aides in 
reducing TR or in minimizing leaflet stretch.  
Changes in the 3D geometry of the TV annulus occur in conjunction with annular 
dilatation, the major cause of TR11. In the case of dilatation, the leaflets are unable to 
compensate for the enlarged orifice. TR resulting from isolated annular dilatation is 
rare12, while combined annular dilatation and papillary muscle (PM) displacement is 
more common.  This is due to the fact that dilatation is typically a secondary condition, 
and is associated with a dilated right ventricle2. Additionally, PM displacement also 
contributes to TR. The role of annular dilatation and PM displacement have been 
demonstrated to have a significant impact on TR, through both in vivo13,14 and in vitro 
investigations15. The anterior PM is displaced with right ventricular dilatation, as it is 
located on the free wall; while the septal and posterior PM is displaced with left 
ventricular dilatation, since they are located on the septal wall.   
Fully understanding the effects of disease on tricuspid valve leaflet stretch is 
necessary as alterations in the mechanical loading environment may have long term 
detrimental affects to the leaflet tissue properties through adverse remodeling. The 
current study will help us understand the effects of annulus shape, annular size and PM 
position on the stretch experienced by the anterior and posterior leaflets of the TV. The 
role of a saddle shaped annulus on TR will also be investigated. 
 
MATERIALS AND METHODS 
Valve Selection 
Fresh porcine hearts (n=8) were obtained from a local abattoir (Holifield Farms, 
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Covington, GA). Tricuspid valves with 6 cm2 annulus area, and leaflet heights and widths 
similar to physiological human measurements16-18 were selected. Each leaflet height and 
width was measured. The relative size of the leaflets was confirmed, ensuring the anterior 
was the largest and the septal was the smallest. The valves were excised, preserving the 
valvular and sub-valvular components: annulus, leaflets, chordae tendineae, and papillary 
muscles as detailed in previously published TV in vitro studies15,19,20.  
Experimental Set-Up 
The valve was sutured to an annulus plate with an adjustable silicone ring, allowing for 
physiological annular dilatation and saddle-shape adjustments. The normal annulus had 
an area of 6 cm2 with an area of 12 cm2 when dilated by 100%. Annular dimensions were 
determined from previous published in vivo studies9,21. Saddle-shape was implemented 
based on the clinical data reported by Fukuda et. al.  The posteroseptal and anterolateral 
segments of the annulus were  pulled into the ventricular chamber 6 mm each, resulting 







FIGURE J.1: Implementation of a saddle shape on the annulus plate A) flat 
configuration, B) saddle configuration with peak to peak saddle height of 6mm. C) 
Schematic of high (red) and low (blue) saddle points,  with posteroseptal and 
anterolateral segments of the annulus low and the anteroseptal and posterolateral 
segments high. 
Dacron cloth and a button was sutured to the papillary muscles to allow for attachment to 
the 3D adjustable PM rods. The valve was then placed in the in vitro Georgia Tech right 






FIGURE J.2: Georgia Tech Right Heart Simulator used to hold tricuspid valve and 
simulate both physiologic and pathologic conditions. High speed cameras are places 
in front of the right atrial chamber to visualize the leaflet markers though out the 
cardiac cycle. 
The rods were used to achieve a normal PM configuration and subsequently 
displaced to mimic PM positions which result from ventricular dilatation. For this study, 
PM displacement was simulated by displacing the anterior PM (APM) laterally and 
apically, and both the posterior (PPM) and septal (SPM) PMs together, laterally, 
anterior/posteriorly and apically. All PMs were displaced 10 mm in each direction. The 
pressure was generated by a compressor system and triggered by an electronic pulse 
programmer box. The flow loop was tuned by adjusting compliances and resistances to 
maintain the following hemodynamic conditions: heart rate of 70 beats per minute; mean 
systolic transvalvular pressure of 40mmHg; and cardiac output of 5 liters per minute. A 
flow probe (600 Series, Carolina Medical Electronics, North Bend, SC) in line with the 
flow, upstream of the atrial chamber, with a differential pressure transducer (DP9-30, 
Validyne Engineering Corp., Northridge, CA) attached to the atrial and ventricle 
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chambers. Flow and pressure were monitored and recorded using an in-house LabVIEW 
data acquisition program. 
The following conditions were simulated in this study.: 1) control, with a normal annulus 
size and PMs in normal positions, 2) a dilated annulus with normal PM positions, 3) a 
normal annulus size with PMs and 4) a dilated annulus with displaced PMs (Figure J.3).  
 
FIGURE J.3: Marker grid on the surface of the TV leaflets. Location of the markers 
selected for analysis are highlighted. 
The four conditions were performed with and without a saddle shape, yielding a 
total of eight conditions. It was verified that the valve coapted properly without 
regurgitation before beginning experimentation. This was achieved with the PMs located 
at the commissures ensuring chords were slightly taught and perpendicular to annulus 
plane.  
Hemodynamic Data Processing 
Tricuspid regurgitation (TR) was determined for each condition by integrating the 
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negative portion of the flow curve and subtracting the closing volume. Closing volume 
was determined as the negative flow in the normal condition. This was averaged over 15 
cardiac cycles for each condition. 
Dual Camera Photogrammetry 
Dual camera photograpmmetry was used to acquire images for measuring stretch 
ratios experienced by the tricuspid leaflets, as previously applied to the mitral and aortic 
valve leaflets 22,23. Markers were placed in a 2mm x 2mm grid (Figure J.4) on the anterior 
and posterior leaflets with tissue dye (Black Tissue Marking Dye, Thermoelectron, 
Pittsburgh, PA) before inserting the annulus plate into the simulator.   
 
FIGURE J.4: Experimental conditions: A) Normal, B) Isolated annular dilatation, C) Isolated PM 
displacement and C) combined annular dilatation and PM displacement. PM displacement: lateral 
and apical displacement of all papillary muscles, posterior and anterior displacement for the 
posterior and septal PMs, respectively, 10 mms in all directions. 
Two high-speed cameras (Basler camera A504K, Basler) with a resolution of 
1280 x 1023 pixels were placed approximately 30 degrees apart on the same plane 
directed through the atrial chamber pointing at the annulus plane. Images were acquired 
at 500 frames per second, using an image grabbing system (EPIX CL3SD, Buffalo 
Grove, IL).  
At the end of each experiment, images were taken of the valve leaflets in the 
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stress free state. This stress-free state was achieved by allowing pressures in the atrial and 
ventricular chambers to equilibrate. These images were used as the zero-stretch, stress-
free reference configurations for the stretch ratio calculations. Lastly images of a 10 mm 
cube in the plane of the annulus at the center of the valve were taken for the direct linear 
transformation (DLT) calibration. 
Leaflet Strain Data Processing 
The following method was used to determine principal stretch ratios at peak 
systole for all experimental conditions. Images from both cameras were imported into 
MatLab (R2010a, Mathworks, Natick MA) and marker grids were manually selected and 
tracked. For the anterior leaflet, the coordinates were found for 16 markers in a 4x4 grid 
(n=8). For the posterior leaflet, since a smaller leaflet area was visible, 9 markers were 
selected in a 3x3 grid (n=6). The same grid for each valve was tracked across all 
experimental conditions for peak systole and the reference “stress-free” state. Peak 
systole was defined as the time point where the leaflets did not move in subsequent 
frames and stretch was maximal. 
The seven visible vertices of the calibration cube were used to resolve the angle 
between the two cameras in order to obtain 3D coordinates of the leaflet markers, using 
the DLT algorithm23. The 3D marker coordinates were then analyzed for leaflet 
deformation. Shell-based 2D isoparametric finite element shape functions were used to fit 
the surface geometry and cover the different groups of markers on the leaflets for 
interpolation. The C-0 continuous quadratic 9 node Lagrangian shape functions were 
used for interpolation, and were fitted to coordinates of arrays of 9 markers (3x3) where 
possible. This was only completed once for the posterior leaflet and repeated four times 
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for the anterior leaflet to include all 16 markers. The following equation was used where 




ip RNR ),( ηξ=     ;   i = 1,9 ;  j,k = 0    (1)   
where Ni was the shape function for each node, Ri was the known coordinates at the 
nodes, and Rp was the interpolated coordinates at the specific location defined by ξ and 
η. j and k are differential indices with respect to ξ and η. 
 The shape functions were subsequently used to compute stretch ratios and strains 
at peak systole. Principal Almansi strains (e) and principal stretch ratios (λ) were 




αβαβαβ gge −=       (2) 
Ie += αβαβλ 2       (3) 
Where g’αβ and gαβ are components of the metric tensor in the deformed 
configuration and in the stress-free reference configuration, respectively. The 
methodology for the computation of stretch ratio and strains has been described 
previously by Smith et al. 24. 
Statistical Analysis 
Leaflet stretch ratio was compared between anterior and posterior leaflets for the 
same PM and annulus geometry, and for each leaflet among different PM and annulus 
geometry. An Anderson Darling test was first used to assess the normality of the data. A 
paired, two-tailed t-test was used, as natural pairing existed within different conditions 
being simulated on the same valve. A one-way ANOVA was used for comparison of the 
absolute stretch of the anterior leaflet to the posterior leaflet, as the data could not be 
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paired for all experiments. Furthermore, a GLM was used to assess the effect of disease 
on leaflet strain with the valve as a random factor to allow for pairing and comparison of 
multiple disease conditions. If data was not normal a Wilcoxon rank test was used in 
place of a paired t-test, Kruskal-Wallis for a One Way ANOVA and a Friedman’s test 
instead of the GLM. All values are expressed as mean ± standard deviation. Minitab® 




Hemodynamic data are shown in Figure J.5.  
 
FIGURE J.5: Tricuspid regurgitation as an effect of a saddled annulus on tricuspid 
regurgitation on both normal and diseased conditions. Significance p < 0.05 (*), 
saddle vs. no saddle, average and standard error shown. 
TR was examined to determine the effect of the presence of the saddle-shape in 
physiologically normal and diseased conditions on regurgitation. Statistical significance 
was only observed with isolated PM displacement (p = 0.009), where a decrease in TR 
was seen with the saddle shape. As has been reported previously15 TR increased with 
both isolated annular dilatation and PM displacement, with the most severe TR observed 
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with a combinations of these anatomical parameters. 
Leaflet Stretch Ratios 
Major, minor and areal stretch ratios for the anterior leaflet are listed in Table 1 
and Figure 6a, while values for the posterior leaflet are listed in Table 2 and in Figure 6b. 
From one valve to the next, significant variability in stretch ratios under the same 
transvauvlar pressure were found, with standard deviations of stretch under normal 
conditions ranging from 0.07 to 0.12, which are consistent with results observed for the 
mitral valve and aortic valve leaflets6,7,23. 
For the anterior leaflet, the saddle-shape displayed major and minor axis stretch 
ratios of 1.22 ± 0.12 and 0.98 ± 0.06. Without a saddle-shaped annulus, the stretch values 
were found to be 1.17 ± 0.07 and 0.98 ± 0.07, respectively (Table J.1).  
Table J.1: Anterior Leaflet: Major, minor, and areal stretch ratios for normal and diseased 
conditions, with and without saddle.  
Major Axis  
Stretch Ratio 
Minor Axis  
Stretch Ratio 
Areal 
Stretch Ratio   
  No Saddle Saddle No Saddle Saddle No Saddle Saddle 
Normal 1.17+0.07# 1.22+0.12*,# 0.98+0.07 0.98+0.05 1.14+0.08# 1.19+0.09*,# 
100% 
Dilatation 1.22+0.12# 1.21+0.07# 1.02+0.10 1.01+0.05 1.25+0.23# 1.22+0.09# 
PM 




1.24+0.14# 1.22+0.13# 0.99+0.13 0.98+0.12 1.25+0.30# 1.19+0.23# 
*=p < 0.05 as compared to same condition, same leaflet, saddle vs. no saddle, paired t-test 
#=p < 0.05 as compared to same condition, anterior vs. posterior leaflet, One Way ANOVA 
#=p < 0.05 as compared to same condition, anterior vs. posterior leaflet, Kruskal-Wallis 
 
For the posterior leaflet control position with saddle-shape, major and minor axis 
stretch ratios were found to be 1.53 ± 0.32 and 0.96 ± 0.32. While the stretch ratios 
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without a saddle-shaped annulus were 1.54 ± 0.33 and 0.96 ± 0.15, respectively (Table 
J.2). 
Table J.2: Posterior Leaflet: Major, minor, and areal stretch ratios for normal and 
diseased conditions, with and without saddle.  
Major Axis  
Stretch Ratio 
Minor Axis  
Stretch Ratio 
Areal 
Stretch Ratio  
  No Saddle Saddle No Saddle Saddle No Saddle Saddle 
Normal 1.54+0.32 1.53+0.32 0.96+0.15 0.96+0.16 1.45+0.24 1.43+0.20 
100% 
Dilatation 1.57+0.24 1.65+0.34 1.04+0.24 1.01+0.19 1.62+0.47 1.63+0.25 
PM 




1.84+0.49 1.62+0.28 1.10+0.23 1.08+0.19 2.01+0.68* 1.74+0.45 
*=p < 0.05 as compared to control (normal annulus size, saddle), normal vs. disease 
 
Normal (Anterior and Posterior) 
Between the posterior and anterior leaflets, significant differences in stretch ratios 
(major and areal stretch ratios) were observed for all conditions at p<0.05. Major axis 
stretch ratios on the posterior leaflet were greater. Minor axis stretch ratios, however, did 
not exhibit any significant difference between the two leaflets.  
Saddle vs. Flat Annulus (Anterior and Posterior) 
For the anterior leaflet in the normal condition, the saddle-shaped annulus resulted 
in significantly greater major and areal stretch values (p= 0.07; 0.07) compared to the flat 
annulus. When the annulus was dilated and/or PMs were displaced, there was no 
significant difference in stretch ratios between the saddle-shaped and flat annulus.  
Additionally, no significant difference was found between saddle and flat for normal or 
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disease conditions for the posterior leaflet. 
Normal vs. Disease (Anterior and Posterior) 
No difference in stretch ratio was observed for disease as compared to normal for 
the anterior leaflet. However, a significant increase in stretch as a result of combined 
dilation and PM displacement was observed in the posterior leaflet in the major (p=0.024) 
and areal (p=0.024) stretches as seen in Figure J.6. 
 
FIGURE J.6: A) Major, minor and areal anterior leaflet stretch ratio for control (saddle), 100% 
annular dilatation (flat), PM Displacement (flat) and combined annular dilatation and PM 
displacement (flat). B) Major, minor and areal posterior leaflet stretch ratio for control (saddle), 
100% annular dilatation (flat), PM Displacement (flat) and combined annular dilatation and PM 




A statistical difference was seen in TR between an annulus with and without a 
saddle in the presence of PM displacement, although the difference was minimal at only 
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2%. The reduction was only about 1 ml on the average, and most likely has very limited 
clinical impact. This difference would not be clinically alarming, as this value is within 
current accepted error associated with measurement techniques of TR, which can vary by 
technique or viewing window.  Saddle-shape did not significantly affect TR in the normal 
or dilated conditions. Thus, this small difference may not warrant the implantation of a 
saddle ring as opposed to a flat ring, to further reduce TR. 
Normal Leaflet Mechanics (Anterior and Posterior) 
For the first time, physiological stretch ratios were recorded for the anterior and 
posterior leaflets of the tricuspid valve. The major principal stretch ratios during peak 
systole observed on the anterior leaflet, with (1.22 ± 0.12) and without saddle (1.17 + 
0.07) were comparable to peak leaflet stretch of the mitral valve leaflets measured in our 
laboratory. Previous mitral valve studies have reported stretch ratios on the anterior 1.30 
± 0.18 and posterior 1.23 ± 0.14 leaflets22,25. This similarity is not unexpected, as while 
the valves are under different loading conditions, the leaflet structures may be similar. 
The rationale for this is that during peak systole the valve is at its maximum stretch. 
Further investigating into the behavior of the collagen fibers shows that while the 
response curve is gradual at first, it then becomes steep6,26. We believe that both the 
mitral and tricuspid valves are within this steep range of the stress-strain curve, in which 
large changes in force have little effect on the stretch as the collagen fibers have already 
locked. While, we believe it is possible that the valve leaflets experience similar stretch, 
it is important to note that the references used in the MV studies were not the same as 
those used here for the TV. The study presented here uses a stress free state as a 
reference, whereas previous MV studies used a low stretch reference. The use a stress 
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free reference ensures proper measurement, and eliminates the possibility of under 
estimating the stretch with a pre-stretched reference which may be the case for previously 
referenced MV studies. 
Interestingly, when comparing the TV anterior and posterior leaflets, the posterior 
leaflet exhibited significantly greater stretch than the anterior leaflet. To better understand 
why the posterior leaflet had higher stretch than the anterior leaflet, leaflet thickness and 
collagen structure were investigated. Back lit images of six valves were taken, focusing 
on the ventricular side of the anterior and posterior leaflets. A representative image 
(Figure J.7) highlights the anterior and posterior leaflet regions analyzed for this paper.  
 
FIGURE J.7: Representative image of ventricular side of TV with anterior PM and 
anterior and posterior leaflets. Location of strain measurement is highlighted. Deep 
insertion of strut chordae is clearly present on the anterior leaflet, but not the 
posterior leaflet. 
A difference in the leaflet structure was observed between the two leaflets in the 
region in which stretch was measured. More specifically, the strut chordae insert deep 
into the belly of the anterior leaflet, which was not as pronounced on the posterior leaflet.  
This increased localization of collagen structures does not allow the leaflet to stretch as 
much at or near the location of chordal insertion. This phenomenon has been presented 
previously in which a reduced stretch was observed at the location on the leaflet closest 
to strut chordae insertion27,28. For the posterior leaflet, the insertion of the chordae did not 
extend as deep into the leaflet belly, thus this phenomenon was not present in the region 
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in which we measured stretch, This may also explain why the differences in the leaflets 
were only seen in the major and areal directions, as the anterior leaflet may have been 
restricted by the increased collagen content. 
The results thus suggest that different TV leaflets can have very different stretch 
responses to transvalvular pressure. Detailed information on the mechanics of the valve 
leaflets will aid in FEA modeling studies by providing realistic physiologic inputs . While 
a previous finite element simulation was published which predicted the stretch on the 
leaflets, its results were contradictory to those presented here. Stevanella et al performed 
finite element analysis of the tricuspid valve29 and reported the posterior leaflet to have 
the less stretch as compared to the anterior leaflet, whereas this study found no difference 
between the leaflet stretch. This may be due to the fact that their model assumed the same 
material properties for the leaflets. Both our stretch findings as well as physical 
observations of the leaflets lead us to believe that the structure and material properties of 
the leaflets are different. Thus further detailed studies of the fiber architecture and stretch 
response mechanics of the TV leaflets are warranted.  
Saddle vs. Flat Annulus (Anterior and Posterior) 
Interestingly, the saddle shaped annulus led to a significantly increased stretch on 
the anterior leaflet of the TV, but not the posterior leaflet. This finding differed from that 
observed in the MV, where a saddle was shown to decrease the stretch on both leaflets6. 
This may be attributed to the inherent 3D geometrical differences between the tricuspid 
and mitral valves. In the MV, the apical motion of the commissures results in a saddle, 
with each leaflet flanked by a dip in the saddle at the commissures30,31. In the case of the 
TV, the posterior leaflet is flanked by two annular points with apical motion (low points) 
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similar to the MV, while the anterior leaflet is flanked by one annular point with apical 
motion (low point) and one annular point with basal motion (high point)8,9. The result of 
two adjacent annulus points moving in opposite directions may explain the larger stretch 
observed in the anterior leaflet as compared to the posterior leaflet, as it experiences in 
more tethering and deformation as a result of the saddle. Thus the stretch configuration of 
the anterior leaflet of the TV is not comparable to the MV. 
Since the tricuspid valve has three leaflets, the saddle applied at two points may 
affect each leaflet’s curvature differently. Additionally, the TV is in a lower pressure 
environment, and the leaflets may possess different material properties than the MV. For 
the posterior leaflet, two high points exist on either side of the leaflet, similar to what is 
seen in the mitral valve. However, no significant decrease in stretch, as seen with the 
MV, was observed when comparing the saddle to the flat annulus for this leaflet. When 
comparing the effect of saddle on the TV to the MV, it is important to understand that the 
annular height to commissural width ratio (AHCWR) observed in the TV is 
approximately 10%, whereas for the MV it is 20%30,31. Previous studies investigating the 
effect of the saddle on MV leaflet strains, saw no differences with 10% AHCWR. It was 
not until the AHCWR was increased to 20% that the strains were significantly decreased 
with a saddle shape as compared to flat6,7. 
Normal vs. Disease (Anterior and Posterior) 
Only combined annular dilation and PM displacement resulted in significantly 
increased stretch for the posterior leaflet; while the anterior leaflet showed no changes.  
These finding are consistent with MV studies which were unable to show a difference in 
stretch as an effect of PM displacement22. Since neither isolated annular dilatation nor 
286 
 
PM displacement resulted in increased stretch, significant changes in valve geometry 
appeared to be necessary for any significant alterations to stretch patterns. The 
mechanism of this alteration has been demonstrated previously19 was as such: the PM 
displacement restricts leaflet mobility, tethering the leaflets away from the annulus, while 
annular dilatation forced the leaflets to stretch further and compensate for the increased 
orifice area. 
While restoring the tricuspid valve to its anatomic state is appealing, through 
implantation of a 3-dimensional annuloplasty ring, its benefits have yet to be 
demonstrated. Thus additional studies are needed to support the benefit of a 3D ring as 
compared to a traditional flat ring. 
 
LIMITATIONS 
The major limitation of this study was variability of the location of the stretch 
ratio measurements on the leaflets. Although a similar area was chosen, the grid was not 
always in the exact same location for every valve.  
The intrinsic limitations of using an in vitro system exist, such as the rigid 
ventricle which is not physiologic. We do not believe this significantly impacts the results 
of this study as this study is focused on analyzing the stretch on the leaflets at peak 
systole. As such a dynamic ventricle is not necessary as annulus and PM positions are 
simulated at peak systole. In vitro experiments such as these have been successful in 
providing mechanistic understanding of the mitral and aortic valves under both 





 In conclusion, physiological stretch ratios of the TV leaflets were investigated for 
the first time in vitro. In addition, the affects of annular geometry and disease were 
examined and shown to increase strain in the case of combined annular dilatation and PM 
displacement. This study provides a better understanding of how the valve mechanics are 
altered with disease, which could allow for improved valve repair procedures in the 
future. The data/results from this study may also be of used to validate future numerical 
FEA models.  
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IN VIVO RAW DATA 
 
 The raw data for all in vivo, for both MRI and echocardiograph studies is included 





Table K.1: MRI measurements for normal subjects to determine PM position. 
Abbreviations: Papillary Muscle (PM). 
Aorta  
Diameter (mm)  Image # 
Coordinate Distance (mm) 
x y x y z 3D 
BSCI_1 (Normal) 
Annulus Reference Plane 28 0 
Anterior PM 17 166 182 182 12 9 183 
33.1 (slice 33) Posterior PM 8 204 242 10 -20 9 24 
Septal PM 13 300 188 -40 8 1 41 
PM Centroid 13 223 204 0 0 0 
BSCI_2 (Normal) 
Annulus Reference Plane 49 0 
Anterior PM 35 198 260 11 -13 6 18 
30.1 (slice 47) Posterior PM 29 239 258 -18 -12 6 22 
Septal PM 32 203 205 7 25 0 26 
PM Centroid 32 213 241 0 0 0 
BSCI_3 (Normal) 
Annulus Reference Plane 44 0 
Anterior PM 29 88 43 13 8 1 16 
29.5 (slice 45) Posterior PM 24 81 78 18 -16 9 26 
Septal PM 33 152 44 -32 8 9 34 
PM Centroid 29 107 55 0 0 0 
BSCI_4 (Normal) 
Annulus Reference Plane 37 0 
Anterior PM 19 179 254 19 -3 5 20 
31.5 (slice 37) Posterior PM 23 200 283 5 -23 3 24 
Septal PM 22 241 214 -24 26 1 35 
PM Centroid 21 207 250 0 0 0 
BSCI_5 (Normal) 
Annulus Reference Plane 41 0 
Anterior PM 56 211 321 6 -23 23 33 
29 (slice 37) Posterior PM 68 253 300 -16 -12 41 45 
Septal PM 57 205 211 9 35 24 43 
PM Centroid 60 223 277 0 0 0 
BSCI_6 (Normal) 
Annulus Reference Plane 45 0 
Anterior PM 66 205 230 15 -13 32 37 
37.8 (slice 41) Posterior PM 68 252 235 -18 -16 35 42 
Septal PM 67 222 169 3 29 33 44 




Table K.2: MRI measurements for diseased subjects to determine PM position. 
Abbreviations: Papillary Muscle (PM). 
Aorta  
Diameter (mm)  Image # 
Coordinate Distance (mm) 
x y x y z 3D 
BSCI_7 (Abnormal) 
Annulus Reference Plane 42 0 
Anterior PM 58 92 174 10 -13 28 33 
29.4 (slice 40) Posterior PM 62 127 173 -14 -12 35 40 
Septal PM 54 102 118 3 25 21 33 
PM Centroid 58 107 155 0 0 0 
BSCI_8 (Abnormal) 
Annulus Reference Plane 44 0 
Anterior PM 62 81 205 17 -9 27 33 
36.6 (slice 46) Posterior PM 62 133 227 -19 -24 27 40 
Septal PM 70 103 145 2 32 39 51 
PM Centroid 65 106 192 0 0 0 
BSCI_9 (Abnormal) 
Annulus Reference Plane 48 0 
Anterior PM 64 276 350 10 -8 24 8 
28.9 (slice 46) Posterior PM 61 300 367 -5 -18 20 12 
Septal PM (fused) 63 302 296 -6 26 23 17 
PM Centroid 63 293 338 0 0 0 
BSCI_10 (Abnormal) 
Annulus Reference Plane 50 0 
Anterior PM 31 209 304 13 -5 29 32 
30.3 (slice 50) Posterior PM 32 253 313 -17 -12 27 34 
Septal PM 34 221 271 5 17 24 30 
PM Centroid 32 228 296 0 0 0 
BSCI_11 (Abnormal) 
Annulus Reference Plane 57 0 
Anterior PM 36 206 284 13 -13 32 36 
41.6 (slice 57) Posterior PM (fused) 35 249 285 -17 -14 33 40 
Septal PM 37 218 224 4 28 30 41 
PM Centroid 36 224 264 0 0 0 
BSCI_12 (Abnormal) 
Annulus Reference Plane 56 0 
Anterior PM 71 195 259 18 -15 23 32 
32 (slice 52) Posterior PM 74 251 263 -21 -18 27 39 
Septal PM 71 216 187 3 34 23 41 
PM Centroid 72 221 236 0 0 0 
BSCI_13 (Abnormal) 
Annulus Reference Plane 52 0 
Anterior PM 63 172 260 15 -9 17 24 
38 (slice 48) Posterior PM 68 215 286 -15 -27 24 39 
Septal PM 70 194 195 0 36 27 45 




Echo Patient Data 
Table K.3: Echocardiograph data for all patients.  Abbreviations: Body Surface 
Area (BSA), Pulmonary Arterial Pressure (PA Press.), Mitral Regurgitation (MR), 
Tricuspid Regurgitation (TR), Right Ventricle (RV), Left Ventricle (LV). 
Gender Age BSA  ( m2) 
PA Press. 




 (cm2) Patient 
1 M 42 1.80 24.4 1 1 1 10 26 
3 M 83 1.58 61.0 3 3 4 29 32 
4 F 46 1.74 24.4 1 2 1 9 19 
6 M 56 1.6 56.2 1 4 2 43 5 
8 M 43 2.17 21.0 2 1 1 28 40 
9 F 53 1.86 75.2 2 3 2 38 17 
10 F 52 2.02 97.4 1 4 2 46 10 
15 M 57 2.02 61.2 4 3 4 41 47 
16 M  1.92 26.2 1 1 1 5 8 
17 M  2.15 1 1 4 25 
18 M 58 2.15 33.4 2 1 1 23 24 
19 M 91 1.64 47.5 3 1 1 12 42 
20 M 34 2.06 26.2 1 1 1 18 22 
21 F 85 1.77 86.4 2 3 1 15 9 
22 F 90 1.56 66.9 3 2 3 11 43 
23 F 60 1.86 30.0 4 2 3 16 33 
24 M  2.06 23.0 1 1 1 6.5 15 
25 M 50 2.02 53.6 3 4 4 39 48 
26 M 27 1.84 28.0 1 1 1 32 38 
27 M  2.12 22.0 1 1 1 13 15 
28 M 42 2.24 19.4 1 1 1 31 34 
29 M  1.75 1 1 1 22 31 
30 M  1.87 32.1 1 1 1  
31 M  1.91 32.9 1 2 1 2 7 
32 M 28 2.04 41.0 1 3 2 47 29 
33 M 49 2.08 22.6 2 1 3 8 44 
34 F 63 1.47 76.0 2 3 2 26 11 
35 F 57 1.71 85.6 3 4 4 37 51 
36 F 60 1.87 41.4 3 4 4 36 41 
37 M 35 2.11 49.6 1 1 2 34 27 
38 F 36 1.61 43.6 4 4 3 24 45 
39 F 66 1.67 59.0 3 4 3 14 36 
40 M 21 2.36 32.0 2 3 2 45 50 
41 F 25 1.15 32.0 1 1 1 25 15 
42 F 33 1.55 112.2 1 4 2 51 12 
43 F 45 1.69 108.4 1 3 2 21 37 
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Gender Age BSA ( m2) 
PA Press. 
(mmHg) MR Grade TR Grade Group 
RV area  
(cm2) 
LV area 
 (cm2) Patient 
44 M 41 2.10 59.0 1 4 2 48 23 
45 M 60 1.83 80.6 1 4 2 40 30 
46 F 20 1.68 37.0 2 3 4 35 35 
47 M 69 1.87 74.8 1 4 2 49 3.5 
48 F 47 1.96 23.0 1 1 2 44 18 
49 M 37 1.96 37.0 3 1 3 20 49 
50 F 32 1.67 33.0 1 3 1 6.5 28 
51 F 20 1.85 46.4 1 2 1 17 39 
52 F 47 1.52 44.2 2 2 3 19 46 
53 F 45 1.99 94.0 1 4 1 27 21 
54 M 26 2.23 46.0 2 3 4 22 54.3 
55 F 51 1.80 108.4 1 3 2 28.2 32.7 
56 F 57 1.90 84.0 2 3 2 35.6 33.9 
57 M 78 2.19 50.0 2 3 4 38.2 36.6 
58 M 46 2.05 35.0 1 1 2 26 30.8 
59 M 52 1.72 46.0 1 4 4 17.8 52.7 
60 F 58 1.87 59.8 2 3 2 23.1 33.1 
61 M 60 2.04 58.6 3 2 3 20.2 51.4 
62 M 84 1.74 61.6 2 3 4 15.6 33 
63 F 34 2.08 36.4 3 2 3 14 57.7 
64 M 63 1.87 21.0 2 3 14 35.1 
65 M 45 1.99 25.2 2 1 4 22.3 42.4 
66 F 50 2.06 71.8 3 4 3 16.5 58.5 
67 M 43 1.92 58.6 4 3 3 17.3 44.6 
68 M 76 1.69 61.8 3 2 4 24.1 43.3 
69 F 77 1.63 49.9 1 2 1 18.2 29.5 
70 M 63 1.84 31.2 2 2 3 13.3 55.9 





Table K.4: Echocardiograph measurements for all patients.  Abbreviations: 
Annulus (Ann.) (BSA), Anterior Papillary Muscle (APM), Septal Papillary Muscle 
(SPM), Posterior Papillary Muscle (PPM), 4-Chamber View (4ch), Tenting Area 
(TA), Tenting Height (TH), Septal/Anterior Coaptation (S/A), Septal/Posterior 
Coaptation (S/P), Anterior/Posterior Coaptation (A/P). 
Ann. 
APM SPM PPM 4ch S/A S/P A/P 
Patient 
x y z x y z x y z TA TH TA TH TA TH TA TH 
1 3.2 -0.3 -1.1 0.9 0.7 0.0 0.7 0.0 -0.4 0.6 1.9   
3 5.9 -0.2 -1.3 2.0 0.9 0.3 1.1 0.5 -0.9 1.3   
4 4.1 0.1 -0.7 0.9 0.2 0.3 0.6 0.1 -0.7 0.9 0.5 0.4 0.6 0.4 0.5 0.3 0.8 0.4 
6 10.1 -1.8 -1.0 2.3 1.3 0.4 0.9 1.1 -1.6 0.9 3.3 1.2 3.4 1.2 3.6 1.5 2.9 1.2 
8 7.8 -0.4 -0.5 1.7 0.6 0.6 0.7 0.1 -0.3 1.0 2.3 0.7 2.3 0.7 2 0.5 2.2 0.9 
9 3.8 -0.5 -0.4 1.8 1.0 0.4 1.5 0.5 0.0 1.0 1.4 0.7 1.5 0.8 1.1 0.6 0.6 2.0 
10 6.3 -0.6 -0.2 1.6 0.0 0.7 1.6 0.6 -0.7 1.3 2.4 1.3 1.6 0.8 2.0 1.0 1.6 1.0 
15 5.3 -1.1 -0.9 1.7 0.7 0.3 0.9 0.7 -1.2 0.6 2.2 1.3 2.3 1.3 1.6 0.9 2.2 1.3 
16 3.3 -0.2 -0.4 1.2 0.4 0.3 0.7 0.3 -1.1 1.0 0.7 0.5 0.5 0.3 0.5 0.4 0.7 0.5 
17 3.2 -0.1 -0.3 1.4 0.3 0.7 0.7 0.4 -0.8 0.5 0.6 0.6 0.9 0.6 0.4 0.5 0.9 0.3 
18 5.1 -0.1 -0.5 1.6 0.7 0.3 1.1 0.6 -0.9 0.5   
19 5.0 0.0 0.0 1.8 0.4 0.2 0.7 0.7 -0.5 0.9   
20 3.9 -0.4 0.0 1.8 0.6 0.0 0.9 0.6 -0.3 1.0 1.5 0.9 1.2 0.7 0.8 0.6  
21 5.1 -0.5 -0.4 1.4 0.8 0.0 0.4 0.6 -0.8 0.7 1.0 0.4 0.8 0.3 1.0 0.6 0.8 0.4 
22 5.4 -0.3 -0.5 2.2 0.6 0.6 1.0 0.6 -0.3 0.8 1.1 0.5 0.7 0.4 1.0 0.3 0.8 0.5 
23 4.8 -0.3 -0.5 1.5 0.8 0.3 0.4 0.9 -0.6 0.5   
24 3.4 -0.4 -0.6 1.5 0.5 0.0 0.4 0.7 -0.2 0.3 1.2 0.5 1.0 0.7 0.6 0.4 1.0 0.6 
25 5.7 -0.4 0.0 1.7 0.9 0.2 0.7 0.9 -0.9 0.9 5 1.2 4.8 1.2 4.6 1.1 3.1 1.2 
26 4.3 -0.2 -0.4 1.6 0.9 0.0 1.0 0.5 -0.9 0.8 0.9 0.5 0.6 0.3 1.1 0.5 0.8 0.6 
27 3.3 0.0 -0.5 1.4 0.6 0.2 0.7 0.6 -0.6 0.6 1.3 0.6 0.8 0.5 1.2 0.7 0.9 0.6 
28 3.7 -0.3 -0.5 1.5   0.4 -0.8 0.7 1.2 0.5 0.8 0.4 0.6 0.5 0.9 0.5 
29 3.7 0.0 -0.6 1.4 0.6 0.0 0.5 1.2 0.5 1.3 0.5  0.5 0.6 
30 4.8 -0.4 -0.7 2.0 0.2 1.1 0.9 0.8 -0.5 0.8   
31 3.9 -0.7 -0.2 1.4 0.7 0.0 0.5 0.4 -0.7 0.6 1.3 0.7 1.0 0.5 0.6 0.4  
32 4.0 -0.8 -0.7 1.7 0.7 0.2 0.9 0.6 -0.7 1.2 2.9 1.1 2.6 1.1 1.1 0.9 1.5 1.2 
33 4.0 -0.6 -1.1 1.2 0.4 -0.3 0.7 0.3 -1.3 1.1 1.0 0.6 0.7 0.5 1.1 0.6 1.1 0.5 
34 5.9 -0.5 0.0 2.2 0.9 0.2 0.7 0.6 -0.5 1.6 2.6 1.0 2.7 1.1 1.6 0.7 2.2 1.0 
35 6.5 -0.3 -0.6 2.7 0.8 0.0 0.9 0.6 -0.9 1.7 2.7 1.1 1.9 0.9 1.9 1.0 2.2 1.0 
36 7.0 -0.8 0.0 2.5 0.6 0.2 1.2 2.4 1.0 2.5 1.0 2.3 1.0 2.4 1.2 
37 3.9 -0.3 -0.3 2.0 0.9 0.2 0.9 2.4 1.1 2.1 0.9 2.0 0.7 1.4 0.8 
38 7.0 -0.5 0.0 2.7 0.4 0.1 1.1 0.6 -1.3 1.0 3.1 1.2 2.6 1.2 3.1 1.2 2.6 1.0 
39 5.7 0.0 -0.5 1.3 0.5 0.0 0.9 0.6 -0.7 0.8 1.2 0.6   




APM SPM PPM 4ch S/A S/P A/P 
Patient 
x y z x y z x y z TA TH TA TH TA TH TA TH 
41 5.5 -1.2 -0.5 1.8 0.7 -0.3 1.4 0.9 0.5 1.0 0.5 0.6 0.5 0.9 0.5 
42 15.1 0.3 -1.0 4.2 2.3 -0.1 1.0 2.6 -0.8 2.3 4.5 1.1 3.3 1.0 2.7 1.2 2.9 1.3 
43 6.4 -0.9 -0.5 1.7 0.8 0.0 1.1 0.8 0.2 1.4 2.4 1.4 2.8 1.4 1.8 0.8 1.4 0.8 
44 6.8 -1.0 -0.3 1.0 1.5 0.5 1.7 1.0 0.0 1.3 3.6 1.3 3.3 1.4 4.3 1.5 2.0 1.0 
45 6.2 -0.7 -0.4 1.2 0.6 -0.2 1.2 2.0 0.9 2.2 1.0 1.1 0.6 2.2 0.9 
46 6.3 -1.3 -0.5 1.6 0.2 -0.2 1.0 1.5 0.9 1.7 0.8 1.5 0.9 2.2 0.8 
47 6.9 -0.7 0.0 2.9 1.2 0.5 1.2 1.1 -0.2 1.9 2.7 0.9 2.8 0.9 2.8 1.1 2.2 1.1 
48 4.4 -0.5 -0.3 2.4 0.7 -0.2 1.2 0.9 -0.3 1.0 2.9 1.3 2.6 1.1 2.0 0.9 1.4 1.0 
49 7.3 0.3 0.2 2.2 0.2 0.7 0.7 0.6 -0.4 0.7 2.7 1.0 2.3 0.8 1.5 0.9 1.2 0.8 
50 6.0 -0.3 0.0 1.7 0.8 0.4 0.8 0.7 0.0 0.7 0.9 0.7 0.8 0.6 1.8 0.6 1.3 0.7 
51 5.4 -0.6 -0.2 1.8 0.4 -0.5 0.9 0.8 0.5 0.8 0.5 1.1 0.6 0.9 0.5 
52 8.6 -1.9 0.8 2.7 0.9 0.9 1.2 3.5 1.3 2.6 1.0 1.9 1.0 3.5 1.3 
53 6.6 0.8 -0.4 1.1 0.7 0.2 0.9 0.6 -0.5 1.4    
54 4.3 -0.4 0.0 2.2 0.6 0.1 0.9 0.7 0.0 0.4 1.9 0.9 2.0 0.9 1.7 0.8 1.7 0.6 
55 7.0 -0.8 0.8 1.8 1.0 0.1 1.3 0.8 -0.8 1.2 3.0 1.6 2.5 1.1 2.0 1.4 2.9 1.0 
56 4.8 0.0 0.0 2.1 0.8 0.4 1.1 1.3 -0.3 1.2 2.8 0.4 2.8 1.3 3.6 1.2 1.9 0.8 
57 7.1 -0.3 -0.5 1.9 0.8 0.2 1.1 0.8 -0.1 0.9 4.1 1.0 2.6 1.0 4.3 1.5 2.9 1.4 
58 4.1 0.0 -0.5 1.7 0.8 0.2 0.8 0.6 0.0 0.7 1.8 1.1 1.4 0.7 1.6 1.0 0.9 0.5 
59 7.6    0.6 -0.2 1.6 0.9 -0.4 1.3 4.0 1.7 3.9 1.5 4.5 1.8 1.9 0.9 
60 2.6 0.6 0.4 1.2 0.9 0.4 0.9 0.4 -0.4 1.0 1.3 0.8 1.0 0.6 0.9 0.7 0.6 0.7 
61 2.7 0.0 0.0 2.0 0.4 0.0 0.8 0.3 -0.3 0.8 1.3 0.6 1.2 0.6 0.8 0.6 1.1 0.9 
62 7.1 0.0 0.0 1.7 0.9 0.5 0.9 1.8 0.6 2.1 0.8 1.6 0.6 2.2 0.8 
63 4.1 0.0 0.0 2.4 0.3 0.1 0.5 0.5 0.7 0.7 1.8 0.7 1.8 0.7 0.8 0.7 0.7 0.4 
64 4.1 0.5 -0.4 1.1 0.4 0.3 0.9 0.6 -0.5 0.9 1.9 0.6 0.7 0.5 1.3 0.6 1.3 0.5 
65 6.1 -0.6 0.0 1.7 0.5 -0.8 0.8 2.5 1.0 1.8 0.8 1.8 0.9 1.5 0.8 
66 5.3 0.5 -0.5 2.0 0.4 0.3 0.6 0.6 -0.2 0.7 2.6 1.2    
67 9.6 0.3 0.3 2.2 1.0 0.6 0.7 0.9 -0.2 1.1 3.2 1.1 3.1 1.1 2.4 1.3 3.1 1.0 
68 6.5 -0.6 0.8 2.0 0.6 0.0 0.9 0.8 -0.7 1.3 1.3 0.7 1.2 0.6 1.5 0.8 0.5 0.4 
69 4.6 1.2 0.1 1.0 0.6 0.0 1.2 0.8 -0.2 1.0 1.2 0.6 1.4 0.6 0.9 0.5 
70 5.6 0.3 -0.5 2.7 0.9 0.6 1.1 0.7 -0.4 1.1 1.2 0.8 1.5 0.7 1.4 0.4 1.4 0.7 





IN VITRO RAW DATA 
 
 The raw data for all in vitro studies is included in this section including: 
hemodynamics, residual leaflet length, echocardiograph and force measurements. Within 
each section the data is divided into isolated annular dilatation, isolated PM displacement 
and combined annular dilatation and PM displacement. 
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Hemodynamics: Isolated Annular Dilatation  
 
Table L.1: Hemodynamics results for all experiments for isolated annular dilatation 
for 0%, 20%, 40%, 60%, 80%, 100%. Abbreviations: Stroke Volume (SV), 
Tricuspid Regurgitation (TR). 
Percent Dilatation 
Date 0 20 40 60 80 100 
SV TR SV TR SV TR SV TR SV TR SV TR 
31909 73.7 9.9 72.8 12.7 73.2 15.1 73.7 19.1 70.4 20.3 71.3 25.4 
32109 71.3 7.4 71.7 11.4 71.0 20.0 72.2 23.0 74.6 31.0 71.1 34.0 
32509 72.5 17.2 74.1 18.6 73.3 24.7 71.6 26.8 72.5 31.4 73.5 34.7 
33009 69.3 19.4 69.3 25.3 75.4 31.7 73.4 33.5 72.5 39.7 68.5 43.2 
40109 75.3 19.0 72.1 22.1 67.3 28.1 73.7 32.1 72.8 40.7 69.6 45.1 
40209 74.9 17.9 72.1 20.7 70.8 25.4 73.4 30.1 71.7 34.6 75.1 42.3 
40609 69.2 12.0 72.6 15.5 75.4 18.8 76.1 20.6 75.2 24.3 71.5 30.1 
40909 72.1 14.9 73.4 15.9 66.0 17.2 70.3 18.9 74.4 22.5 74.2 23.6 
 
Hemodynamics: Isolated PM Displacement 
 
Table L.2: Hemodynamics results for all experiments for isolated anterior papillary 
muscle (APM) displacement. Abbreviations: Stroke Volume (SV), Control Volume 
(CV), Negative Volume (NV), Tricuspid Regurgitation (TR). 
Control APM (Lateral) APM (Apical) APM (Apical+Lateral) Date 
SV CV TR SV NV TR SV NV TR SV NV TR 
92309 71.2 7.1 0.0 68.4 7.7 0.6 74.1 15.7 8.6 69.6 12.3 5.2 
93009 74.4 5.2 0.0 71.1 5.2 0.0 72.9 6.5 1.3 70.2 5.5 0.3 
100709 67.1 9.5 0.0 69.7 10.6 1.1 71.2 11.9 2.4 72.2 11.0 1.5 
102109 70.4 13.5 0.0 71.3 15.8 2.3 70.3 15.9 2.4 69.1 19.5 6.0 
110409 67.1 17.9 0.0 70.8 23.9 6.0 71.9 31.0 13.1 68.9 30.4 12.5 
111009 70.5 16.8 0.0 69.9 17.4 0.6 71.6 17.7 0.9 70.3 18.8 2.0 
111109 71.7 15.4 0.0 70.6 18.6 3.2 75.9 20.6 5.2 70.0 23.6 8.2 




Table L.3: Hemodynamics results for all experiments for isolated septal and 
posterior papillary muscle (SPM/PPM) displacement. Abbreviations: Stroke 
Volume (SV), Control Volume (CV), Negative Volume (NV), Tricuspid 
Regurgitation (TR). 






SV CV TR SV NV TR SV NV TR SV NV TR SV NV TR 
92309 71.2 7.1 0.0 73.1 13.9 6.8 67.2 20.7 13.6 71.4 14.8 7.7 69.9 14.4 7.3 
93009 74.4 5.2 0.0 71.6 8.0 2.8 72.1 7.3 2.1 73.6 8.5 3.3 68.6 8.7 3.5 
100709 67.1 9.5 0.0 71.3 11.8 2.3 70.9 12.0 2.5 69.9 13.4 3.9 72.3 13.4 3.9 
102109 70.4 13.5 0.0 68.9 17.5 4.0 69.9 16.1 2.6 68.7 18.8 5.3 71.2 20.6 7.1 
110409 67.1 17.9 0.0 73.2 23.2 5.3 76.2 36.6 18.7 71.2 18.5 0.6 70.5 17.2 -0.7 
111009 70.5 16.8 0.0 69.5 18.7 1.9 69.8 19.0 2.2 68.5 21.2 4.4 69.6 21.3 4.5 
111109 71.7 15.4 0.0 70.5 18.6 3.2 69.9 17.3 1.9 71.8 18.4 3.0 70.6 18.8 3.4 
111309 69.5 18.6 0.0 67.6 23.9 5.3 70.5 26.6 8.0 70.7 21.0 2.4 74.6 25.3 6.7 
 
Table L.4: Hemodynamics results for all experiments for isolated displacement of 
the anterior (APM), septal (SPM) and posterior (PPM) papillary muscles. 
Abbreviations: Stroke Volume (SV), Control Volume (CV), Negative Volume (NV), 




PPM (Posterior+Lateral+Apical) Date 
SV CV TR SV NV TR 
92309 71.2 7.1 0.0 70.5 15.8 8.7 
93009 74.4 5.2 0.0 72.7 9.1 3.9 
100709 67.1 9.5 0.0 73.2 13.7 4.2 
102109 70.4 13.5 0.0 71.7 22.4 8.9 
110409 67.1 17.9 0.0 69.8 31.3 13.4 
111009 70.5 16.8 0.0 70.8 21.3 4.5 
111109 71.7 15.4 0.0 67.3 22.1 6.7 
111309 69.5 18.6 0.0 74.4 26.7 8.1 
 
Hemodynamics: Combined 40% Dilation and PM displacement 
 
Table L.5: Hemodynamics results for all experiments for combined annular 
dilatation (40%) and anterior papillary muscle (APM) displacement. Abbreviations: 
Stroke Volume (SV), Control Volume (CV), Negative Volume (NV), Tricuspid 
Regurgitation (TR). 
Control APM (Lateral) APM (Apical) APM (Apical+Lateral) 
Date 
SV CV TR SV NV TR SV NV TR SV NV TR 
92309 70.3 12.2 0.0 68.5 12.9 0.7 70.5 22.3 10.1 72.5 22.0 9.8 
93009 69.3 8.6 0.0 72.0 9.3 0.7 72.3 10.4 1.8 75.0 11.0 2.4 
100709 71.0 14.8 0.0 67.6 14.6 -0.2 70.4 16.2 1.4 68.9 15.6 0.8 
102109 71.9 17.2 0.0 68.3 21.8 4.6 70.7 21.4 4.2 70.3 24.2 7.0 
110409 69.5 26.6 0.0 61.5 28.8 2.2 69.6 36.5 9.9 70.4 35.2 8.6 
111009 67.9 24.4 0.0 73.5 22.4 -2.0 70.2 22.9 -1.5 68.0 23.5 -0.9 
111109 67.8 22.9 0.0 67.4 26.1 3.2 72.4 28.5 5.6 67.9 32.2 9.3 




Table L.6: Hemodynamics results for all experiments for combined annular 
dilatation (40%) and septal and posterior papillary muscle (SPM/PPM) 
displacement. Abbreviations: Stroke Volume (SV), Control Volume (CV), Negative 
Volume (NV), Tricuspid Regurgitation (TR). 






SV CV TR SV NV TR SV NV TR SV NV TR SV NV TR 
92309 70.3 12.2 0.0 72.5 18.8 6.6 68.8 29.8 17.6 67.1 20.3 8.1 73.2 19.3 7.1 
93009 69.3 8.6 0.0 73.4 12.1 3.5 71.9 13.0 4.4 73.0 13.7 5.1 74.9 13.0 4.4 
100709 71.0 14.8 0.0 69.0 17.6 2.8 68.5 17.9 3.1 69.0 18.9 4.1 70.9 19.4 4.6 
102109 71.9 17.2 0.0 71.1 21.5 4.3 70.4 20.1 2.9 72.9 22.1 4.9 69.5 24.1 6.9 
110409 69.5 26.6 0.0 73.2 30.8 4.2 71.6 45.7 19.1 70.6 26.0 -0.6 73.1 27.5 0.9 
111009 67.9 24.4 0.0 67.1 26.0 1.6 72.3 25.3 0.9 71.6 30.1 5.7 72.1 30.3 5.9 
111109 67.8 22.9 0.0 67.4 24.0 1.1 69.3 23.7 0.8 68.5 27.8 4.9 73.3 28.0 5.1 
111309 70.8 26.1 0.0 68.4 35.8 9.7 68.2 35.3 9.2 68.2 28.4 2.3 73.2 34.1 8 
 
Table L.7: Hemodynamics results for all experiments for combined annular 
dilatation (40%) and displacement of the anterior (APM), septal (SPM) and 
posterior (PPM) papillary muscles. Abbreviations: Stroke Volume (SV), Control 




PPM (Posterior+Lateral+Apical Date 
SV CV TR SV NV TR 
92309 70.3 12.2 0.0 72.6 22.4 10.2 
93009 69.3 8.6 0.0 69.8 14.9 6.3 
100709 71.0 14.8 0.0 70.6 18.9 4.1 
102109 71.9 17.2 0.0 68.2 25.6 8.4 
110409 69.5 26.6 0.0 71.4 37.3 10.7 
111009 67.9 24.4 0.0 67.5 26.5 2.1 
111109 67.8 22.9 0.0 73.5 32.8 9.9 
111309 70.8 26.1 0.0 69.5 41.8 15.7 
 
Hemodynamics: Combined 100% dilation and PM displacement 
 
Table L.8: Hemodynamics results for all experiments for combined annular 
dilatation (100%) and anterior papillary muscle (APM) displacement. 
Abbreviations: Stroke Volume (SV), Control Volume (CV), Negative Volume (NV), 
Tricuspid Regurgitation (TR). 
Control APM (Lateral) APM (Apical) APM (Apical+Lateral) Date 
SV CV TR SV NV TR SV NV TR SV NV TR 
92309 68.5 17.3 0.0 67.9 17.8 0.5 75.1 22.9 5.6 70.2 25.9 8.6 
93009 75.5 13.0 0.0 74.9 13.5 0.5 72.1 15.6 2.6 71.3 15.0 2.0 
100709 75.7 19.2 0.0 74.2 19.6 0.4 75.1 19.7 0.5 75.3 19.9 0.7 
102109 72.8 21.0 0.0 68.8 25.5 4.5 70.5 24.9 3.9 69.6 29.8 8.8 
110409 69.4 30.5 0.0 71.0 32.5 2.0 67.6 38.3 7.8 69.9 38.2 7.7 
111009 68.8 30.6 0.0 71.9 28.8 -1.8 69.4 28.5 -2.1 69.3 28.7 -1.9 
111109 69.3 29.2 0.0 67.5 31.3 2.1 71.1 34.2 5.0 69.3 39.0 9.8 




Table L.9: Hemodynamics results for all experiments for combined annular 
dilatation (100%) and septal and posterior papillary muscle (SPM/PPM) 
displacement. Abbreviations: Stroke Volume (SV), Control Volume (CV), Negative 
Volume (NV), Tricuspid Regurgitation (TR). 






SV CV TR SV NV TR SV NV TR SV NV TR SV NV TR 
92309 68.5 17.3 0.0 72.7 23.3 6.0 68 37.5 20.2 73.3 24.6 7.3 72.3 22.5 5.2 
93009 75.5 13.0 0.0 72.6 17.5 4.5 73.0 17.0 4.0 71.1 17.9 4.9 69.9 17.0 4.0 
100709 75.7 19.2 0.0 72.2 22.0 2.8 70.2 21.5 2.3 69.4 24.4 5.2 69.7 25.3 6.1 
102109 72.8 21.0 0.0 70.4 25.1 4.1 70.1 20.6 -0.4 71.7 25.4 4.4 68.1 28.9 7.9 
110409 69.4 30.5 0.0 72.2 22.5 -8.0 68.5 49.4 18.9 71.4 28.9 -1.6 69.3 31.8 1.3 
111009 68.8 30.6 0.0 70.8 31.2 0.6 70.0 30.1 -0.5 68.1 36.2 5.6 66.4 38.8 8.2 
111109 69.3 29.2 0.0 70.6 31.0 1.8 70.5 30.7 1.5 68.3 34.2 5.0 72.4 32.5 3.3 
111309 69.5 32.8 0.0 67.6 43.1 10.3 68.6 36.6 3.8 68.4 32.1 -0.7 68.6 47.3 14.5 
 
Table L.10: Hemodynamics results for all experiments for combined annular 
dilatation (100%) and displacement of the anterior (APM), septal (SPM) and 
posterior (PPM) papillary muscles. Abbreviations: Stroke Volume (SV), Control 




PPM (Posterior+Lateral+Apical Date 
SV CV TR SV NV TR 
92309 68.5 17.3 0.0 71.6 28.7 11.4 
93009 75.5 13.0 0.0 72.8 20.2 7.2 
100709 75.7 19.2 0.0 73.6 22.3 3.1 
102109 72.8 21.0 0.0 66.5 32.5 11.5 
110409 69.4 30.5 0.0 70.3 41.6 11.1 
111009 68.8 30.6 0.0 63.2 28.6 -2.0 
111109 69.3 29.2 0.0 71.3 38.3 9.1 




Residual Leaflet Length: Isolated Annular Dilatation 
 
Table L.11: Residual leaflet length measurements for all experiments for isolated 
annular dilatation for 0%, 20%, 40%, 60%, 80%, 100%. Abbreviations: Posterior 
Leaflet (P), Septal Leaflet (S), Anterior Leaflet (A). 
Percent Dilatation 
Date 0 20 40 60 80 100 
P S A P S A P S A P S A P S A P S A 
31909 1.2 0.2 1.8 1.0 0.0 1.0 0.8 0.2 0.8 0.8 0.2 0.6 0.8 0.2 0.4 0.6 0.0 0.4 
32109 1.8 1.4 0.6 1.6 1.2 0.4 1.6 0.4 0.4 1.4 0.4 0.4 1.2 0.4 0.0 0.8 0.2 0.0 
32509 2.0 0.8 1.6 1.6 0.6 1.4 1.4 0.6 0.8 1.4 0.4 0.0 1.4 0.2 0.0 1.4 0.2 0.0 
33009 2.0 0.2 1.2 1.8 0.2 1.2 1.6 0.2 0.6 1.6 0.0 0.2 1.6 0.0 0.2 1.4 0.0 0.0 
40109 1.2 0.6 0.8 1.2 0.6 0.2 0.8 0.8 0.2 0.8 0.6 0.2 1.0 0.8 0.2 1.2 0.4 0.0 
40209 1.4 0.8 0.8 1.2 0.6 0.8 1.0 0.6 0.6 1.0 0.4 0.6 1.0 0.6 0.6 0.8 0.6 0.6 
40609 1.0 0.8 1.0 1.0 0.8 0.8 0.8 0.8 0.6 0.8 0.6 0.4 0.6 0.6 0.4 0.6 0.6 0.4 
40909 1.6 1.8 1.0 1.6 1.6 0.8 1.4 1.4 0.2 1.2 1.6 0.2 1.0 1.6 0.2 0.8 1.6 0.0 
 
Residual Leaflet Length: Isolated PM Displacement 
 
Table L.12: Residual leaflet length measurements for all experiments for isolated 
anterior papillary muscle (APM) displacement. Abbreviations: Posterior Leaflet (P), 
Septal Leaflet (S), Anterior Leaflet (A). 
Control 
APM 
Date Lateral Apical Apical+Lateral 
P S A P S A P S A P S A 
92309 1.0 0.6 1.6 1.2 0.6 1.4 0.8 0.6 2.0 1.0 0.2 1.6 
93009 1.4 1.2 1.0 1.4 0.8 1.4 1.6 0.6 1.8 1.6 0.6 1.8 
102109 0.4 2.0 1.0 0.4 1.4 1.2 0.6 1.2 1.0 0.4 1.4 1.0 
110409 0.2 0.6 0.8 0.4 0.6 1.0 0.6 0.8 1.0 0.4 0.8 1.2 
111009 0.6 0.8 0.6 0.4 0.8 0.8 0.4 0.8 1.0 0.8 0.6 1.0 
111309 1.0 1.4 0.8 1.2 1.0 0.8 1.2 1.2 1.0 1.4 0.8 1.0 
120309 1.6 0.8 2.4 1.6 0.6 2.2 1.6 0.8 2.6 1.6 0.8 2.6 
 
Table L.13: Residual leaflet length measurements for all experiments for isolated 
septal (SPM) and posterior (PPM) papillary muscle displacement. Abbreviations: 
Posterior Leaflet (P), Septal Leaflet (S), Anterior Leaflet (A). 
Control 
SPM/PPM 
Date Anterior/Posterior Lateral Apical Anterior/Posterior +Lateral+Apical 
P S A P S A P S A P S A P S A 
92309 1.0 0.6 1.6 1.4 0.4 2.4 1.0 0.0 2.4 1.0 0.2 1.6 1.6 0.4 2.2 
93009 1.4 1.2 1.0 1.8 0.6 1.6 1.8 0.4 1.6 0.2 0.8 1.8 1.6 0.6 2.0 
102109 0.4 2.0 1.0 0.6 2.2 1.0 0.6 1.6 1.2 0.6 2.0 0.6 0.8 1.6 0.4 
110409 0.2 0.6 0.8 0.2 0.6 0.6 0.6 0.4 1.4 0.2 0.6 0.8 0.4 0.6 0.0 
111009 0.6 0.8 0.6 0.6 0.8 0.6 0.6 0.8 0.6 1.0 0.6 0.4 0.6 0.8 0.4 
111309 1.0 1.4 0.8 1.6 0.8 1.2 0.4 1.6 1.0 1.0 1.4 1.2 1.6 0.8 0.8 




Table L.14: Residual leaflet length measurements for all experiments for isolated 
anterior (APM), septal (SPM) and posterior (PPM) papillary muscle displacement. 
Abbreviations: Posterior Leaflet (P), Septal Leaflet (S), Anterior Leaflet (A). 
Control 
APM (Lateral+Apical) 
SPM (Anterior +Lateral+Apical) 
PPM (Posterior+Lateral+Apical) Date 
P S A P S A 
92309 1.0 0.6 1.6 1.6 0.2 2.4 
93009 1.4 1.2 1.0 1.6 0.6 2.2 
102109 0.4 2.0 1.0 1.2 1.2 0.8 
110409 0.2 0.6 0.8 0.4 0.6 1.4 
111009 0.6 0.8 0.6 0.6 0.8 0.6 
111309 1.0 1.4 0.8 2.0 0.6 0.8 
120309 1.6 0.8 2.4 1.6 1.0 2.4 
 
Residual Leaflet Length: Combined 40% Annular Dilatation and PM Displacement  
 
Table L.15: Residual leaflet length measurements for all experiments for combined 
40% dilatation and anterior (APM) papillary muscle displacement. Abbreviations: 
Posterior Leaflet (P), Septal Leaflet (S), Anterior Leaflet (A). 
Control 
APM 
Date Lateral Apical Apical+Lateral 
P S A P S A P S A P S A 
92309 0.6 0.6 1.0 0.8 0.4 1.0 0.8 0.2 1.2 0.6 0.2 1.2 
93009 1.0 1.0 0.2 1.2 0.6 0.4 1.4 0.6 0.4 1.0 0.6 0.6 
102109 0.6 1.8 0.6 0.4 1.2 1.0 0.4 1.2 1.0 0.4 1.4 1.0 
110409 0.0 0.6 0.0 0.2 0.6 0.0 0.4 0.6 0.2 0.4 0.6 0.0 
111009 0.2 0.8 0.4 0.2 0.8 0.6 0.4 0.6 0.6 0.8 0.4 0.6 
111309 1.0 1.0 0.0 1.2 1.0 0.2 1.2 1.0 0.4 1.4 0.8 0.2 
120309 1.4 0.8 1.8 1.6 0.6 1.8 1.6 0.6 2.2 1.6 0.4 2.2 
 
 
Table L.16: Residual leaflet length measurements for all experiments for combined 
40% dilatation and septal (SPM) and posterior (PPM) papillary muscle 




Date Anterior/Posterior Lateral Apical Anterior/Posterior +Lateral+Apical 
P S A P S A P S A P S A P S A 
92309 0.6 0.6 1.0 1.2 0.4 1.6 0.6 0.0 1.2 0.6 0.2 1.4 1.2 0.4 1.8 
93009 1.0 1.0 0.2 0.2 0.2 1.0 0.4 0.2 1.0 0.0 0.8 0.8 1.0 0.4 1.6 
102109 0.6 1.8 0.6 0.4 1.8 0.8 0.6 1.4 0.8 0.4 1.8 0.6 0.6 1.4 0.2 
110409 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.2 0.6 0.0 0.6 0.0 0.2 0.6 0.0 
111009 0.2 0.8 0.4 0.6 0.6 0.4 0.6 0.6 0.4 0.6 0.8 0.4 0.4 1.0 0.4 
111309 1.0 1.0 0.0 1.4 0.8 0.4 0.4 1.2 0.2 1.0 1.2 0.8 1.4 0.8 0.2 




Table L.17: Residual leaflet length measurements for all experiments for combined 
40% dilatation and anterior (APM), septal (SPM) and posterior (PPM) papillary 
muscle displacement. Abbreviations: Posterior Leaflet (P), Septal Leaflet (S), 




PPM (Posterior+Lateral+Apical) Date 
P S A P S A 
92309 0.6 0.6 1.0 1.2 0.2 2.2 
93009 1.0 1.0 0.2 1.0 0.4 1.8 
102109 0.6 1.8 0.6 0.8 1.0 0.6 
110409 0.0 0.6 0.0 0.4 0.4 0.4 
111009 0.2 0.8 0.4 0.6 0.6 0.6 
111309 1.0 1.0 0.0 1.8 0.6 0.2 
120309 1.4 0.8 1.8 1.4 1.0 2.0 
 
Residual Leaflet Length: Combined 100% Annular Dilatation and PM 
Displacement  
Table L.18: Residual leaflet length measurements for all experiments for combined 
100% dilatation and anterior (APM) papillary muscle displacement. Abbreviations: 
Posterior Leaflet (P), Septal Leaflet (S), Anterior Leaflet (A). 
Control 
APM 
Date Lateral Apical Apical+Lateral 
P S A P S A P S A P S A 
92309 0.6 0.2 0.8 0.6 0.4 0.8 0.8 0.0 1.0 0.6 0.2 1.0 
93009 0.8 0.8 0.0 0.4 0.4 0.0 0.8 0.4 0.2 0.8 0.6 0.2 
102109 0.6 1.8 0.6 0.4 1.2 1.0 0.2 1.0 0.8 0.4 1.4 1.0 
110409 0.0 0.6 0.0 0.0 0.6 0.0 0.4 0.6 0.2 0.2 0.4 0.0 
111009 0.2 0.6 0.2 0.0 0.6 0.6 0.4 0.6 0.6 0.4 0.4 0.6 
111309 0.8 1.0 0.0 1.0 0.8 0.2 1.0 0.8 0.2 1.2 0.8 0.2 
120309 1.0 0.6 1.2 1.4 0.4 1.8 1.4 0.4 2.0 1.2 0.4 2.0 
 
Table L.19: Residual leaflet length measurements for all experiments for combined 
100% dilatation and septal (SPM) and posterior (PPM) papillary muscle 




Date Anterior/Posterior Lateral Apical Anterior/Posterior +Lateral+Apical 
P S A P S A P S A P S A P S A 
92309 0.6 0.2 0.8 1.0 0.0 1.0 0.6 0.0 1.2 0.6 0.4 1.0 1.2 0.2 1.2 
93009 0.8 0.8 0.0 0.0 0.2 0.4 0.2 0.2 1.0 0.0 0.4 0.6 0.8 0.4 1.4 
102109 0.6 1.8 0.6 0.2 1.4 0.6 0.6 1.4 0.6 0.4 1.4 0.6 0.6 1.0 0.2 
110409 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.6 0.0 
111009 0.2 0.6 0.2 0.2 0.8 0.2 0.6 0.6 0.2 0.2 0.8 0.2 0.2 0.6 0.2 
111309 0.8 1.0 0.0 1.2 0.8 0.2 0.2 1.0 0.2 0.6 1.2 0.2 1.4 0.8 0.0 




Table L.20: Residual leaflet length measurements for all experiments for combined 
1000% dilatation and anterior (APM), septal (SPM) and posterior (PPM) papillary 
muscle displacement. Abbreviations: Posterior Leaflet (P), Septal Leaflet (S), 




PPM (Posterior+Lateral+Apical) Date 
P S A P S A 
92309 0.6 0.2 0.8 1.2 0.0 1.8 
93009 0.8 0.8 0.0 1.0 0.4 1.8 
102109 0.6 1.8 0.6 0.8 1.0 0.6 
110409 0.0 0.6 0.0 0.4 0.4 0.2 
111009 0.2 0.6 0.2 0.4 0.6 0.4 
111309 0.8 1.0 0.0 1.6 0.6 0.2 
120309 1.0 0.6 1.2 1.4 0.8 1.8 
 
Leaflet Mobility: Isolated Annular Dilatation 
Table L.21: Echocardiograph leaflet mobility measurements for all experiments for 
isolated annular dilatation for 0%, 40%, 100%. Abbreviations: Tenting Height 
(TH), Tenting Area (TA), Septal and Anterior Coaptation (SA), Septal and 
Posterior Coaptation (SP), Anterior and Posterior Coaptation (AP). 
Percent Dilatation 
Date 0 40 100 
TH TA TH TA TH TA 
SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP 
92309 0.7 0.3 0.6 0.6 0.2 0.5 0.3 0.4 0.5 0.2 0.2 0.5 0.2 0.6 0.8 0.2 0.6 0.7 
93009 0.5 0.7 0.8 0.3 0.8 0.6 0.7 0.8 1.0 0.4 0.9 1.0 0.8 0.8 0.8 0.8 1.0 1.1 
100709 0.4 0.3 0.4 0.3 0.1 0.2 0.5 0.3 0.3 0.4 0.3 0.2 0.5 0.3 0.3 0.6 0.3 0.4 
102109 0.7 1.1 0.5 0.3 0.9 0.3 0.8 1.2 0.6 0.7 0.8 0.5 0.8 1.1 0.6 1.0 0.8 0.5 
110409 0.5 0.9 0.4 0.5 0.7 0.2 0.7 0.9 0.6 0.6 0.5 0.5 0.6 0.8 0.6 0.7 0.7 0.4 
111009 0.7 0.8 0.3 0.5 0.6 0.3 0.7 0.7 0.4 0.7 0.6 0.2 0.5 0.8 0.5 0.3 0.4 0.3 
111109 0.5 0.7 0.8 0.5 0.6 1.0 0.5 0.5 1.0 0.3 0.7 1.1 0.7 0.7 0.8 0.7 0.8 1.0 




Leaflet Mobility: Isolated Papillary Muscle Displacement 
Table L.22: Echocardiograph leaflet mobility measurements for all experiments for 
isolated anterior papillary muscle (APM) displacement. Abbreviations: Tenting 
Height (TH), Tenting Area (TA), Septal and Anterior Coaptation (SA), Septal and 
Posterior Coaptation (SP), Anterior and Posterior Coaptation (AP). 
APM 
Date 
Lateral Apical Lateral+Apical 
TH TA TH TA TH TA 
SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP 
92309 0.3 0.4 0.3 0.3 0.3 0.3 0.4 0.4 0.8 0.3 0.3 0.5 0.3 0.3 0.6 0.5 0.4 0.7 
93009 0.9 0.8 0.7 0.9 1.0 0.7 0.9 0.7 0.8 0.8 0.6 0.8 0.7 0.5 0.8 0.6 0.5 0.8 
100709 0.5 0.3 0.3 0.5 0.2 0.1 0.4 0.3 0.6 0.3 0.3 0.5 0.3 0.3 0.5 0.3 0.3 0.5 
102109 1.2 0.9 0.6 0.9 0.7 0.4 1.0 1.1 1.0 1.1 1.0 0.6 1.2 1.2 1.1 1.4 1.0 1.2 
110409 0.5 1.0 0.4 0.4 0.8 0.2 0.5 0.6 0.5 0.4 0.5 0.2 0.7 0.5 0.6 0.6 0.6 0.5 
111009 0.7 0.8 0.6 0.4 0.6 0.6 0.6 0.8 0.7 0.4 0.7 0.5 0.7 0.7 0.7 0.8 0.8 0.6 
111109 0.5 0.6 0.6 0.5 0.5 0.9 0.8 0.4 0.9 0.6 0.3 0.6 1.1 0.4 0.7 0.9 0.3 0.7 
111309 0.6 0.9 0.7 0.3 0.7 0.4 0.7 1.0 0.4 0.3 0.7 0.3 0.8 0.9 0.9 0.4 0.7 0.9 
 
Table L.23: Echocardiograph leaflet mobility measurements for all experiments for 
isolated septal (SPM) and posterior (PPM) papillary muscle displacement. 
Abbreviations: Tenting Height (TH), Tenting Area (TA), Septal and Anterior 




Anterior/Posterior Lateral Apical Anterior/Posterior +Lateral+Apical 
TH TA TH TA TH TA TH TA 
SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP 
92309 0.5 0.4 0.5 0.3 0.5 0.5 0.6 0.5 0.9 0.8 0.7 1.0 0.6 0.6 0.3 0.5 0.8 0.3 0.6 0.4 0.3 0.5 0.6 0.4 
93009 0.9 0.9 0.7 1.1 1.3 0.7 0.9 0.7 0.6 1.0 0.8 1.0 1.1 0.9 0.3 1.3 0.8 0.4 1.1 0.8 0.2 1 0.6 0.2 
100709 0.6 0.4 0.6 0.4 0.3 0.5 0.8 0.6 0.3 0.8 0.6 0.4 0.6 0.8 0.5 0.4 0.8 0.5 1.2 0.8 1.0 0.9 0.9 0.9 
102109 0.9 1.0 0.3 0.4 0.7 0.2 0.7 1.1 0.5 0.7 0.7 0.3 0.7 1.7 0.8 0.3 1.6 0.9 1.0 1.3 0.3 0.7 1.1 0.3 
110409 0.6 0.6 0.5 0.4 0.5 0.3 0.2 0.6 0.6 0.1 0.4 0.3 0.9 0.9 0.5 0.6 0.7 0.3 0.8 0.9 0.5 0.7 1.1 0.5 
111009 0.5 0.8 0.5 0.5 0.5 0.5 0.4 0.6 0.5 0.2 0.5 0.4 0.6 0.6 0.4 0.6 0.5 0.3 0.5 1.2 0.5 0.4 1.0 0.4 
111109 0.8 0.5 0.5 0.6 0.3 0.4 0.8 0.7 0.8 0.5 0.4 0.8 0.5 0.8 0.5 0.7 0.4 0.4 0.7 1.0 1.0 0.5 1.2 1.1 




Table L.24: Echocardiograph leaflet mobility measurements for all experiments for 
isolated anterior (APM), septal (SPM) and posterior (PPM) papillary muscle 
displacement. Abbreviations: Tenting Height (TH), Tenting Area (TA), Septal and 
Anterior Coaptation (SA), Septal and Posterior Coaptation (SP), Anterior and 
Posterior Coaptation (AP). 
APM (Lateral+Apical) 




S/A S/P A/P S/A S/P A/P 
92309 0.4 0.5 0.6 0.4 0.5 0.7 
93009 1.2 0.7 0.6 1.4 0.9 0.8 
100709 0.7 0.7 0.8 1.1 0.7 1.0 
102109 1.2 1.1 0.4 0.8 1.0 0.3 
110409 1.0 1.0 0.8 1.0 0.9 0.6 
111009 1.1 1.1 0.9 1.4 1.4 0.9 
111109 1.0 0.9 0.9 0.6 0.9 0.9 
111309 0.8 1.1 0.9 0.8 1.1 0.3 
 
Leaflet Mobility: Combined 40% Annular Dilatation and PM Displacement 
Table L.25: Echocardiograph leaflet mobility measurements for all experiments for 
combined 40% dilatation and anterior papillary muscle (APM) displacement. 
Abbreviations: Tenting Height (TH), Tenting Area (TA), Septal and Anterior 




Lateral Apical Lateral+Apical 
TH TA TH TA TH TA 
SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP 
92309 0.3 0.3 0.5 0.3 0.2 0.6 0.5 0.6 1.0 0.6 0.7 1.2 0.4 0.5 0.8 0.4 0.5 0.8 
93009 0.7 0.5 0.7 0.7 0.4 0.9 1.1 0.4 1.1 1.3 0.4 1.4 0.9 0.3 1.2 0.9 0.4 1.1 
100709 0.4 0.3 0.3 0.4 0.2 0.2 0.5 0.4 0.6 0.5 0.5 0.6 0.4 0.4 0.4 0.3 0.4 0.5 
102109 1.2 1.0 0.7 1.2 0.8 0.7 1.2 0.9 1.0 1.6 0.8 0.8 1.4 0.9 0.9 1.2 1.0 1.1 
110409 0.4 0.8 0.4 0.4 0.5 0.2 0.3 0.5 0.6 0.3 0.4 0.7 0.2 0.4 0.6 0.1 0.3 0.5 
111009 0.7 0.8 0.4 0.5 0.7 0.5 0.6 0.9 0.7 0.4 0.8 0.9 0.6 0.7 0.8 0.7 0.7 0.7 
111109 0.7 0.6 0.9 0.7 0.6 1.3 0.8 0.4 0.9 0.5 0.3 0.7 0.5 0.6 0.7 0.3 0.3 0.6 




Table L.26: Echocardiograph leaflet mobility measurements for all experiments for 
combined 40% dilatation and septal (SPM) and posterior (PPM) papillary muscle 
displacement. Abbreviations: Tenting Height (TH), Tenting Area (TA), Septal and 
Anterior Coaptation (SA), Septal and Posterior Coaptation (SP), Anterior and 
Posterior Coaptation (AP). 
SPM/PPM 
Date 
Anterior/Posterior Lateral Apical Anterior/Posterior +Lateral+Apical 
TH TA TH TA TH TA TH TA 
SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP 
92309 0.5 0.3 0.6 0.5 0.4 0.5 0.5 0.3 0.4 0.6 0.3 0.6 0.6 0.5 0.7 0.6 0.7 0.7 0.8 0.4 0.7 1.2 0.5 0.6 
93009 0.9 0.7 0.7 0.6 0.9 0.8 0.7 0.3 0.3 0.6 0.3 0.4 0.6 0.9 0.7 0.4 0.7 0.8 1.1 1.1 0.1 0.8 1.0 0.1 
100709 0.7 0.7 0.5 0.6 0.7 0.7 0.6 0.7 0.4 0.7 0.5 0.5 0.7 1.1 0.6 0.7 1.0 0.9 0.9 1.0 0.5 0.9 0.9 0.7 
102109 1.3 0.9 0.3 1.1 0.7 0.2 0.6 0.8 0.6 0.6 0.7 0.4 0.9 1.6 0.6 0.7 1.2 0.7 1.2 1.4 0.5 0.8 1.0 0.7 
110409 0.9 0.9 0.5 0.8 0.6 0.5 0.2 0.6 0.6 0.2 0.4 0.5 0.9 1.0 0.5 1.0 0.8 0.3 1.0 0.9 0.6 0.8 1.2 0.5 
111009 0.6 0.8 0.4 0.3 0.6 0.2 0.5 0.7 0.4 0.4 0.7 0.6 0.9 0.9 0.4 0.7 1.0 0.2 0.9 1.1 0.5 0.7 1.0 0.3 
111109 0.5 0.7 0.6 0.4 0.7 0.6 0.7 0.5 0.8 0.5 0.4 0.6 0.7 0.6 0.6 0.5 0.3 0.5 0.9 1.0 1.1 0.7 1.2 1.4 
111309 0.7 1.4 0.8 0.5 1.2 0.7 0.8 1.0 0.8 0.4 0.6 0.5 0.8 1.0 0.7 0.4 0.8 0.3 1.0 1.3 0.9 0.6 0.7 0.5 
 
Table L.27: Echocardiograph leaflet mobility measurements for all experiments for 
combined 40% dilatation and anterior (APM), septal (SPM) and posterior (PPM) 
papillary muscle displacement. Abbreviations: Tenting Height (TH), Tenting Area 
(TA), Septal and Anterior Coaptation (SA), Septal and Posterior Coaptation (SP), 
Anterior and Posterior Coaptation (AP). 
APM (Lateral+Apical) 




SA SP AP SA SP AP 
92309 0.8 0.5 0.6 1.1 0.4 0.6 
93009 1.0 0.7 1.1 0.7 0.7 1.1 
100709 0.9 0.8 0.6 0.8 1.0 0.7 
102109 1.5 1.2 0.9 1.6 1.1 0.9 
110409 0.7 0.8 0.8 0.8 1.2 0.9 
111009 1.1 0.9 0.9 1.3 0.8 1.1 
111109 0.8 0.8 0.9 0.6 0.9 1.0 




Leaflet Mobility: Combined 100% Annular Dilatation and PM Displacement 
Table L.28: Echocardiograph leaflet mobility measurements for all experiments for 
combined 100% dilatation and anterior papillary muscle (APM) displacement. 
Abbreviations: Tenting Height (TH), Tenting Area (TA), Septal and Anterior 




Lateral Apical Lateral+Apical 
TH TA TH TA TH TA 
SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP 
92309 0.5 0.3 0.7 0.7 0.5 1.2 0.5 0.4 1.1 0.4 0.5 1.3 0.5 0.5 1.1 0.4 0.4 1.5 
93009 0.7 0.9 0.4 0.5 0.8 0.3 1.2 0.4 1.0 1.5 0.2 1.2 0.9 0.5 1.1 1.0 0.4 1.6 
100709 0.4 0.3 0.2 0.3 0.1 0.2 0.5 0.4 0.7 0.5 0.4 0.9 0.4 0.6 0.5 0.5 0.8 0.8 
102109 0.8 1.1 0.9 0.8 0.9 0.8  1.2 1.2 1.2 2.1 1.1 1.4 
110409 0.4 0.7 0.4 0.4 0.6 0.4 0.2 0.6 0.7 0.3 0.4 0.6 0.3 0.6 0.8 0.3 0.5 0.8 
111009 0.5 0.8 0.4 0.3 0.8 0.3 0.2 0.7 0.7 0.1 0.7 0.8 0.6 0.6 0.7 0.6 0.6 0.8 
111109 0.6 0.7 0.9 0.4 0.5 1.4 0.5 0.9 1.1 0.5 0.4 1.1 1.0 0.7 1.0 1.2 0.9 1.3 
111309 1.1 1.3 0.5 0.8 1.0 0.3 1.0 1.1 0.8 0.8 1.0 1.0 0.9 1.1 0.5 0.6 1.2 0.3 
 
Table L.29: Echocardiograph leaflet mobility measurements for all experiments for 
combined 100% dilatation and septal (SPM) and posterior (PPM) papillary muscle 
displacement. Abbreviations: Tenting Height (TH), Tenting Area (TA), Septal and 
Anterior Coaptation (SA), Septal and Posterior Coaptation (SP), Anterior and 
Posterior Coaptation (AP). 
SPM/PPM 
Date 
Anterior/Posterior Lateral Apical Anterior/Posterior+Lateral+Apical 
TH TA TH TA TH TA TH TA 
SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP SA SP AP 
92309 0.6 0.5 0.9 0.8 0.7 1.0 0.9 0.2 0.6 0.9 0.1 0.8 0.6 0.5 0.7 0.8 0.5 0.7 0.6 0.4 0.8 0.5 0.6 0.7 
93009 0.9 0.7 0.6 1.0 0.8 1.0 0.9 0.4 0.4 0.6 0.4 0.4 1.1 0.9 0.2 1.3 1.0 0.4 1.1 1.2 0.2 0.8 1.4 0.1 
100709 0.8 0.6 0.3 0.8 0.6 0.4 0.9 0.6 0.5 0.7 0.5 0.5 0.7 0.8 0.2 0.6 0.8 0.2 0.7 0.6 0.4 0.7 0.5 0.3 
102109 1.1 1.2 0.4 1.0 0.8 0.4 0.6 0.9 0.7 0.4 0.4 0.6 1.1 1.4 0.7 1.1 1.3 1.0 1.1 1.2 0.5 0.8 1.1 0.6 
110409 0.8 1.0 0.5 0.6 0.9 0.5 0.2 0.6 0.7 0.2 0.5 0.7 0.8 0.8 0.4 1.1 0.7 0.3 1.1 0.7 0.5 1.2 1.1 0.5 
111009 0.7 0.9 0.4 0.3 0.6 0.3 0.5 0.6 0.6 0.2 0.5 0.7 1.1 1.2 0.2 0.8 1.1 0.1 1.0 1.1 0.5 0.8 0.8 0.3 
111109 0.6 0.9 0.6 0.5 0.8 0.4 0.7 0.8 0.7 0.7 0.7 0.5 0.7 0.6 0.6 0.7 0.3 0.5 0.9 1.1 1.0 0.8 1.4 1.4 




Table L.30: Echocardiograph leaflet mobility measurements for all experiments for 
combined 100% dilatation and anterior (APM), septal (SPM) and posterior (PPM) 
papillary muscle displacement. Abbreviations: Tenting Height (TH), Tenting Area 
(TA), Septal and Anterior Coaptation (SA), Septal and Posterior Coaptation (SP), 
Anterior and Posterior Coaptation (AP). 
APM (Lateral+Apical) 




SA SP AP SA SP AP 
92309 0.8 0.7 0.9 1.0 0.7 1.4 
93009 1.0 0.8 1.2 0.9 1.0 1.2 
100709 0.7 0.7 0.5 0.7 0.8 0.9 
102109 1.2 1.4 0.9 1.3 1.4 0.9 
110409 1.0 0.9 1.1 1.6 1.1 1.3 
111009 1.1 1.3 0.8 1.0 1.7 1.3 
111109 0.9 0.9 1.1 1.1 0.8 1.0 




Chordal Forces: Isolated Annular Dilatation 
Table L.31: Chordal force measurements for all experiments for isolated annular 




Marginal Intermediate Strut Marginal Intermediate Strut 
0  0.118 0.065 0.061 0.334 41510 
100  0.221 0.129 0.083 0.345 
0  0.429 0.017 0.749 42210 
100  0.961 0.046 0.961 
0 0.007 0.651 0.027 0.068 0 
52510 
100 0.037 0.808 0.085 0.172 0 
0 0.027 0.087 0 0.025  52710 
100 0.245 0.373 0 0.539  
0  0.105 0.946 0.036 0.565 60110 
100  0.369 1.315 0.114 0.598 
0 0.002 0.009 0.017 1.057 
60210 
100 0.018 0.017 0.034 1.071 
0  0.011 0.971 0.369 0.389 60310 
100  0.029 1.259 0.618 0.465 
0  0.715 60810 
100  0.989 
0 0.019 0.037 0.406 0.236 0.008  61010 
100 0.427 0.148 0.47 0.596 0.032  
0 0.098 0.078 0.049 0.197 0.267 
61510 
100 0.344 0.254 0.189 0.33 0.433 
0  0.174 0.143 0.023 0.407 61610 
100  0.374 0.276 0.112 0.788 
0  0.907 0.016  61710 
100  1.501 0.024  
0 0.103 0.019 0.008  62210 
100 0.296 0.021 0.038  
0 0.012  62310 
100 0.331  
0  0.22 0.146  62410 
100  0.334 0.24  
0 0.021  70710 




Chordal Force: Isolated PM Displacement 
Table L.32: Marginal chordal force measurements for all experiments for isolated 
displacement of the anterior (APM) papillary muscle and all papillary muscles 
(Anterior, APM, Septal, SPM, Posterior, PPM). Abbreviations: Anterior Leaflet 
(A), Posterior Leaflet (P). 
Control 
APM APM (Apical+Lateral) 
SPM (Anterior+Apical+Lateral)  
PPM (Posterior+Apical+Lateral) Date Apical Lateral Apical+Lateral 
A P A P A P A P A P 
41510 0.065 0.071 0.201 0.145 0.126 
42210 0.017 0.026 0.039 0.034 0.035 
52510 0.007 0.027 0.013 0.03 0.01 0.022 0.024 0.047 0.027 0.05 
52710 0.027 0.025 0.018 0.315 0.027 0.496 0.048 0.428 0.049 0.199 
60210 0.002 0 0.002 1E-03 0.002 
61010 0.019 0.236 0.004 0.223 0.005 0.15 0.069 0.266 0.008 0.173 
61510 0.098 0.049 0.093 0.07 0.099 0.078 0.108 0.059 0.141 0.063 
61710 0.016 0.011 0.016 0.035 0.023 
622/10 0.103 0.008 0.115 0.009 0.1 0.005 0.041 0.018 0.025 0.008 
62310 0.012 0.331 0.115 0.213 0.106 
62410 0.146 0.102 0.072 0.07 0.064 
70710 0.021 0.089 0.09 0.034 0.142 
 
Table L.33: Intermediate chordal force measurements for all experiments for 
isolated displacement of the anterior (APM) papillary muscle and all papillary 
muscles (Anterior, APM, Septal, SPM, Posterior, PPM). Abbreviations: Anterior 
Leaflet (A), Posterior Leaflet (P). 
Control 
APM APM (Apical+Lateral) 
SPM (Anterior+Apical+Lateral) 
PPM (Posterior+Apical+Lateral) Date Apical Lateral Apical+Lateral 
A P A P A P A P A P 
41510 0.061 0.041 0.104 0.08 0.046 
52510 0.068 0.139 0.092 0.148 0.195 
52710 0.087 0.134 0.088 0.15 0.191 
60110 0.105 0.036 0.018 0.097 0.022 0.154 0.004 0.116 0.034 0.1 
60210 0.009 0.017 0.004 0.014 0.002 0.01 0.002 0.015 0.011 0.049 
60310 0.011 0.369 0.006 0.228 0.015 0.107 0.007 0.073 0.005 0.07 
61010 0.037 0.008 0.005 0.004 0.029 0.008 0.164 0.01 0.274 0.013 
61510 0.078 0.197 0.036 0.324 0.038 0.349 0.08 0.227 0.044 0.194 
61610 0.174 0.023 0.187 0.005 0.169 0.006 0.223 0.052 0.448 0.03 
622/10 0.103 0.011 0.025 0.005 0.025 
62310 0.193 0.161 0.242 0.058 0.09 




Table L.34: Strut chordal force measurements for all experiments for isolated 
displacement of the anterior (APM) papillary muscle and all papillary muscles 
(Anterior, APM, Septal, SPM, Posterior, PPM). Abbreviations: Anterior Leaflet 
(A), Posterior Leaflet (P). 
Control 
APM APM (Apical+Lateral)  
SPM (Anterior+Apical+Lateral)  
PPM (Posterior+Apical+Lateral) Date Apical Lateral Apical+Lateral 
A P A P A P A P A P 
41510 0.118 0.334 0.116 0.367 0.025 0.4 0.066 0.37 0.038 0.575 
42210 0.429 0.749 0.416 0.874 0.461 0.617 0.509 0.882 0.39 1.12 
52510 0.651 0.609 0.625 0.694 0.552 
60110 0.946 0.565 0.772 0.479 0.784 0.193 0.528 0.442 1.044 0.708 
60210 1.057 1.127 0.834 1.056 0.889 
60310 0.971 0.389 1.206 0.47 0.567 0.363 1.195 0.477 1.432 0.459 
60810 0.715 0.827 0.727 0.499 1.224 
61010 0.406 0.362 0.44 0.443 0.463 
61510 0.267 0.352 0.379 0.246 0.544 
61610 0.143 0.407 0.261 0.929 0.285 0.527 0.185 0.232 0.468 0.72 
61710 0.907 0.946 0.897 0.845 2.02 
 
Chordal Force: Combined 100% Annular Dilatation and PM Displacement 
Table L.35: Marginal chordal force measurements for all experiments for combined 
100% annular dilatation and displacement of the anterior (APM) papillary muscle 
and all papillary muscles (Anterior, APM, Septal, SPM, Posterior, PPM). 
Abbreviations: Anterior Leaflet (A), Posterior Leaflet (P). 
Control 
APM APM (Apical+Lateral) 
SPM (Anterior+Apical+Lateral) 
PPM (Posterior+Apical+Lateral) Date Apical Lateral Apical+Lateral 
A P A P A P A P A P 
41510 0.129 0.125 0.144 0.191  0.187 
42210 0.046 0.042 0.033 0.054  0.04 
52510 0.037 0.085 0.019 0.039 0.022 0.045 0.025 0.058 0.025 0.069 
52710 0.245 0.539 0.146 0.468 0.243 0.77 0.103 0.603 0.069 0.713 
60210 0.018 0.002 0.001 0.002 0.052  
61010 0.427 0.596 0.244 0.526 0.34 0.374 0.562 0.534 0.449 0.59 
61510 0.344 0.189 0.327 0.192 0.348 0.204 0.475 0.264 0.329 0.212 
61710 0.024 0.021 0.024 0.05  0.035 
62210 0.296 0.038 0.211 0.014 0.285 0.014 0.041 0.018 0.06 0.017 
62410 0.24 0.225 0.111 0.19  0.107 




Table L.36: Intermediate chordal force measurements for all experiments for 
combined 100% annular dilatation and displacement of the anterior (APM) 
papillary muscle and all papillary muscles (Anterior, APM, Septal, SPM, Posterior, 
PPM). Abbreviations: Anterior Leaflet (A), Posterior Leaflet (P). 
Control 
APM APM (Apical+Lateral) 
SPM (Anterior+Apical+Lateral) 
PPM (Posterior+Apical+Lateral) Date Apical Lateral Apical+Lateral 
A P A P A P A P A P 
41510 0.083 0.065 0.067 0.099 0.087 
42210 
52510 0.172 0.194 0.154 0.207 0.33 
52710 0.373 0.289 0.395 0.27 0.202 
60110 0.369 0.114 0.159 0.138 0.209 0.184 0.055 0.221 0.118 0.161 
60210 0.017 0.034 0.003 0.016 0.01 0.024 0.002 0.02 0.006 0.057 
60310 0.029 0.618 0.021 0.379 0.027 0.173 0.021 0.219 0.009 0.152 
60810 
61010 0.148 0.032 0.049 0.007 0.069 0.004 0.297 0.014 0.344 0.058 
61510 0.254 0.33 0.218 0.458 0.193 0.464 0.392 0.375 0.197 0.4 
61610 0.374 0.112 0.359 0.063 0.42 0.057 0.427 0.094 0.691 0.094 
61710 
62210 0.021 0.022 0.011 0.005 0.013 
62410 0.334 0.327 0.346 0.359 0.193 
 
Table L.37: Strut chordal force measurements for all experiments for combined 
100% annular dilatation and displacement of the anterior (APM) papillary muscle 
and all papillary muscles (Anterior, APM, Septal, SPM, Posterior, PPM). 
Abbreviations: Anterior Leaflet (A), Posterior Leaflet (P). 
Control 
APM APM (Apical+Lateral) 
SPM (Anterior+Apical+Lateral) 
PPM (Posterior+Apical+Lateral) Date Apical Lateral Apical+Lateral 
A P A P A P A P A P 
41510 0.221 0.345 0.227 0.375 0.014 0.314 0.055 0.394 0.116 0.533 
42210 0.961 0.961 0.634 1.146 0.716 0.973 0.829 1.359 0.523 1.394 
52510 0.808 0 1.067 0 0.92 0 1.238 0 1.088 0 
52710 0 0 0 0 0 
60110 1.315 0.598 1.469 0.7 1.098 0.302 1.183 0.438 1.105 0.665 
60210 1.071 1.365 0.857 1.235 0.966 
60310 1.259 0.465 1.15 0.466 0.902 0.418 1.187 0.486 1.554 0.549 
60810 0.989 1.11 0.826 0.816 1.369 
61010 0.47 0.537 0.606 0.44 0.402 
61510 0.433 0.538 0.549 0.373 0.674 
61610 0.276 0.788 0.52 1.309 0.489 0.988 0.199 0.314 0.587 1.086 







LIST OF VIDEOS 
 
 Included in this section is the list of videos for the in vitro analysis of both 




(In Vitro DVD 1) Folder: Residual Leaflet Length: 
Folder: Isolated Annular Dilatation: 
Folder: 031909 (All conditions are contained within single video) 
Folder: 032109 (All conditions are contained within single video) 
Folder: 032509 (All conditions are contained within single video) 
Folder: 033009 (All conditions are contained within single video) 
Folder: 040109 (All conditions are contained within single video) 
Folder: 040209 (All conditions are contained within single video) 
Folder: 040609 (All conditions are contained within single video) 
Folder: 040909 (All conditions are contained within single video) 
Folder: PM Displacement (Isolated and Combined) 
Folder: 092309 (All conditions are contained within this folder) 
Folder: 093009 (All conditions are contained within this folder) 
Folder: 102109 (All conditions are contained within this folder) 
Folder: 110409 (All conditions are contained within this folder) 
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Folder: 111309 (All conditions are contained within this folder) 
Folder: 120309 (All conditions are contained within this folder) 
 
Echocardiograph: 
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